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ABSTRACT 
               
            In nanopore analysis, peptides and proteins can be detected by the change in current 
when single molecules interact with an α-hemolysin pore embedded in a lipid membrane.  
Studies into the effects of fluorenylmethoxycarbonyl (Fmoc), acetylation or proline 
modification to negatively charged α-helical peptides showed that Fmoc peptides give more 
translocations than acetylated peptides.  The addition of a proline in the middle of an acetylated 
peptide further reduces the number of translocations compared to Fmoc.  The effect of peptide 
conformation on translocation or intercalation was studied with small α-helical and β-sheet 
hairpins.  The capped β-hairpin increased translocations compared to the uncapped.  The Fmoc-
α-helical hairpin, containing a disulfide link, displayed both bumping and translocations 
whereas in the unlinked peptide the proportion of translocations was greater. 
            Prion diseases arise from the misfolding and aggregation of the normal cellular prion 
protein.  Nanopore analysis of prion peptides with α-helical and β-strand sequences show 
changes to the event parameters that help distinguish them.  The interaction of bovine prion 
protein (bPrP), with α-hemolysin showed both bumping (type-I) and intercalation/translocation 
(type-II) events.  There are several lines of evidence that indicate these type-II events with a 
blockade current of -65 pA for bPrP, represent translocations.  Nanopore analysis showed that 
about 37% events were translocations.  The interaction of metal ions with bPrP showed that 
Cu(II) or Zn(II) reduced translocations.  Surprisingly, Mn(II) caused an increase in 
translocation events to about 64%.   
            Complex formation between antibodies and prion peptides and proteins can be detected 
by nanopore analysis.  The PrP/antibody complex is too large to translocate whereas the event 
parameters for unbound molecules are unchanged.  In principle, a nanopore can detect a single 
molecule; thus, this work represents the first step towards the development of a prion detector.  
The nanopore will provide the sensitivity and the antibodies will provide the specificity to 
distinguish between PrP
C
 and PrP
Sc
.   Also, the prion N- and C-terminal signal peptides interact 
with bPrP changing the event parameters, relating to a new mechanism.  Finally, the folding 
intermediates of bPrP at 0.86 M Gdn-HCl suggests that the protein unfolds and then refolds into 
a different conformation with event parameters similar to those of bPrP. 
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1.0   INTRODUCTION 
 
            The first attempts made by Wallace Henry Coulter to patent his invention the “Coulter 
principle” was turned down by attorneys who believed “you cannot patent a hole” (Graham, 
2003).  Today the Coulter-counter (Beckman Instruments, Inc., Fullerton, CA) is the most 
essential and common analytical tool used in medical laboratories around the world for 
counting and sizing particles in sample testing.  Nanopore analysis uses the same sensing 
principle as Coulter-counters, except that the small aperture in the counter is replaced with a 
nanoscale channel (Bayley and Martin, 2000).  Today, nanopore analysis is a useful tool for the 
study of single molecules. 
            In nanopore analysis, individual molecules can be detected by the change in ionic 
current when they interact with a nanopore (Kasianowicz et al., 1996).  Nanoscale channels are 
of two types.  The first are natural protein pore toxins such as α-hemolysin and the second type 
are synthetic nanoscale pores manufactured on inorganic material such as silicon nitride, silicon 
dioxide, and organic material.  The initial work included the analysis of DNA and RNA by 
David Deamer and Daniel Branton (Deamer and Branton, 2002).  Subsequently, the detection 
of peptides, proteins, enzymes, organic polymers, and many other small molecules followed.  
Recently an engineered α-hemolysin channel with a covalently lodged adapter was able to 
discriminate all four DNA bases with 99% accuracy (Clarke et al., 2009).  This achievement 
suggests that sequencing of DNA with single nanopores will be possible in the future (Deamer 
and Akeson, 2000; Marziali and Akeson, 2001; Clarke et al., 2009).  In another vein, nanopore 
analysis of peptides and proteins in Jeremy Lee’s laboratory has demonstrated the ability to 
detect conformational changes due to interactions with the α-hemolysin pore (Sutherland et al., 
2004b; Stefureac et al., 2006, 2008; Stefureac and Lee, 2008). 
            In principle, a nanopore can detect a single molecule; thus, this method may be useful to 
identify and quantify infectious particles present in very low concentrations in biological 
samples.  Prion diseases are infectious, neurodegenerative disorders caused by a change in 
protein conformation (Prusiner, 1982).  The disease has a long incubation period in addition to 
having a very low amount of infective molecules in the blood during the pre-symptomatic 
period.  It has been estimated that only 60,000 infectious molecules are present in 100 µl of 
rodent blood.  This number is much lower in humans and cattle (Soto, 2004).  Nanopore 
detection of prion proteins could be useful to develop an electrophoretic prion detector.  
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Therefore the introduction of this thesis will focus on the development of the nanopore 
technique, types of pores, and the large spectrum of molecules analyzed using nanopore 
analytics.  To integrate the development of an electrophoretic prion detector, an introduction on 
prions including the present methods used in prion diagnostics will also be discussed.   
 
1.1     Single-molecule analysis using nanopores 
 
 
1.1.1    Origin of single-channel current recording 
 
The Coulter-counter patented in 1953 by W.H.  Coulter opened the door to an exciting 
new area of research, the analysis of nanoscale particles (Coulter, 1953).  The simplicity in 
method and operation of this counter made it tremendously popular as a device used to count 
and size small particles present in various scientific fields.  The Coulter-counter (Beckman 
Coulter, Fullerton, CA) is routinely used in medical laboratories around the world, mainly for 
blood cell, spermatozoa, and platelet counts and more recently in the areas of human 
immunodeficiency virus (HIV) transmission from mother to child and also to assess the number 
of cell nuclei in cancer cell lines (Ramon et al., 1999; Hwa et al., 1999; Bhat and Gartel, 2008; 
Mehta et al., 2009).  The Coulter-counter consists of two chambers filled with electrolyte 
solution connected by an aperture of 20 µm to 2 mm (Coulter, 1953; Bayley and Martin, 2000).  
The addition of electrodes to each chamber with an applied potential across the chamber 
(Figure 1.1a) drives an ionic current through the aperture (Henriquez et al., 2004).  When a 
particle having a size on the order of the aperture diameter enters the channel, it reduces the 
magnitude of the ionic current (Henriquez et al., 2004).  During the residence time of the 
particle in the aperture, the aperture resistance increases.  This increase in aperture resistance 
corresponds to an increase in transaperture voltage drop (Bayley and Martin, 2000).  Coulter-
counter results may be easily presented with a plot of current vs. time (Figure 1.1b), for a string 
of ionic current pulses (Henriquez et al., 2004).   
            The pulse height relates to molecular size and the width of the current pulse measured as 
time may under some conditions determine the charge carried by the molecule (DeBlois and 
Bean, 1970; Sun and Crooks, 2000; Henriquez et al., 2004).  The surface charge of a molecule 
can be determined if the geometry and chemical characteristics of the channel are well defined.  
The number of particles can be reasonably calculated using the frequency of the current pulses  
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Figure 1.1   The general experimental set up of a Coulter-counter.  (a) Schematic diagram of an 
electric field-driven Coulter-counter consisting of two chambers filled with electrolyte solution, 
divided by an insulating membrane that contains a single channel.  When an appropriate 
potential is applied across the membrane, an ionic current is driven through the channel.  (b) 
Typical Coulter-counter data which is recorded as a series of current pulses (Δic) and 
represented in a plot of current vs. time.  (Reprinted by permission from Henrquez et al., 2004.  
Copyright 2004 Royal Society of Chemistry).   
 
 
 
 
4 
 
in an experiment.  The pulse height depends mainly on the volume of electrolyte displaced 
when the molecule interacts with the aperture.  An increase in solution resistance is observed 
but is quickly reversed when the molecule traverses the aperture (Henriquez et al., 2004).  
Coulter-counters can be used to analyze very low concentrations of analyte as only one particle 
enters the sensing zone at any given time.  In the early years these counters could only size 
particles between 2% to 40% of aperture diameter, meaning that below 2%, the signals were 
overcome by electronic noise and above 40% they blocked the aperture (McCave and Syvitski, 
2007).  The mathematical relationship between particle size and ionic current is shown as:  
                                                     ∆ic  ∕ ic  = S(dc,ds) .  ds
3 ∕ lc.dc
2                       Equation 1.1 
 
where ∆ic is the pulse height, ic is the open channel current, ds is the diameter of a spherical 
particle, dc is the channel diameter, S (dc,ds) is the correction factor that depends on ds and dc, 
and lc is the channel width.  The channel length, lc’ is calculated after the correction due to the 
“end effect” ( lc’= lc + 0.8 dc)
3 
(Henriquez et al., 2004).  This equation can be very useful when 
analyzing smaller molecules using very small apertures (DeBlois and Bean, 1970; Henriquez et 
al., 2004).   
            The principle of voltage clamping was first developed by K.S.  Cole in the 1950’s (Cole, 
1965).  Following this, an introductory study involving the measure of membrane potentials 
was first published in 1972 (Katz and Miledi, 1972).  This group analyzed the membrane noise 
caused due to drug-receptor interactions.  They investigated the neurotransmitter, acetylcholine 
(ACh), which is released by neurons and is an essential factor for signaling between neurons 
and muscle, at neuromuscular junctions (Picciotto et al., 2002).  ACh once released, binds to 
the acetylcholine receptor located on the endplate of muscle fibers, which then responds by 
opening the ligand-gated sodium ion channels (Martyn et al., 2009).  These experiments were 
conducted using micro-electrodes on regions of frog sartorius muscle fiber in response to the 
application of ACh (Katz and Miledi, 1972).  A significant drawback in these experiments was 
that when single channels open or close the discrete changes in conductance were not properly 
measured due to excessive background noise.  The study of the flow of ions across membranes 
which is facilitated by ion channels, transporters, pumps, co-transporters/exchangers, and 
electrogenic transporters paved the way for single-channel current measurements (Hille, 1992).  
Hladky and Haydon were able to record the opening and closing of channels formed by 
gramicidin A (peptide antibiotic) on planar bilayers (Hladky and Haydon, 1970).  The first 
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successful recording of single-channel currents on intact biological membranes was established 
by Erwin Neher and Bert Sakman using membrane regions of denervated frog muscle fibers 
(Neher and Sakmann, 1976).  These experiments were conducted by limiting the membrane 
area to a small patch and thereby decreasing background membrane noise.  This method was 
improved and is known as the “patch clamp” technique which is widely used in the field of 
electrophysiology (Hamil et al., 1981; Neher and Sakmann, 1992). 
            Ion channels, a subset of proteins which span the lipid bilayer membranes, include 
several bacterial toxins and outer membrane proteins (Gouaux, 1997; Sansom, 1999).  These 
proteins regulate the flow of ions by a mechanism known as gating (opening and closing of the 
channel) due to external factors such as voltage, hormones, neurotransmitters, Ca
+2
,  and 
phosphorylation (Molleman, 2008).  The gating mechanisms are caused by a change in protein 
conformation of the channel (Franco-Obregón and Lansman, 2002; Grosman, 2003; Wan et al., 
2004).  Nanopore analyses measures current changes using the same principle as Coulter-
counters which represent resistive-pulse sensing (Howorka and Siwy, 2009a).  By contrast, 
nanopore analytics use artificial membranes to reconstitute pores as compared to biological ion 
channels which measure the gating of many channels in cell membranes (Montal and Mueller, 
1972).  Also the ionic current changes recorded in nanopore analysis are due to molecules 
interacting with the pore via steric or electrostatic effects.  In biological ion channels, analytes 
specifically bind the channel and cause conformational changes in the protein channel which 
then changes the magnitude of the ionic current (Bezrukov and Kasianowicz, 1997; Nestorovich 
et al., 2002).   
 
1.1.2    The principle of single-molecule detection with nanopores 
            Single-molecule nanopore detection is a simple technique for the analysis of individual 
molecules using the same principle as Coulter-counters.  In Coulter-counters, particles are 
counted and sized (Coulter, 1953).  Nanopore analysis uses the same sensing principle (Figure 
1.2) and records molecular movement through a channel as short modulations of electrical 
conductance (Bayley and Martin, 2000; Marziali and Akeson, 2001; Deamer and Branton, 
2002; Howorka and Siwy, 2009b).  This simple technique comprises a biological, inorganic or 
polymeric membrane with a single nanopore inserted into it.  The nanoscale channel could be a 
biological toxin or a solid-state pore.  The nanoscale channel connects the two chambers filled  
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Figure 1.2   The principle of nanopore recording.  (A) Schematic diagram showing the applied 
potential drives a constant flow of ionic current (KCl) through a single-channel.  (B) Shows 
molecules that interact and pass through the pore cause temporary current blockades which are 
quickly reversed when the molecule traverses the channel.  (C) Shows current fluctuations 
caused by the reversible binding of analytes to specifically engineered binding sites on the 
channel.  I and t represent blockade current and  duration respectively. (Reprinted by 
permission from Howorka and Siwy, 2009b.  Copyright 2009 Springer Science + Business 
Media, LLC).   
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with electrolyte solution.  An electrode is immersed in each chamber and connects a 
potentiostat that sets a transmembrane potential which drives an ionic current through the 
nanopore (Howorka and Siwy, 2009b).  Most channels conduct constant open pore currents 
(Figure 1.2A) and when molecules are added to one chamber they traverse the pore leading to 
transient conductance blockades (Figure 1.2B).  If specific binding sites in relation to the 
analyte are engineered on the pore, these current modulations are reflected with constant 
channel blocks (Figure 1.2C). 
            The most attractive benefit in using this method is that the molecules being analyzed are 
label free and need not be immobilized on a solid surface.  Most other single-molecule methods 
including in vitro fluorescence, fluorescent probes, atomic force microscopy, optical traps, and 
magnetic traps need analytes labeled and immobilized (Selvin and Ha, 2008).  Due to its 
simplicity, nanopore analysis offers a relatively cheap and less complex pathway to analyze 
single molecules.  Another attractive feature is that nanopores are usually blank pores that do 
not bind analytes, but artificially engineered pores can be designed to bind specific analytes for 
experimental purposes (Kasianowicz et al., 1999; Wu et al., 2007).  Nanopore analytics can be 
used to study a variety of features including chemical, physical, electrostatic and kinetic 
properties in a wide range of molecules.  Among bacterial toxins, the α-hemolysin (αHL) pore 
is currently the most popular biological channel for nanopore analysis (Song et al., 1996).  
Today, the most common biological nanopore apparatus (Figure 1.3) consist of a single αHL 
channel inserted in a planar lipid membrane of diphytanoyl phosphatidylcholine (DPhPC: 
C48H96NO8P) (Akeson et al., 1999a, b; Meller et al., 2001).  The chambers are filled with 1 M 
KCl, and a steady voltage is applied across the membrane.  The αHL channel has a steady open 
pore current of 120 pA at a voltage of 120 mV (Deamer and Branton, 2002).  The conductance 
is monitored by an Axopatch 200B amplifier (Axon Instruments, Union city, CA) using Ag-
AgCl electrodes.  When single-molecules interact with the αHL channel, translocation is driven 
by an electric field across the channel (Meller et al., 2001).   
            For example, it has been possible to detect and characterize single stranded ribonucleic 
acid (RNA) and deoxyribonucleic acid (DNA) through αHL pores (Kasianowicz et al., 1996; 
Akeson et al, 1999a, b; Henrickson et al., 2000).  Furthermore, homopolymers containing 
cytosine (C) and adenosine (A) show different blockade patterns suggesting that sequencing of 
DNA with single nanopores will be possible in the future (Deamer and Akeson, 2000; Marziali 
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Figure 1.3   A common biological nanopore apparatus.  Diphytanoyl phosphatidylcholine 
(C48H96NO8P) is painted across the teflon support to separate two chambers.  Each chamber is 
filled with KCl buffer.  A single αHL pore is inserted into the planar lipid bilayer and a 
transmembrane potential causes a constant flow of ionic current through the single αHL 
channel.  Nanopore analysis of negatively charged single stranded DNA molecules is added and 
they are electrically driven through the pore.  (Reprinted by permission from Meller et al., 
2001.  Copyright 2001 American Physical Society).   
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and Akeson, 2001; Clarke et al., 2009).  Nanopores have also been used to detect the 
translocation of charged polypeptides (Movileanu et al., 2005; Stefureac et al., 2006).  
Chemically modified αHL pores have been used to detect the binding of tetravalent lectin and 
study the kinetics of protein-ligand interaction (Howorka et al., 2004).  Furthermore, the 
investigation of full-length proteins in the presence and absence of a denaturing agent has been 
successfully accomplished using an αHL channel.  The maltose binding protein (MBP) does not 
translocate in the absence of guanidinium chloride (Gdn-HCl), but in presence of concentrations 
greater than 0.8 M Gdn-HCl, the protein starts to unfold and displays well defined current 
blockades (Oukhaled et al., 2007). 
 
1.1.3   Pores 
 
1.1.3.1   Biological pore-forming toxins 
 
            The most widely used molecular-scale nanopore toxin, α-Hemolysin (αHL), has also 
proven to be the most successful pore for the initial groundbreaking work for single-molecule 
analysis of nucleic acids (Song et al., 1996; Kasianowicz et al., 1996; Akeson et al., 1999a; 
Meller et al., 2000; Deamer and Branton, 2002; Lin et al., 2010).  α-Hemolysin secreted by 
staphylococcus aureus is a self-assembling 232 kDa  β-barrel pore-forming toxin (βPFT) that 
forms transmembrane channels (Aksimentiev and Schulten, 2005).  A 293 residue long 
polypeptide monomer assembles to form a mushroom-shaped, heptameric pore consisting of a 
14 stranded β-barrel stem (Bhakdi et al., 1981; FÜssle et al., 1981; Song et al., 1996).  α-
Hemolysin causes a number of human diseases which involve cell lysis and hemolytic activity 
by the leakage of ions, water, and low molecular weight molecules.  The toxin can insert into 
cells such as human blood monocytes or platelets (May et al., 1996; Menestrina et al., 2001).  
The conductance of αHL has a linear dependence with solution conductivity and suggests a 
water-filled channel (Menestrina, 1986).  The single channel conductance of αHL in 1 M KCl is 
~ 0.8 nS at 22ºC (Wong et al., 2006).  The αHL channel contains a hydrophilic interior and a 
hydrophobic exterior and the conductance of the αHL channel increases with decreasing pH 
(Kasianowicz and Bezrukov, 1995; Song et al., 1996).  The αHL pore remains as an open 
channel in concentrated KCl solutions which is very advantageous for biosensing (Menestrina, 
1986; Korchev et al., 1995a; Bashford et al., 1996).   
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            The crystal structure of αHL was solved in 1996 (Song et al., 1996).  The external 
dimensions of αHL are 100 Å in height and 100 Å in diameter (Figure 1.4) (Song et al., 1996).  
The mushroom-shaped pore consists of a cap concealing a vestibule which is connected to the 
β-barrel stem of approximately 50 Å in height and a diameter of 15 Å at its narrowest 
constriction (Figure 1.4A).  The vestibule which lies entirely outside the membrane spans from 
14 Å to 46 Å in diameter and the β-barrel stem forms the transmembrane domain which inserts 
into the lipid bilayer (Figure 1.4B) (Song et al., 1996).  Figure 1.4C depicts the dimensions of 
the αHL channel:  the cap has a 26 Å diameter at the cis entrance, 36 Å in the internal cavity, 15 
Å at the inner constriction, containing a ring of lysine and glutamate residues, and 22 Å at the 
trans entrance of the stem (Deamer and Branton, 2002).  The suitability of αHL for single-
molecule analysis is due to several features.  First, it forms ionic channels with a well-defined 
conductance in neutral and negatively-charged membranes at a wide range of pH (Menestrina, 
1986).  Second, the assembly of αHL is temperature dependent and is stable up to 50ºC while 
the transmembrane pore remains open without gating from 15ºC to 50ºC (Belmonte et al., 1987; 
Meller et al., 2000).  Third, αHL channels form spontaneously in biological or synthetic lipid 
bilayers giving a unitary conductance which can only fluctuate under low salt concentrations 
(Korchev et al., 1995a, b).  This is advantageous for the analysis of molecules that can cause 
changes in the current blockade.  Wild-type αHL (wt-αHL) is considered a blank pore that lacks 
any intrinsic ability to bind analytes.  However genetically engineered pores can be designed to 
bind specific analytes and αHL has an added benefit due to its homo-heptameric assembly.  
This means that a single mutation in one subunit can be multiplied seven fold when the pore 
assembles (Bayley, 1999; Kasianowicz et al., 1999; Clark et al., 2009; Banerjee et al., 2010).   
            Aerolysin, secreted from the gram-negative bacteria Aeromonas hydrophila, was 
identified in 1974 and is a human pathogen that causes gastroenteritis, deep wound infection 
and meningitis (Bernheimer and Avigad, 1974; Chakraborty et al., 1987).  Though the channel-
forming toxin aerolysin was known to form ion channels in planar lipid bilayers in voltage-
clamped experiments, its use in single-molecule detection was only recently confirmed with the 
analysis of the translocation of negatively charged helical peptides (Wilmsen et al., 1991, 1992; 
Stefureac et al., 2006).  The interaction of aerolysin with erythrocyte-membranes is mediated 
by specific binding to a glycoprotein receptor followed by the formation of channels and 
selective permeabilization of small ions, such as potassium and calcium (Howard and Buckley, 
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Figure 1.4 Representation of the heptameric α-hemolysin pore using ribbon diagrams and a 
general configuration of the pore.  (A) Shows the side view approximately parallel to the 
membrane and (B) shows the top view.  The seven monomers that form the heptameric channel 
are represented in different colors.  (c) Shows a cross section of the α-hemolysin pore, using 
general configurations for nanopore analysis, where 10 Ångstroms (Å) = 1 nm.  PDB ID: 
7AHL.  (Reprinted by permission from Song et al., 1996.  Copyright 1996 AAAS; Deamer and 
Branton, 2002.  Copyright 2002 ACS).   
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1982; Abrami et al., 2000).  The protein was purified in 1981 and is secreted as an inactive 
precursor proaerolysin, having a molecular weight of 52 kDa (Buckley et al., 1981; van der 
Goot et al., 1993).  The precursor is activated by a proteolytic nicking of ~ 25 amino acids from 
the carboxy terminus (Howard and Buckley, 1985; van der Goot et al., 1992, 1994a, b).  The 
gene coding aerolysin designated as aerA has been cloned, expressed, and sequenced with most 
of the sequence being unrelated to the αHL toxin (Chakraborty et al., 1986; Howard and 
Buckly, 1986; Howard et al., 1987).  The activated aerolysin binds to cell surface receptors via 
glycosylphosphatidyl inositol (GPI) anchors and oligomerizes into heptameric rings that insert 
holes in the membrane (Garland and Buckley, 1988; Parker et al., 1994; Fivaz et al., 1999).  
Oligomerization of aerolysin decreases with increasing pH and the rate of channel formation is 
effective between a pH range of 6.5 to 8.5 (Buckley et al., 1995).  The transmembrane region of 
aerolysin has a β-barrel configuration and the turn of the β-hairpin composed of five 
hydrophobic residues drives membrane insertion of the oligomerized channel (Lacovache et al., 
2006).   
             The proaerolysin dimer has a crystal structure (2.8 Å resolution) that adopts a 
hydrophobic environment between monomer-monomer interfaces (Parker et al., 1994).  Based 
on this crystal structure, an electron micrograph model of the aerolysin channel was described 
(Figure 1.5).  The model of the aerolysin oligomer presents a wheel-like structure which lies 
entirely outside the membrane and a stem like central cylindrical section which presumably 
inserts into the lipid bilayer to form channels very similar in size as those of αHL (Figure1.5b 
and Figure 1.5d) (Parker et al., 1994).  The wheel-like cap does not contain a vestibule as in 
αHL, but has a well defined diameter of 140 Å and is 30-40 Å thick (Figure 1.5a and Figure 
1.5c).  The central cylindrical transmembrane channel has a diameter of approximately 17 Å 
and is 70 Å in height (Wilmsen et al., 1992; Parker et al., 1994).  In voltage-clamp experiments, 
aerolysin maintained a homogeneous ionic current and the channels remained open between -70 
mV to +70 mV.  The channels switch between open and closed states in a voltage-dependent 
manner regardless of polarity outside the previously mentioned voltage range.  At a constant 
membrane voltage of +50 mV, the open pore current of one aerolysin channel was 21 pA with a 
conductance of 420 pS (Wilmsen et al., 1990, 1991). 
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Figure 1.5 Image of the heptameric aerolysin channel derived from electron microscopy. 
(a) Shows the electron microscopy of the channel when viewed down onto the membrane 
surface.  (b) Shows a side view of the channel from electron microscopy.  (c) & (d) Show a top 
view and a side view of the channel, respectively, with the seven monomers that form the 
heptameric channel represented in a different color.  PDB ID: 1PRE.  (Reprinted by permission 
from Parker et al., 1994.  Copyright 1994 Nature Publishing Group). 
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            MspA is the major porin in Mycobacterium smegmatis (Trias and Benz, 1994).  
Mycobacterium porin A has been purified, cloned, and sequenced with data showing that MspA 
is a channel-forming protein with properties different from those of gram-negative bacteria 
(Niederweis et al., 1999).  MspA is the main channel-forming protein that maintains the 
hydrophilic pathway and mediates the diffusion of hydrophilic nutrients in Mycobacterium 
smegmatis (Stahl et al., 2001; Niederweis, 2003).  The X-ray structure of MspA reveals a 
homooctameric goblet-like monomeric association with a single channel having an 
approximately  1 nm wide constriction at the limiting aperture (Figure 1.6).  Each subunit which 
forms the octamer in MspA consists of a 134-residue globular domain which builds the thick 
rim of the goblet and a 50-residue loop that forms the stem of the channel.  MspA contains two 
consecutive β-barrels having a width of 37 Å which form a ribbon around the porin.  The β-
barrels are composed of nonpolar outer surfaces.  The external dimensions of MspA are 96 Å in 
height and up to 88 Å in diameter (Figure 1.6A).  The channel’s internal diameter varies 
between 10 to 48 Å (Figure 1.6B) (Faller et al., 2004).  MspA oriented with the mouth of the 
goblet on the cis compartment  and the stem  embedded in a lipid bilayer has a single channel 
conductance of 4.9 nS in 1 M  KCl at  20ºC  with a positive voltage of 60 mV applied to the 
trans compartment.  Above an applied voltage of 60 mV, MspA demonstrates frequent and 
spontaneous blockades (Butler et al., 2008).  The constricted region of MspA contains three 
negatively charged residues of aspartic acid which prevent the translocation of single stranded 
DNA (ssDNA).  The replacement of these three residues with asparagines allowed the 
translocation of ssDNA through MspA and also permitted all four DNA nucleotides to be 
distinguished (Derrington et al., 2010).  MspA may prove to be an important pore for nanopore 
DNA sequencing in the future.   
     Gram-negative bacteria contain a number of channels known as porins in their outer 
membrane that assist in the passage of ions and nutrients for cell survival.  Some of the major 
outer membrane proteins (Omp) from Escherichia coli include OmpF, OmpC, and PhoE that 
are all trimers and allow the free diffusion of small (<600 Da) molecules (Conlan et al., 2000; 
Conlan and Bayley, 2003).  OmpG is also an outer membrane porin obtained from Escherichia 
coli, but is monomeric in structure (Fajaro et al., 1998).  OmpG forms a 14 stranded β-barrel 
(β1–β14) with seven extracellular loops (L1-L7) and short periplasmic turns (Yildiz et al., 
2006).  Early studies using proteoliposome swelling assays that measure the pore forming   
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Figure 1.6 Structure of MspA.  (A) Shows the channel lining in black which reveals a goblet 
like shape.  The dimensions are given in Ångstroms (Å).  (B) Shows the top view, from the 
external compartment.  Green represents polar and yellow represents nonpolar amino acid 
residues.  PDB ID: 1UUN.  (Reprinted by permission from Faller et al., 2004.  Copyright 2004 
AAAS).   
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activity showed that OmpG forms large channels with a diameter of approximately 20 Å 
(Fajardo et al., 1998).  The crystal structure for the monomeric porin OmpG was solved in 2006 
and has its largest diameter of 20-22 Å at the periplasmic exit (Figure 1.7A) (Subbarao and van 
den Berg, 2006).  The constriction of this channel is mainly established due to the side chains of 
the residues that line the wall of the barrel pointing inwards and not due to the surface loops 
protruding inwards (Figure 1.7B).  The approximately circular shaped OmpG has a diameter of 
~13 Å at the constriction zone and is much larger than other porins (Subbarao and van den 
Berg, 2006).  The conductance of OmpG in 1 M KCl is ~ 0.8 nS and is similar to the 
conductance of a αHL channel (Wong et al., 2006; Conlan et al., 2000).  The OmpG channel 
closure occurs at pH values below 7 and voltages above ±100 mV, suggesting that it has a 
gating mechanism which is voltage-dependent and pH-dependent (Conlan et al., 2000; Conlan 
and Bayley, 2003).  The monomeric structure of OmpG and its orientation in planar lipid 
bilayers to form channels like αHL may show future prospects as a biosensor (Chen et al., 
2008a, b).  However, due to the spontaneous gating of wild-type OmpG, site-directed 
mutagenesis was performed on the pore resulting in a 95% reduction in gating activity.  This 
variant form of OmpG was introduced with two modifications.  Firstly, the flexibility of the L6 
loop was reduced by the addition of a disulfide bond between β-strands 12 and 13.  Secondly, 
the deletion of residue D215 caused an increase in hydrogen bonding between β11 and β12.  
Then a cyclodextrin molecular adopter was fitted to the mutated OmpG, which could be used to 
detect adenosine diphosphate (ADP) (Chen et al., 2008b).   
There are many other biological nanopores that are rarely used in biosensing, but may 
serve as important channels for future applications (Majd et al., 2010).  Gramicidin A secreted 
by the bacterium Bacillus brevis is a channel forming peptide with a molecular weight of 1.9 
kDa (Hladky and Haydon, 1970; Stankovic et al., 1989).  Gramicidin A spontaneously inserts 
into lipid bilayers and forms an amino terminal-to-amino terminal helical dimeric channel that 
conducts ionic current (Wallace, 1986; Woolley and Wallace, 1992).  The use of Gramicidin A 
as a biosensor was first demonstrated by Cornell and co-workers by linking antibodies to this 
channel (Cornell et al., 1997).  The lipid bi-layer containing gramicidin A (attached to 
antibody) was tethered to a gold electrode.  When an antigen binds the antibody, gramicidin A 
no longer conducts (Cornell et al., 1997).  In another study, the pore formed by Bacillus 
anthracis PA63 protein, forms a heptameric ion channel in planer lipid bilayers (Nablo et al.,  
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Figure 1.7 Structure of OmpG.  (A) Shows OmpG viewed from the plane of the membrane  and  
(B) shows a  top view.  Loops L1 to L7 are shown in orange strings.  PDB ID: 2F1C.  
(Reprinted by permission from Subbarao and van den Berg, 2006.  Copyright 2006 Elsevier 
Ltd). 
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2008).  The limiting diameter of PA63  is < 2 nm and features a much narrower channel than 
αHL (Nablo et al., 2008).  A single channel of PA63 displays an ionic current of ~ 4 pA at +50 
mV.  The introduction of the lethal factor (LF) protein completely blocked this channel current 
(Halverson et al., 2005).  In the future, the detection of low level toxins for anthrax in animal 
blood may be possible (Halverson et al., 2005).  Furthermore, the maltoporin trimer was 
subjected to a single-channel study in the presence of differently sized maltodextrins (Kullman 
et al., 2002).  It was shown that only one molecule of maltohexose is required to completely 
block one pore in the maltoporin trimer (Kullman et al., 2002).  Finally, alamethicin and 
melittin which form helix bundles  in planer lipid bilayers have also been used in single-channel 
experiments but will probably have limited applications (Majd et al ., 2010). 
 
 
1.1.3.2   Genetically engineered protein pores 
            Engineered protein pores are extremely useful for specific tasks in nanopore analysis.  
The most widely engineered pore is αHL, while others such as MspA and OmpG pores have 
also been subjected to mutation (Chen et al., 2008b; Derrington et al., 2010).  Variant αHL 
pores were synthesized by replacing five glycine residues (residue 130-134) with histidine 
residues in an effort to detect divalent metal ions.  The addition of 100 µM of Zn(II) caused 
current blockades in this mutant (Walker et al., 1994; Kasianowicz et al.,1999).  Similarly, a 
cluster of imidazole side chains was introduced within the lumen of αHL by replacing residues 
123, 125, 133, and 135 with histidines serving as binding sites for Zn(II), Co(II), and other 
divalent metal ions (Braha et al., 1997).  Bayley and co-workers also designed several other 
mutants of αHL that caused Zn(II) induced current blockades which varied with divalent cation 
concentration (Bayley, 1999; Kasianowicz et al., 1999).   
 Wild-type αHL was also subjected to site directed mutagenesis, where a single 
oligonucleotide was covalently attached to a cysteine residue within the lumen of the pore, to 
form a “DNA-nanopore” complex (Howorka et al., 2001a, b).  Following the addition of 
ssDNA which binds the tethered DNA, changes in ionic current blockades were observed 
(Howorka et al., 2001a, b).  Engineered αHL pores have also been used to try and develop a 
method for DNA sequencing.  For example, a mutant αHL, (M113R)7 fitted with a cyclodextrin 
adapter near the constriction of the pore, was able to recognize all four DNA bases with distinct 
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levels of current blockades (Astier et al., 2006).  In another approach, single stranded DNA 
(ssDNA) was immobilized within an engineered αHL pore that contained substituted residues 
E111N and K147N (Stoddart et al., 2009, 2010).  The capture of this ssDNA was through an 
applied potential and translocation was hindered due to a biotin tag at the 3’ terminus of the 
DNA that in turn formed a complex with streptavidin.  The recognition of all four DNA bases 
in this immobilized ssDNA strand was possible using this variant pore (Stoddart et al., 2009, 
2010).  In a further attempt to sequence DNA using nanopores, Bayley and co-workers used an 
engineered form of αHL that contained substituted residues at M113R/N139Q/L135C (Figure 
1.8a) (Clarke et al., 2009).  This substituted channel also contained a covalently attached 
cyclodextrin adapter at position 135 that was able to discriminate all four DNA base pairs with 
99% accuracy (Figure 1.8b) (Clarke et al., 2009).  Furthermore, recently the translocation of 
double stranded DNA (dsDNA) at pH 11.7 was investigated using an engineered αHL pore at 
residue M113R, where arginine would remain protonated under alkaline conditions (Maglia et 
al., 2009).  The strand separation of dsDNA at pH 11.7 promoted translocation of DNA through 
this mutated pore (Maglia et al., 2009).   
            Two variants of the MspA pore, M1MspA (D90N/D91N/D93N) and M2MspA 
(D90N/D91N/D93N/D118R/D134R/E139K) were investigated with electrophoretically driven 
ssDNA (Butler et al., 2008).  The rate of ssDNA blocking was ~ 20 times faster for M2MspA 
than M1MspA, which was due to the additional exchange of negatively-charged to positively-
charged residues at D118R/D134R/E139K (Butler et al., 2008). 
            In a different approach, protein-ligand interactions were investigated in the presence of a 
lectin (class of sugar binding proteins) using a αHL pore modified with cysteine residues that 
were tethered to a natural ligand disaccharide (Howorka et al., 2004).  Lectin caused reversible 
binding to this tethered ligand-receptor which produced transient current blockades (Howorka 
et al., 2004).  In addition, the kinetics of peptide-protein channel interactions have also been 
investigated using engineered αHL pores (Zhao et al., 2009).  Two variants of αHL, M113F and 
M113F/K147N/T145F, were investigated in an effort to evaluate the effect of protein channel 
architecture on peptide translocation (Zhao et al., 2009).   The results indicated that stronger 
binding affinities between the peptide and protein pore correlates with an increase in aromatic 
binding sites within the pore (Zhao et al., 2009). 
           In another vein, the αHL pore has also been engineered to detect second messengers 
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Figure 1.8   Structure of the mutated αHL pore.  (a) Shows cyclodextrin attached at position 
135 and 139.  (b) Shows a close-up of the β-barrel with mutated residues.  Substituted residues 
are stated in single amino acid codes (for example: L135C denotes Lys- 135 replaced by Cys).  
(Reprinted by permission from Clarke et al., 2009.  Copyright   2009 Nature Publishing Group). 
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such as inositol 1,4,5 trisphosphate (IP3) (Cheley et al., 2002).  Engineered αHL with 
substituted residues at M113R and T145R containing a ring of 14 arginine residues near the 
constriction area of the pore permitted the detection of IP3 at nanomolar concentrations (Cheley 
et al., 2002).  In another study, engineered pores were also used to distinguish small chiral 
molecules of ibuprofen and thalidomide (Kang et al., 2006).  For this purpose, a β-cyclodextrin 
adapter lodged into an engineered αHL pore that contained substituted residues M113F and 
K147N produced a distinct current signal for each bound molecule (Kang et al., 2006).  A 
similar strategy has also been used for the stochastic sensing of terrorist agents such as 
trinitrotoluene (TNT), organophosphorus nerve gas, organic arsenicals, and mustard gas using 
engineered αHL pores (Liu et al., 2010).  α-Hemolysin variants M113F and M113F/K147N 
were incorporated with a β-cyclodextrin adaptor and used for the detection of TNT and 
organophosphorus nerve gases, respectively (Guan et al., 2005).  Finally, the addition of a 
cysteine residue at position 117 allowed the monitoring of organic arsenicals and mustard gas 
through covalent interactions (Wu and Bayley, 2008; Wang et al., 2009).   
 
1.1.4    Protein pores in planar lipid membranes 
 
One of the main problems with biological nanopores is that they have to be first inserted 
into a planar lipid bilayer in contrast to solid-state nanopores which are generated on synthetic 
membranes.  The main concern is the stability of the lipid bilayer into which the biological pore 
is inserted.  For single-molecule analysis, first an artificial lipid bilayer is made across an ~ 100 
µm diameter orifice made from teflon having a thickness of 25 µm.  Smaller apertures ranging 
from 20 µm to 150 µm have also been used for these experiments (Kasianowicz et al., 1996; 
Akeson et al., 1999b; Braha et al., 2000; Meller et al., 2000; Sutherland et al., 2004a).  The 
pore is then added to the chamber holding the planer lipid bilayer filled with an electrolyte 
solution.  Random pore insertion into the lipid bilayer occurs within a short time.  However, the 
time taken for single-channel insertion as well as multiple pore insertions that cause membrane 
rupture are the main drawbacks in this method.  Flushing out excess protein pores is one 
approach that helps reduce multiple channel insertions.  On the other hand, single-channel 
insertions can be enhanced by using a mechanical probe coated with pores fitted on an agarose 
gel that helps to insert a single pore (Holden and Bayley, 2005).  Another method involves the 
use of a sharp glass tip, dipped into a bacterial colony expressing membrane proteins which is 
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then driven into an artificial lipid bilayer using a micromanipulator (Holden et al., 2006).  Also, 
polymerisable phospholipids, such as 1-palmitoyl-2-10,12 tricosadiynoyl-sn-glycero-3-
phosphoethanolamine (PTPE), enhance membrane stability  after channel insertion  due to the 
formation of lipid cross-links (Shenoy et al., 2005).  Other methods for membrane stability 
include the use of 100 to 400 nm diameter wide glass nanopipettes coated with 3-
cyanopropyldimethylchlorosilane which link the membrane through the hydrophobic tail of the 
lipid (Atanasov et al., 2005, 2006; White et al., 2007).   
 
1.1.5     Solid-state pores 
The possibility of longer recording hours and conducting experiments within a wide 
range of pH and temperatures has recently made the use of synthetic nanopores popular for 
single-molecule analysis.  Charles Martin’s laboratory was the first to develop synthetic 
membranes made from polycarbonate filters that contained monodispersed Au nanotubes with 
internal diameters of less than 1 nm (Jirage et al., 1997).  Further development using reversible 
electromodulation methods on the inner wall of this Au nanotube permitted the transport of 
neutral molecules (Lee and Martin, 2002).  The fabrication of 5 nm diameter solid-state pores 
on  silicon nitride (Si3N4) membranes using ion-beam sculpture capable of identifying a 500 
base pair dsDNA molecule was first developed in 2001 ( Li et al., 2001, 2003).  The technique 
using argon ion-beam sputtering is a two stage process.  First, a bowl-shaped cavity or a single 
hole of ~ 0.1 µm is made on a Si3N4 membrane using reactive ion etching (RIE) or  a focused 
ion beam (FIB) (Li et al., 2001).  RIE is a process that incorporates an electron beam focused 
onto a Si3N4 membrane that uses a chemically reactive etch of CHF3/O2 to remove material 
from Si3N4 (Ralls et al., 1989).  FIB uses a focused beam of gallium ions that can be directed on 
to a membrane to create a hole (Nagoshi et al., 2009).  At the end of the first step, an argon ion-
beam is used to remove material from a Si3N4 membrane with a cavity (Li et al., 2001).  
Second, a feed-back controlled argon ion-beam is then used to laterally deposit material onto 
the pore until the desired pore size is reached (Figure 1.9a) (Li et al., 2001).   
            Dekker and co-workers used silicon oxide (SiO2) to manufacture single pores with   
diameters between 20 nm and 200 nm (Figure 1.9b) (Dekker, 2007).  SiO2 layered on both sides 
of a free standing silicon membrane is first subjected to electron beam lithography and RIE to 
form squares up to 500 nm in dimension (Dekker, 2007).  Finally, anisotropic KOH  
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Figure 1.9    Methods used in the fabrication of solid-state nanopores.  (a) Shows the use of 
ion-beam sputtering and feed-back controlled ion-beam sculpting used on Si3N4 membranes as 
shown in Li et al., 2001.  (b) Shows the method of transmission electron microscope (TEM) 
used on SiO2 membranes to develop 3 nm diameter pores.  (Reprinted by permission from 
Dekker, 2007.  Copyright 2007 Nature Publishing Group).   
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wet etching is used to make pyramid-shaped holes.  Anisotropic wet etching is a process used to 
etch along preferred crystallographic directions and is mainly used to attack silicon which then 
produces an anisotropic V-etched shaped side wall (Bachman, 1999; Holly and Hingerl, 2006).  
To fine tune the desired pore size, the pore is shrunk using a transmission electron microscope 
(TEM) with a 300 kV electron beam (Storm et al., 2003; Dekker, 2007).   
The advantage of using solid-state pores at high pH values is clearly shown in the 
analysis of denatured dsDNA to ssDNA at pH values above 11.6 using a 4 nm diameter Si3N4 
pore (Fologeo et al., 2005).  Translocation of DNA was mostly as single strands (Fologeo et al., 
2005).  Nanopores are also manufactured by the track-etching technique, which first irradiates 
the membrane with heavy ions such as Xe, Pb, Au and U, followed by subsequent chemical 
etching.  Polymer films such as polyethylene, terephthalate (PET), polyimide (PI) and 
polycarbonate (PC) are some of the widely used membranes.  Generally, chemical etching for 
PET uses 9M aqueous NaOH at room temperature and sodium hypochlorite (NaOCl) at 50ºC 
(Siwy et al., 2003; Howorka and Siwy 2009b).   
            A further modification in making solid-state pores was the development of conically 
shaped nanopores.  Ionic current and the resulting transmembrane voltage drop are concentrated 
near the tip of the sensing zone which is advantageous for single-molecule sensing (Harrell et 
al., 2006).  Gold-plated conical nanopores have been used as a biosensor for the detection of 
protein antibody complexes (Siwy et al., 2005).  More modifications to conical nanopores 
prepared in PET include the coating of a thin film of Au which is sandwiched between two Ti 
adhesion layers and insulated with SiO2.  The Au layer functions as a “gate electrode” because 
it is connected to a generator while the membrane voltage is applied.  The change in the 
transport of ions at the entrance of this conical nanopore is thought to be due to the 
concentration depletion that is induced by the metal gate (Kalman et al., 2009). 
           It has also been possible to chemically modify Si3N4 based solid-state pores to enhance 
single-molecule detection.  For example, the deposition of aluminium oxide (Al2O3) onto the 
inner walls of the pore reduced the electrical noise and increased the DNA capture rate 
(Venkatesan et al., 2009).  Another modification included the deposition of Ti/Au on the inner 
walls of the pore to form metalized pores which subsequently demonstrated the translocation of 
λ DNA that interacted with the metallic pore (Wei et al., 2010).  More recently, a solid-state 
pore made from Al2O3 with surface properties that help in the reduction of velocity in DNA 
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translocations was developed by Bashir and co-workers (Venkatesan et al., 2009, 2010).  
Finally, the incorporation of solid-state pores with nanopore force spectroscopy helped detect 
the capture and dissociation of molecular complexes (Tabard-cossa et al., 2009).  For this 
purpose, a 3 nm diameter Si3N4 pore was put under constant applied forces between 400-900 
mV to determine the bond lifetime spectrum of the biotin-neutravidin complex.  The long ionic 
current blockades suggest that a stable complex is formed between biotin and neutravidin.  
These ionic blockades are diminished when the complex dissociates (Tabard-cossa et al., 2009).   
   
1.2   Detection of individual molecules 
 
1.2.1   Nanopore analysis of nucleic acids 
 
1.2.1.1 DNA 
 
            Deamer and co-workers reported the first data on the translocation of nucleic acids 
through αHL pores, where the duration of the current blockades was proportional to polymer 
length and inversely proportional to the applied voltage (Kasianowicz et al., 1996).  DNA 
polymers were analyzed to examine the effects of temperature and secondary structure on the 
process of translocation.  A translocation duration of 120 µsec and 330 µsec was recorded for 
(dC)100  and (dA)100 at 22ºC,  which increased to 200 µsec and 650 µsec, respectively, when the  
temperature was decreased to 15ºC, providing clear discrimination between (dC)100  and 
(dA)100.  Pyrimidine polymers, (dC)100  and (dCdT)50 also showed a 50% difference in 
translocation duration values at 15ºC, thus indicating that low temperature enhances  sensitivity 
(Kasianowicz et al., 1996).  In another study, an increase in temperature reduced the 
translocation duration of DNA polymers, (dA)100, (dC)100, (dA)50(dC)50, (dAdC)50, (dC)50(dT)50, 
and (dCdT)50 (Meller et al., 2000).  At lower temperatures, such as 5ºC, poly(dA)100 forms an 
extensively stacked structure which then transforms into a random coil when the temperature is 
increased to 50ºC.  A decrease in translocation duration is seen with increased temperature 
which corresponds to translocations that are temperature dependent in relation to secondary 
structure formation (Meller et al., 2000: Deamer and Branton, 2002).  In nanopore analysis, the 
capture and translocation of DNA strands are electrophoretically driven by the voltage applied 
across the membrane, provided the voltage drives anions from that side into the pore 
(Henrickson et al 2000; Meller and Branton, 2002; Nakane et al., 2002).  Also, the use of 
engineered αHL pores by site-directed mutagenesis, which increased the positive charges inside 
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the pore, showed a 10 fold increase in the translocation frequency as compared to wt-αHL 
(Maglia et al., 2008).  Studies of a captured ssDNA inside the αHL pore suggest a strong 
dependency on strand orientation.  For example, the 3’-end DNA entry into the pore produces a 
larger current blockade as compared to the 5’-end threading into the pore (Mathe et al., 2005).   
            Further studies on DNA hairpins with varying compositions (number of base pairs in the 
stem, number of base mismatches, and varying loop length) show that the stem of the hairpin 
has to first unzip to translocate as an extended strand (Vercoutere et al., 2001).  In another 
study, the discrimination of hairpins based on the number of base pairs and individual 
nucleotides at the terminal ends were also possible (DeGuzman et al., 2006).  In a different 
approach, the unzipping of dsDNA and the identification of mismatched DNA pairs can also be 
analyzed with αHL pores (Sutherland et al., 2004a).  In this study, a 50-base Guide strand that 
contained a 10-base probe was hybridized with a 10-base target sequence that contained up to 3 
mismatches.  Complementary dsDNA took a significantly longer time to pass through 
compared to the dsDNA that contained up to 2 mismatches.  The dsDNA having 3 mismatches 
was indistinguishable from the Guide strand (Sutherland et al., 2004a). 
            Solid-state pores manufactured with various materials as mentioned earlier have also 
been used for sensing DNA and RNA (Li et al., 2001, 2003; Storm et al., 2003; Chang et al., 
2004; Heng et al., 2004; Wanunu et al., 2008).  Using Si3N4 pores, the translocation time for a 
dsDNA molecule decreased exponentially with increasing voltage (Wanunu et al., 2008).  Also, 
the translocation of DNA through a solid-state pore would experience a hydrodynamic drag 
force, opposite to its electrical driving force giving a power law (τ ≈ Lα) dependency, where  
the exponent α,  is 1.27,  L is DNA length, and τ is translocation dwell time that  are correlated ( 
Storm et al., 2005a,b; Wanunu et al., 2008; Howorka and Siwy, 2009a).  Recently, Dekker and 
co-workers demonstrated the use of optical tweezers with solid-state nanopores in measuring 
the force acting on a single DNA molecule bound to a streptavidin/biotin complex (Keyser et 
al., 2006a, b).  This method can also be used to slow or even stop the translocation of a DNA 
molecule by manipulating the opposing force exerted from the optical tweezer (Keyser et al., 
2006a, b).  Finally, the development of a single-molecule nanopore sequencing method for 
DNA would be an attractive option due to low cost and label-free analysis (Marziali and 
Akeson 2001; Branton et al., 2008;  Stoddart et al., 2009, 2010). 
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1.2.1.2 RNA 
            Homopolymers of RNA, polycytidylic acid (poly C), polyadenylic acid (poly A), and 
polyuridylic acid (poly U) can be distinguished from each other using translocation data 
through an αHL pore (Akeson et al., 1999b).  Poly C translocates with a 95% current blockade 
and a blockade duration of 2 µs/base while poly A recorded a 85% current blockade and 20 
µs/base blockade duration.  Though cytosine is a smaller base than adenine, the percentage 
increase in current blockade for poly C is because poly C forms a single-stranded helix having a 
diameter of 1.34 nm, which can then easily translocate and produce a higher ionic current 
blockade with the 1.5 nm diameter αHL channel, as compared to the 2.1 nm diameter helix 
formed by poly A which translocates only when partially unwound (Akeson et al., 1999b).  
Also, the translocation of an A30C70Gp copolymer demonstrates that the thinner oligo C helix 
first threads into the pore as the leader, while the oligo A helix follows.  The purine and 
pyrimidine bases within this copolymer can also be distinguished based on current blockade 
traces (Akeson et al., 1999b; Deamer and Branton, 2002).  Furthermore, poly U which lacks an 
ordered structure, translocates as a disordered but extended strand that can be distinguished by 
the difference in blockade time (Kasianowicz et al., 1996).  Recent investigations also show 
that current blockade data contains information about RNA orientation pertaining to 5’-end or 
3’-end entry into the pore (Butler et al., 2006).  For example, two RNA molecules, A25C50  and  
C50A25,  with opposite orientations showed that  3’→5’ translocation of the poly C segment 
causes a higher current obstruction than 5’→3’ translocation (Butler et al., 2006).  In another 
vein, the detection of RNA-protein interactions have also been analyzed with αHL channels 
(Astier et al., 2007).  In this experiment, the blockade duration for the translocation of 
oligonucleotide 5’-C25A25-3’ was increased in the presence of a RNA binding ATPase protein 
P4.  The long events disappeared with the addition of ATP due to the dissociation of the P4-
RNA complex (Astier et al., 2007).  Furthermore, the measurement of the force applied on 
dsRNA molecules has been investigated using solid-state nanopores (van den Hout et al., 
2010).  The dsRNA is attached to an optically-trapped bead, which is manipulated by optical 
tweezers coupled with solid-state pores.  The force needed to be applied on dsRNA was found 
to be slightly smaller than that of dsDNA (van den Hout et al., 2010).   
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1.2.1.3 DNA-Enzyme complex 
            The association and dissociation rates of DNA-enzyme interactions have been studied 
using nanopore force spectroscopy (Hornblower et al., 2007).  Single-stranded DNA bound to 
Exonuclease I, does not translocate the pore due to the bulky enzyme, lodged at the top of the 
pore.  However, the negative transmembrane potential pulls on the ssDNA which finally 
dissociates from the enzyme, releasing the ionic current blockade (Hornblower et al., 2007).  
Similarly, a 14 base pair DNA hairpin, with a 35 residue single-stranded overhang, was 
analyzed using αHL (Benner et al., 2007).  The single-stranded end of the hairpin enters the 
pore, unfolds, and translocates with an average dwell time of 1 ms before dissociation.  Yet 
when the DNA hairpin is bound to a Klenow fragment (KF) of Escherichia coli DNA 
polymerase I, the blockade current and number of events change.  Furthermore, the DNA-KF 
(binary state) complex has little effect on the dwell time duration, but the presence of the 
correct substrate, for example dGTP, causes a dramatic increase in the dwell time, indicating a 
stable ternary complex of DNA-KF-dGTP (Benner et al., 2007; Hurt et al., 2009; Deamer, 
2010).   
 
1.2.2 Nanopore sensing of peptides and proteins 
1.2.2.1   Analysis of peptides 
            The first report on nanopore analysis of peptides was reported by Lee and co-workers in 
2004 (Sutherland et al., 2004b).  This group analyzed peptides having repeats of (Gly-Pro-Pro)n  
where n = 1, P1; n = 2, P2 or  n = 3, P3 that were terminated with ferrocene (Fc).  These 
peptides exist as mixtures of single, double or collagen-like triple helices.  Also, the single 
strand may exist in two different conformations, such as single linear strands or folded U-
shaped strands.  Nanopore analysis using an αHL pore clearly showed all of the different 
conformations that these peptides adopt, based on their blockade currents and durations 
(Sutherland et al., 2004b).  Furthermore, all peptides could be distinguished from one another 
which also included their intermediate conformations (Sutherland et al., 2004b).  In another 
approach, a series of negatively charged α-helical peptides containing a 
fluorenylmethoxycarbonyl (Fmoc) group at the N-terminus were analyzed using  αHL and 
aerolysin pores (Stefureac et al., 2006).  This study helped identify two types of events.  The 
first, stated as type-I or bumping events, comprise small current blockades and longer current 
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durations whereas the type-II or translocation events have larger current blockades and shorter 
durations.  This study demonstrates that single-molecule nanopore analysis can provide 
important structural information with regard to peptide-pore interactions.  Another important 
observation in this study was the influence of the dipole moment on peptide translocation.  The 
dipole moment increases the probability for peptides to translocate (Stefureac et al., 2006).    
            Following these preliminary studies with peptides, nanopore analysis of a set of β-
hairpin peptides with various folding properties was reported by Movileanu and co-workers 
(Goodrich et al., 2007).  The amino acid sequence of the β-hairpin peptide was from the C 
terminal residue of the B1 domain of protein G.  The three negatively charged β-hairpins named 
as Ac-G40, G41 and K41 contained < 5%, ~ 30%, and ~ 50% fraction of the folded peptide, 
respectively (Goodrich et al., 2007).  Nanopore analysis and Langevin molecular dynamics 
showed that the unfolded peptides have shorter translocation times compared to the folded 
peptides.  An important observation was that at a similar force of 3.8 pN, the average dwell 
time of the long-lived events for the hairpin peptides, Ac-G40, G41, and K41 were 730 µs, 
1150 µs and 1210 µs, respectively (Goodrich et al., 2007).  These data suggest an increase in 
blockade duration with an increase in the folded fraction of the peptide.  Also, an increase in 
transmembrane potential revealed an exponential decrease in the event duration for these long-
lived events.  These results demonstrate that the translocation time depends on the applied 
voltage (Goodrich et al., 2007).   
            Recently, Lee’s laboratory analyzed a series of tethered peptides with αHL (Meng et al., 
2010).  Peptides comprising 12 amino acids were tethered via a terminal cysteine to mono-, di-, 
tri- and tetrabromomethyl-substituted benzene to construct bundles of one to four peptide 
strands.  Nanopore analysis of these peptide bundles at different applied potentials of -50, -100 
and -150 mV helped to identify a new set of events called “intercalation events”, in addition to 
the bumping (Figure 1.10A) and translocating events (Figure 1.10C) mentioned in Stefureac et 
al., 2006 (Meng et al., 2010).  An “intercalation event” is used to describe those molecules that 
transiently enter the pore but do not translocate.  These events give large current blockades, and 
their blockade duration increases with increasing voltage (Figure 1.10B) (Meng et al., 2010).  
These molecules diffuse back using the same route they entered the pore.  On the other hand for 
a translocation event, the molecule threads through the pore with large current blockades, where 
the blockade time decreases with increasing voltage (Figure 1.10C).  This study is important  
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Figure 1.10 Types of events (top) with corresponding event profiles (bottom).  (A) Shows a 
bumping event comprising a small blockade current and short duration.  (B) Shows an 
intercalation event comprising a larger blockade current where the molecule enters the pore but 
does not translocate.  (C) Shows a translocation event comprising a larger blockade current and 
blockade duration where the molecule threads through the pore.  (Reprinted by permission from 
Meng et al., 2010.  Copyright 2010 European Peptide Society and John Wiley & Sons, Ltd) 
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because events having large current blockades could be either an intercalation or a translocation 
event, and they can only be distinguished if voltage studies are carried out (Meng et al., 2010).   
            Engineered αHL pores have also proven to be useful for peptide analysis.  Variant αHL 
pores with negatively charged binding sites within the lumen facilitated the translocation of 
cationic peptides in contrast to hydrophobic peptides (Wolfe et al., 2007).  In addition, the 
interaction of a small positively charged ~ 25-residue polypeptide with αHL containing  an 
acidic ring (aspartic acid) engineered to the cis and trans entrance of the pore increased the total 
event frequency (Mohammed and Movileanu, 2008; Movileanu, 2008).  In another approach, 
the study of protease kinetics for enzyme-peptide interactions was analyzed using αHL pores 
(Zhao et al., 2009).  New current blockades and blockade durations were recorded due to 
enzymatic cleavage of the peptide in contrast to the event profiles obtained for the substrate 
only (Zhao et al., 2009).   
            In a different vein, the interaction of peptides with divalent metal ions was investigated 
using a small 28-residue zinc finger peptide, Zif268 (Stefureac and Lee, 2008).  Zif268 is 
comprised of a β-sheet, α-helix, and a turn motif.  In the absence of Zn(II), only weak binding 
to its target DNA was seen due to the unfolded conformation of the peptide.  Using
  
nanopore 
analysis, in the absence of Zn(II), the peptide translocated with a large current blockade of -80 
pA  and  a corresponding translocation-to-bumping events ratio of 2.49.  But in the presence of 
equimolar Zn(II), translocation-to-bumping events ratio  decreased to 0.69.  The reduction in 
translocation events is due to folding of the peptide on binding with Zn(II)
 
(Stefureac and Lee, 
2008).  Another report on peptide-metal analysis using nanopores was reported for the prion 
peptides within the octarepeat region (Stefureac et al., 2010).  The N-terminus of the cellular 
prion protein, PrP
C
, is involved in the binding of copper at the four octarepeat regions 
(PHGGGWGQ) located between residues 51 and 91 (Berlett and Stadtman, 1997; Miura et al., 
1999).  Nanopore analysis of prion peptides, Octa2 (PHGGGWGQ)2, Octa4 (PHGGGWGQ)4, 
and PrP(106-126) in the presence of  divalent cations (Cu(II), Mg(II), Mn(II) and Zn(II)) were 
conducted using an αHL pore.  All three peptides translocate freely through the αHL in the 
absence of divalent metal ions.  However in the presence of Cu(II), translocation events 
decreased for PrP(106-126), Octa2 and Octa4 in the presence of equimolar, 16-fold, and 64-fold 
excess Cu(II) concentrations, respectively.  The addition of Zn(II) caused some changes to the 
event parameters, but Mg(II) and Mn(II)  had no effect on the translocation parameters.  These 
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experiments demonstrate that conformational changes due to complex formation in the presence 
of divalent metal ions can be distinguished using nanopore technology (Stefureac et al., 2010).   
                   
1.2.2.2 Analysis of folded and unfolded proteins 
            The translocation of proteins in the presence of a chemical denaturant using αHL pores 
was first reported by Auvray and co-workers (Oukhaled et al., 2007).  In the absence of 
guanidinium hydrochloride (Gdn-HCl), the 370-residue long maltose binding protein (MBP) 
displayed no current blockades.  The translocation of the unfolded MBP was observed between 
concentrations of 0.8 M to 1.35 M of Gdn-HCl (Oukhaled et al., 2007).  In contrast, current 
blockades, which were assumed to be translocations, were observed for a small 86-residue 
protein (Stefureac et al., 2008).  The wild-type 86-residue long histidine-containing protein 
(HPr) remains uncharged at neutral pH.  The structure of HPr contains two α-helices and four β-
strands that fold into an open-faced β-sandwich (Jia et al., 1993; Napper et al., 1996).  Single 
point mutations of HPr, comprising S34D and T34N were also analyzed using these nanopores.  
Surprisingly, a single conservative substitution of threonine to asparagine without changing the 
overall charge of the protein was sufficient to alter the event profile.  The authors speculate that 
T34N may unfold differently or may interact differently with the pore compared to wild-type 
HPr.  Yet the S34D variant of HPr which is negatively charged assists in the unfolding and 
translocates the pore (Stefureac et al., 2008).  Lee and co-workers also investigated metal-
protein interactions using an intrinsically disordered myelin basic protein (Baran et al., 2010).  
In the absence of divalent metal ions the myelin basic protein apparently translocates in an 
unfolded conformation.  The addition of divalent metal ions, Cu(II) and Zn(II)  reduced the 
translocation events to 28% and 52%, respectively, indicating a more compact conformation in 
the presence of metal ions (Baran et al., 2010). 
            In another approach, an engineered αHL pore containing a tethered polyethylene glycol 
(PEG) which also contained a covalently attached biotinyl group linked to the untethered end, 
was used to analyze the binding of streptavidin (Movileanu et al., 2000).  The binding of a low-
affinity streptavidin variant was detected at the cis side through transient current blockades but 
with rare captures on the trans side of the pore (Howorka et al., 2000; Movileanu et al., 2000).  
Similarly, electrostatic traps of aspartic acid rings engineered onto the limiting aperture and 
stem (trans side) of αHL, were used to study protein-protein interactions (Mohammad et al., 
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2008).  The protein analyte (pb2-Ba) used for these experiments was made by fusing together 
the positively charged pre-sequences of the N-terminal region of pre-cytochrome b2(pb2)  and 
the N-terminus of the small ribonuclease barnase (Ba).  Pre-sequences of varying length were 
used to prepare the protein analyte.  The interaction of pb2-Ba with αHL was greatly enhanced 
by these electrostatic traps.  This study also demonstrates some important factors that affect 
protein-protein interactions which include length of the pre-sequence, the location of the 
electrostatic trap, and the ionic strength of the electrolyte solution (Mohammad et al., 2008).   
            The use of solid-state pores as protein biosensors is popular due to the capacity to 
manufacture larger-sized pores (Siwy et al., 2005).  A 5 nm diameter solid-state pore was used 
to detect bovine serum albumin (BSA) when added to the negatively biased compartment (Han 
et al., 2006).  Similarly, a ~ 16 nm diameter Si3N4 pore was used for the analysis of BSA which 
was added to the cis compartment of the chamber with pH variations from pH < 5 to pH 7 
(Fologea et al., 2007).  At pH < 5, BSA is positively charged and only translocates the pore 
when the trans side is negatively biased.  However, when the pH of the electrolyte solution was 
increased to pH 7, BSA would only translocate the pore when the cis side was negatively biased 
because at pH  7 the protein has an overall negative charge (Fologea et al., 2007).  This group 
was also able to distinguish between fibrinogen and BSA using the event distribution plots for 
these proteins (Fologea et al., 2007).  A new approach, where dsDNA filaments were coated 
with the protein RecA and then analyzed using solid-state pores, was first reported by Dekker 
and co-workers (Smeets et al., 2009; Kowalczyk et al., 2010).  Si3N4 pores which had diameters 
ranging from 20-35 nm was used for the RecA coated dsDNA complex which exhibited large 
current durations as compared to the profiles obtained for dsDNA molecules.  More recently, 
Si3N4 pores have also been used to detect the native, folded and unfolded conformational states 
of the protein, bovine β-lactoglobulin variant a (β-Lga) (Talaga and Li, 2009).  These 
experiments were conducted in the presence of varying concentrations of the denaturant urea, 
and the results suggested that nanopores can distinguish between the folding states of the 
protein (Talaga and Li, 2009).  The authors suggested that when a pro-sequence segment of a 
polypeptide chain in the protein enters the pore, the volume excluded helps distinguish between 
folded states.  This analysis also suggested that most of the protein molecules translocate in a 
linear, looped or unfolded configuration (Talaga and Li, 2009).  Furthermore, the analysis of the 
protein avidin across Si3N4 pores revealed electroosmotic (the motion of liquid induced by an 
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applied potential across porous material) transport may reverse electrophoretic transport 
(Firnkes et al., 2010).   
 
1.2.2.3    Analysis of protein-antibody complexes using solid-state pores 
           The first publication on protein-antibody complexes analyzed with solid-state pores was 
reported from Charles Martin’s group (Siwy et al., 2005).  Gold-plated conical nanopores were 
used for the detection of biotin/streptavidin, protein G/immunoglobulin, and the protein, 
ricin/ricin-antibody complexes (Siwy et al., 2005).  The biotin, protein-G, and ricin were 
attached to Au via a thiolated biotin, biotinylated protein G, and biotinylated ricin derivative, 
respectively (Siwy et al., 2005).  When the protein binds to the corresponding analyte, a 
complete blockade of the ionic current was observed (Siwy et al., 2005).  In another study, BSA 
and a BSA-Fab complex were investigated using a PEG-thiol group attached to a gold-plated 
conical nanotube (Sexton et al., 2007).  The tip of these gold-plated solid-state pores had a 
diameter of ~ 17 nm.  The current-pulse duration (τ) for BSA was 520 ms and changed to 2200 
ms when complexes were formed with the anti-BSA-Fab fragments.  The current pulse 
signatures obtained for BSA and the BSA/Fab complexe were also different (Sexton et al., 
2007).  Furthermore, latex colloids were analyzed using a polydimethylsiloxane (PDMS) pore 
which was 7 µm long and 1 µm wide (Saleh and Sohn, 2003).  Latex colloids coated with 
streptavidin can be differentiated from a complex of latex colloids-streptavidin and colloids-
streptavidin/ anti-streptavidin antibody (Saleh and Sohn, 2003).  The main goal of this study 
was to detect an increase in the magnitude of the pulse caused by an increase in volume due to 
complex formation.  Histograms showing the number of events vs. colloid diameter clearly 
depict the difference between latex colloids coated with streptavidin and the complex (Saleh 
and Sohn, 2003).  In a similar strategy, a 28 nm diameter Si3N4 pore was used to distinguish 
between β-human chroionic gonadotropin (β-hCG) and β-hCG-antibody complex (Han et al., 
2008).  The experiments with antibody only showed large translocation blockade currents 
whereas the β-hCG-antibody complex reduced translocation events due to the change in 
electrophoretic mobility of the antibody when bound to β-hCG (Han et al., 2008). 
               
1.2.3 Analyte detection using covalent and non-covalent adaptors 
            The αHL pore has been used to covalently link tethered ligands, antibodies, lectins, and 
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enzymes for the analysis of specific molecules (Movileanu et al., 2000;  Howorka et al., 2000, 
2004; Xie et al., 2005).  A covalently attached protein kinase inhibitor peptide (PKIP) at the 
trans entrance of the pore interacts with the catalytic subunit C of cAMP-dependent protein 
kinase (PKA) (Xie et al., 2005).  PKIP is tethered to a cysteine at position 129 through a 
disulfide link and a tetraethylene glycol (TEG) linker.  The binding of PKA C subunit to PKIP 
is monitored by the change in ionic current through the pore (Xie et al., 2005).  In a similar 
strategy, an engineered αHL pore containing a covalently attached polyethylene glycol (PEG) 
bound to biotin was used for the analysis of complex formation (Movileanu et al., 2000).  Due 
to the capture of streptavidin and anti-biotin monoclonal antibody (IgG1) to biotin, it was 
observed that the tethered biotinyl group moved from one side of the pore (cis) to the other side 
(trans) (Movileanu et al., 2000).  A set of large current blockades was also obtained when the 
engineered αHL pore containing the tethered arm of biotin was incorporated into a lipid bilayer.  
When wild-type streptavidin was added to the cis side of the bilayer, the large blockades 
disappeared (Movileanu et al., 2000).  Addition of the wild-type streptavidin to the trans side 
caused a permanent current blockade.  Similar results were also obtained when IgG1 was added 
to the cis and trans side of the lipid bilayer.  In contrast, when a mutant form of streptavidin 
was added, transient current blockades were obtained as compared to the permanent blockades 
obtained with wild-type.  This indicates low affinity capture between the mutant streptavidin 
and biotin.  The distinct current blockade signatures obtained from nanopore analysis helps 
distinguish these interactions (Movileanu et al., 2000). 
            In another aspect, the reaction cycle of a covalently attached dithiobis-2-nitrobenzoic 
acid (DNTB) at cysteine 117 that forms a disulfide bond  with αHL, was monitored by the 
change in blockade currents (Luchian et al., 2003).  An increase in the open pore current of the 
engineered αHL pore was seen when DNTB formed the disulphide bond.  However when the 
disulfide link was cleaved with DTT, the open pore current was reversed.  Nanopore analysis 
was able to detect these short lived intermediate processes (Luchian et al., 2003).  Similarly, an 
azobenzene derivative (photochemical dyes which can convert from the trans to cis isomer by 
using light at 380 nm wavelength) covalently attached to the αHL pore, can be photo-induced to 
change configurations (Loudwig and Bayley, 2006).  The difference in open pore current 
between the trans and cis configurations of azobenzene help detect this izomerization event 
(Loudwig and Bayley.  2006).  Finally, it has also been possible to detect protein-ligand 
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interactions using lectin which was previously explained in section 1.1.3.2 (Howorka et al., 
2004).   
            A non-covalently bound molecular adapter, β-cyclodextrin (βCD), fitted into the lumen 
of an engineered αHL pore, was able to detect organic ligands and small drugs (Gu et al., 
1999).  Similarly, the interaction of 2-deoxyribonucleoside 5’monophosphate with the non-
covalent adapter heptakis-(6 deoxy-6 amino)-β-cyclodextrin, positioned at M113R in αHL, 
gave distinct current blockades for each base (Astier et al., 2006).  In a another study, 
Cucubit[6]uril (CB6) lodged into the lumen of αHL was shown to  act as a carrier but not as an 
adapter (Braha et al., 2005).  The interactions of tetrahydrofuran (THF) with CB6 in the 
presence of Na
+ 
ions could be distinguished by the different event profiles generated for the 
number of counts vs. blockade current (Braha et al., 2005).  
  
1.3 Single-molecule sensing for bioanalytical applications 
1.3.1 Nanopore sensors for genomic screening 
            Single-molecule nanopore sensors have been used recently to detect barcoded DNA.  
This label-free method could be useful in human genomics and diagnostic applications 
(Mirsaidov et al., 2010).  Artificial nucleic acid analogs are mostly used in the study of 
hybridization and mismatch of specific DNA sequences.  Peptide nucleic acids (PNA) are a 
class of artificial nucleic acid analogs that can be synthesized to bind one of the dsDNA strands.  
This PNA-tagged genomic fragment showed a characteristic secondary current blockade 
signature when compared to the untagged dsDNA (Singer et al., 2010).  The concept of 
nanopore sequencing, discussed in detail earlier, has the advantage of being a label-free, 
amplification-free, and minimal sample preparation method.  Additionally, it also has the 
potential for direct sequencing of genomic DNA (Bayley and Sanghera, 2008).  For example, 
the use of molecular beacons (luminescent probes used for the identification of nucleic acids) 
coupled with solid-state nanopore arrays, was shown to allow for the  sequencing 50-250 bases 
per second per nanopore (McNally et al., 2010; Krasnoperov et al., 2010).  This method 
incorporates a two step reaction.  First, each nucleotide on the target DNA sequence is 
converted to a pre-defined sequence of oligonucleotides followed by subsequent hybridization 
with molecular beacons that contain specific fluorophores.  Second, this DNA-beacon complex 
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is electrophoretically driven through a 5 nm Si3N4 pore which reads each base through an 
optical detector (McNally et al., 2010).   
 
1.3.2 Nanopores as diagnostic protein biosensors 
            Anthrax is an acute disease that affects mostly animals, but it can also be transmitted to 
humans (Friedlander et al., 1993).  The three anthrax toxins known as the protective antigen 
(PA83), lethal factor (LF), and edema factor (EF) are secreted from Bacillus anthracis 
(Halverson et al., 2005).  The anthrax protein PA63, synthesized from the cleavage of PA83, 
forms transmembrane ion channels that can act as pores in reconstituted lipid bilayers.  When 
nanopore analysis using pores formed from protein PA63 was carried out in the presence of 
protein LF, it decreased the conductance of channel PA63.  Further analysis showed that the 
complex between protein LF and PA63 also formed effective channels (Halverson et al., 2005).  
However, at positive applied potentials, protein EF blocks the channel formed by PA63.  This 
method may be useful as a nanopore-based biosensor for the diagnostic testing of anthrax 
(Halverson et al., 2005; Kasianowickz et al., 2008).  As mentioned earlier (section 1.2.2.3), 
another example of nanopores as protein biosensors is the detection of ricin-antibody complex 
(Siwy et al., 2005).  Ricin, a protein toxin obtained from the castor bean plant, is poisonous if 
inhaled, injected or ingested (Audi et al., 2005).  Thus, protein-protein or protein-antibody 
interactions which cause conformational changes in the complex can be identified with 
nanopores that show different event parameters.   
 
1.3.3 Other single-molecule methods  
            Single-molecule fluorescence resonance energy transfer (FRET) is the most popular and 
general method for studying individual molecules (Ha et al., 1996).  The general principal is 
that the dipole-dipole interactions between two fluorophores transfers energy depending on the 
distance of the donor and acceptor groups (van Holde and Zlatanova, 2006; Zlatanova and van 
Holde, 2006).  This spectroscopic method can measure distance changes in the range of 20 Å – 
80 Å (Ha, 2001).  The applications of FRET require intramolecular and intermolecular labeling.  
Conformational changes in macromolecules, the folding/unfolding of macromolecules, and the 
structural changes of enzymes during catalysis can be analyzed, and may provide information 
pertaining to receptor-ligand and enzyme-substrate interactions (Weiss, 2000).  For FRET 
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experiments, DNA can be immobilized onto quartz surfaces through a biotinylated BSA 
(Biotin-BSA) complex that sticks to the surface which is then attached  to a separate biotin-
DNA complex tagged with donor and acceptor fluorophores via multivalent neutravidin 
(Zhuang et al., 2000; Ha, 2001; Ha  et al., 2002).  For protein analysis, the quartz surfaces may 
be coated with PEG to reduce nonspecific binding (Sofia et al., 1998).   
            Another non-invasive single-molecule method is the use of optical tweezers or optical 
traps (Oddershede et al., 2003).  An optical tweezer is created by focusing a laser beam onto a 
small region that has limited diffraction.  The electromagnetic field created on this small region 
can capture a dielectric sphere when placed on this spot (Ashkin, 1997; van Holde and 
Zlatanova, 2006; Roy et al., 2008).  The radiation pressure from the laser beam is able to trap 
small particles.  Forces in the pico Newton (pN) range can be applied on the object of interest 
with nanometer range displacement.  Optical tweezers have been used to study kinesins, 
myosins (motor proteins), and DNA processing enzymes (Selvin and Ha, 2008).  Optical 
tweezers have also been incorporated with nanopore force spectroscopy to analyze the force 
exerted on DNA molecules (Keyser et al., 2006b; Dekker, 2007).  Another similar single-
molecule method uses magnetic traps.  A magnetic trap or magnetic tweezer can be set up by 
placing two strong magnets above the sample holder of an inverted microscope (Strick et al., 
2000).  Super paramagnetic beads aligned in a strong magnetic field can also be used to tether 
molecules of interest on to the beads and the sample chamber (Neuman and Nagy, 2008).  The 
applied force and displacement of these single molecules can then be measured.  For example, 
magnetic tweezers have been used to study DNA gyrase (a nucleic acid enzyme that maintains 
negative supercoiling of DNA) and DNA topoisomerase IV (enzyme that maintains the 
regulatory DNA topology in the cell) (Charvin et al., 2000; Strick et al., 2000; Gore et al., 
2006).  These experiments showed that in the presence of ATP, DNA gyrase becomes 
significantly less processive as DNA tension increases, and in the absence of ATP, 
topoisomerase IV binds the supercoiled DNA in a cooperative manner (Charvin et al., 2000; 
Gore et al., 2006). 
           Atomic force microscopy (AFM) is another single-molecule method used to study the 
unfolding of proteins, nucleic acids, and the breaking of covalent bonds (Lee et al., 1994; 
Grandbois et al., 1999; Fernandez and Li, 2004).  The atomic force microscope consists of a 
cantilever with a sharp tip, that is above a piezoelectric scanner (piezoelectric materials have a 
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permanent dipole moment across a unit cell) (Cumpson et al., 2004).  A detection laser is 
reflected off the cantilever to a position-sensitive detector, measuring the displacement of the 
lever after it scans the sample surface (Neuman and Nagy, 2008).  AFM has been used for 
single-molecule force-extension studies of DNA and proteins (Lee et al., 1994).  The tip of the 
cantilever is tethered to the sample and the retraction of the tip helps determine the force on the 
sample (Lee et al., 1994; Fernandez and Li, 2004; Bustamante et al., 1994).  These experiments 
investigated the interacting forces between two DNA strands and also the physical basis of 
protein folding reactions.  (Lee et al., 1994; Fernandez and Li, 2004).  For single-stranded 
DNA, the force needed to rupture the interchain and intrachain interactions between these 
strands can be measured and quantified in the nano Newton (nN) range (Lee et al., 1994).  The 
folding trajectory of a single molecule of ubiquitin was observed where the protein was first 
unfolded and then extended at high force.  This stretching force was then removed, causing the 
protein to refold in a natural process that was monitored using AFS (Fernandez and Li, 2004).  
In another study, the active transcription rate of RNA polymerase on DNA, which was loosely 
immobilized on a mica surface, was investigated using AFM (Adelman et al., 2002).   
 
1.4 Prions 
1.4.1 Structure and function 
           Prions are small proteinaceous infectious particles devoid of viruses, plasmids and 
viroids (Prusiner, 1982).  Prion diseases are fatal neurodegenerative diseases thought to arise 
from the post-translational conversion of normal cellular prion protein (PrP
C
) to an oligomeric 
β-sheet-rich form known as the scrapie isoform (PrPSc) (Borchelt et al., 1990; Caughey et al 
1990, 2001; Caughey, 2001; Norstorm and Mastrianni, 2006).  The fundamental event in the 
formation of PrP
Sc 
is the conversion of -helices in PrPC into -sheets.  PrPC has a high - helix 
content (42%) and a low -sheet content (3%) whereas PrPSc has a high -sheet composition 
(43%) and a reduced -helical content of 30% (Pan et al., 1993).  This -sheet-rich isoform, 
PrP
Sc
, often displays intermolecular associations that assemble to form characteristic amyloids 
in the propagation of prion infectivity (StÖhr et al., 2008).  The prion protein [approximately 
253 amino acid (a.a.) residues in mammals] is post-translationally modified to form the mature 
PrP
C 
(Aguzzi et al., 2008).  After the translocation of the bovine prion protein into the 
endoplasmic reticulum (ER) lumen, the attachment of two N-linked carbohydrate moieties at 
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Asn
181
 and Asn
197
 are initiated with the cleavage of the N-terminal signal peptide (a.a.1-22) 
(Heller et al., 2003).  Then, prior to the addition of a glycosylphosphatidylinositol (GPI) anchor 
at Ser 
231
, the C-terminal signal peptide (a.a.231-264) is cleaved.  Subsequently, a disulphide 
bond is formed between Cys
179
 and Cys 
214
 (Figure 1.11a) (Heller et al., 2003; Orsi and Sitia, 
2007; Aguzzi et al., 2008).  Mature PrP
C 
(a.a.  23-230)
 
is a highly conserved ~ 35 kDa protein 
(Hegde et al., 1998).   
            The first nuclear magnetic resonance (NMR) structure for the globular region of mouse 
PrP
C 
(a.a.121-231), containing two anti-parallel β strands and three α-helices, was reported in 
1996 (Riek et al., 1996).  Since this first report, many PrP
C 
structures derived from different 
organisms have been studied and been shown to have similarly folded globular domains (Donne 
et al., 1997; Liu et al., 1999; Zahn et al., 2000).  The prion protein is composed of two domains 
(Figure 1.11b): a C-terminal region that is structured and globular, and the N-terminus which is 
an unstructured region from (a.a.  23-121) (Viles et al., 1999; Aronoff-spencer et al., 2000; 
Zahn et al., 2000; Burns et al., 2002).  The NMR structure of the globular domain in the bovine 
prion protein contains three -helices comprising residues 144-154 (Helix 1), 173-194 (Helix 
2), and 200-226 (Helix 3) and two short anti-parallel -strands comprising residues 128-131 
and 161-164.  Helices 2 and 3 are connected by a disulphide bond (Garcia et al., 2000).   
            PrP
Sc
 is partially hydrolyzed by proteases to form a protease-resistant core designated as 
PrP 27-30 (apparent molecular weight of 27-30 kDa), while PrP
C 
is completely degraded under 
the same conditions (McKinley et al., 1983, 1991; Safar et al., 1993).  Due to the insolubility of 
PrP
Sc
, its structure has not been elucidated using conventional X-ray crystallography or NMR 
spectroscopy.  Electron crystallography has been used to study the structure of PrP 27-30 (Wille 
et al., 2002).  The two-dimensional crystals of PrP 27-30 were negatively stained with heavy 
metals and revealed three negatively charged densities near the center of a trimeric region in the 
unit cell with parallel β-helices (Wille et al., 2002, 2007, 2009). 
            Even though the function of PrP
C
 has not yet been fully established, many possibilities 
have been suggested (Linden et al., 2008).  The cellular prion protein is concentrated in the 
nervous system but is also expressed in most tissues.  The N-terminal region of PrP
C
 is involved 
in the binding of copper, preferentially Cu(II) at the four octarepeat regions (PHGGGWGQ) 
located between residues 51 and 91 (Viles et al., 1999).  Free Cu(II) is highly cytotoxic due to 
the formation of reactive oxygen species (ROS) from redox reactions.  Therefore, the binding of  
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Figure 1.11 The structure and biochemical properties of PrP
C
.  (a) Shows the posttranslational 
modifications of PrP
C
.  N-terminal signal peptide in yellow; proteinase-K resistant core in grey; 
cleavage site for the formation of PrP
Sc
 is depicted in  arrows;  charged cluster (CC) in pink; 
hydrophobic core (HC) in green; S-S is the disulfide bond; membrane anchor (MA); 
glycosylphosphatidyl inositol (GPI); glycosylation sites (CHO); nuclear magnetic resonance 
(NMR).  (b) Shows the tertiary structure of PrP
C
.  The biochemical properties of PrP
C
 and PrP
Sc
 
are stated at the bottom right.  (Reprinted by permission from Aguzzi et al., (2008).  Copyright 
2008 by Annual Reviews). 
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copper to PrP
C
 protects the cell from oxidative damage (Berlett and Stadtman, 1997; Miura et 
al., 1999; Viles et al., 1999; Burns et al., 2002; Aronoff-Spencer et al., 2000).  Binding of 
Cu(II) to PrP
C
 also stimulates endocytosis of PrP
C
 which can generate an antioxidative defence 
(Vassallo and Herms, 2003).   
            The interaction of PrP
C
 as a specific receptor for laminin was investigated for its role in 
memory formation.  The interaction of PrP
C
 in the hippocampal (major component of the brain) 
and laminin play a critical role in memory processing by the activation of protein kinase A 
(PKA) and extracellular regulated kinase (ERK1) or ERK2 signal pathways (Coitinho et al., 
2006).  Since PrP
C
 is a membrane protein, its interactions may be useful in signal transduction 
pathways.  PrP (a.a.106-126) activates the tyrosine kinases, Lyn and Syk, which in turn releases 
intracellular calcium, and activates the protein kinase C and calcium-sensitive tyrosine kinase 
pathways which finally lead to the activation of mitogen activated protein (MAP) kinases ERK1 
and ERK2 (Combs et al., 1999; Herms et al., 2001).  Though PrP-null mice (Nagasaki mice, 
Rcm0 mice, and Zurich II mice) developed normally, they showed progressive ataxia, and 
Purkinje cell degeneration at later stages of their life span (Sakaguchi et al., 1996; Rossi et al., 
2001).  PrP
C
 deficient mice do not form PrP
Sc
 for at least 13 months after inoculation of the 
infective agent (Bueler et al., 1993).  Due to PrP
C
 and PrP
Sc
 having the same identical sequence, 
no specific immune response is generated in prion diseases (Aucouturier et al., 2000).  The 
effects of PrP
C
 on the immune system suggest that PrP
C
 is down-regulated in the presence of 
granulocyte maturation and is up-regulated during the maturation of antigen presenting cells 
(Isaacs et al., 2006).   
 
1.4.2 Prion diseases  
            Prion diseases are infectious diseases of protein conformation that are known as 
transmissible spongiform encephalopathies (TSE’s) (Prusiner, 1998).  Prion diseases are mainly 
characterized by the loss of memory and motor control, dementia, paralysis, and wasting 
(Weissmann, 1996; Zahn et al., 2000).  TSE’s include Kuru, Creutzfeldt-Jakob disease (CJD), 
fatal familial insomnia (FFI), and Gerstmann-Sträussler-Scheinker syndrome (GSS) in humans; 
scrapie in sheep; bovine spongiform encephalopathy (BSE) in cows; chronic wasting disease 
(CWD) in captive mule deer and elk; transmissible mink encephalopathy (TME); and feline 
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pongiform encephalopathy (FSE) in domestic and captive cats (Klatzo et al., 1959; Hartsough 
and Burger, 1965; Roos et al., 1973; Williams and Young, 1980; Wells et al., 1987; Gambetti 
et al., 1995; Ghetti et al., 1995; Wood et al., 1997; Lezmi et al., 2003; Lysek et al., 2005).   
            In humans, Kuru emerged as a prion disease restricted to the Fore linguistic group due 
to the practice of ritualistic cannibalism in the Eastern Highland Province of Papuao New 
Guinea (Gajdusek et al., 1957).  However, the disease has since disappeared due to termination 
of this ritualistic practice and also due to a novel protective prion protein variant, G127V, that 
was found to be exclusively present in the Kuru prevalent region (Mead et al., 2009).  There are 
many forms of CJD.  Sporadic CJD (sCJD) is caused in the absence of an infective agent, 
genetic linkage or somatic mutation (Masters et al., 1978).  In a study done on sCJD in 1998, a 
dominant-negative protective polymorphism at E219K was discovered (Shibuya et al., 1998).  
Another form of CJD, known as familial CJD (fCJD) is due to extra inserts of the octarepeat 
region that can range from one to nine additional repeats compared to the four repeats usually 
present in humans (Owen et al., 1989).  Furthermore, a point mutation, E200K, has also been 
genetically linked to fCJD in Libyan Jews (Goldfarb et al., 1990).  In a more troubling 
perspective, a new form known as variant CJD (vCJD) has been linked to the consumption of 
BSE-infected meat in Britain, Ireland, Italy, and France (Bruce et al., 1997; Spencer et al., 
2002).  Finally, iatrogenic CJD is due to the transmission of the infective agent in contaminated 
neurosurgical instruments, human growth hormone, human dura mater grafts, corneal grafts, 
and depth electrodes (Nevin et al., 1960; Koch et al., 1985; Thadani et al., 1988; Uchiyama et 
al., 1994; Brown et al., 1992).  Genetically-linked Gerstmann-Sträussler-Scheinker syndrome is 
due to P102L, A117V, F198S or Q217R mutations that occur in humans (Hsiao et al., 1989; 
Prusiner, 1989).  FFI has been recorded in more than 30 families around the world and is 
genetically linked to a combination of D178N mutation occurring with M129 (Goldfarb et al., 
1992; Gambetti et al., 1995).   
            In sheep, scrapie was the first spongiform encephalopathy reported in 1732 in England.  
Different breeds of sheep have different susceptibility to scrapie.  For example, the Suffolk 
breeds in the USA are highly susceptible to scrapie (Hunter et al., 1993, 1997).  Sheep having 
Q171R, a dominant-negative polymorphism, are protected from scrapie (Hunter et al., 1993; 
Westaway et al., 1994).  In cattle, the BSE outbreak in Britain in the late 1980’s not only 
caused the mandatory slaughter of thousands of animals but has also been linked to vCJD in the 
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younger population (Wells et al., 1987).  Transmission of the infective agent was suspected to 
have come from the meat and bone meal (MBM) fed to cows contaminated with waste from 
sheep populations infected with scrapie (Wilesmith et al., 1991).  Rapid post-mortem screening 
of animal brains for BSE has improved the safety of the meat industry and also lowered the 
chance of another epidemic.  In cervids, CWD was first discovered in Colorado in the late 
1960s.  At present, the CWD outbreak has been a growing concern due to the rapid horizontal 
transmission of this contagious disease (Miller et al., 1998; Gross and Miller, 2001).  An 
antimortem diagnostic tool for testing CWD is the biopsy of tonsils which might help control 
the spreading of the disease (Wild et al., 2002; Wolfe et al., 2002).  In other animals, TME is a 
rare disease first discovered in ranched mink in Wisconsin.  Only adult minks are affected by 
TME and have a minimum incubation period of seven months (Marsh, 1976).  The first case of 
FSE which affected a captive cheetah born in France was reported in 2003 (Lezmi et al., 2003).  
Another report on the maternal transmission of FSE has also been published (Bencsik et al., 
2009). 
 
1.4.3 Prion strains 
           One of the most difficult concepts to understand in the prion field is the existence of 
different prion strains.  The simplest approach to the concept of prion strains is that prion strains 
arise due to the different conformations of PrP
Sc
.  These can self-replicate using template-
assisted conversion or a seeded nucleation pathway (Prusiner et al., 1990; Jarrett and Lansbury, 
1993; Cohen and Prusiner, 1998; Bartz et al., 2000; Peretz et al., 2001a; Meier et al., 2003).  
The first documented evidence for the existence of prion strains was in goats and was published 
in 1961 (Pattison and Millson, 1961).  The report accounts for two distinct clinical phenotypes 
called “scratching” and “nervous”, which were observed in goats infected by the same scrapie 
agent.  The different genetic background of the goats may have played a role in the 
development of these new strains (Morales et al., 2007a).  Two strains of TME were serially 
passaged to hamsters.  The HYPER (HY) strain of the TME agent produces hyperexcitability 
and cerebellar ataxia in hamsters, while the DROWSY (DY) strain shows progressive lethargy.  
The PrP
Sc
 isolated from hamsters from these two distinct biologic strains of the TME agent had 
different biochemical and physical properties (Bessen and Marsh, 1992).  As stated by Aguzzi 
and Calella, “prion strains” can be interpreted as “infective agents having the ability to exhibit 
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distinct prion-disease phenotypes when transmitted to identical hosts” (Aguzzi and Calella, 
2009).   
            Prion strains can be classified due to their distinct in vivo alterations and different 
biochemical characteristics.  The main in vivo markers are incubation time, neuropathology of 
the brain and clinical symptoms (Figure 1.12) (Collinge and Clark, 2007).  The incubation 
period is calculated as the time interval between inoculation of the infectious agent and the 
onset of clinical symptoms (Bruce et al., 2002).  Intra-species transmission of the infective 
agent is remarkably repeatable.  This was evident in a serial mouse passage study where the 
same mouse strain recorded an incubation time with a standard error of less than 2% of the 
mean incubation period (Bruce, 1993).  Infection by interspecies transmission is slow and 
causes prolonged incubation periods which are different for each strain.  The inability to 
transmit the infective agent between different mammalian species as compared to intra-species 
transmission is known as the “species barrier” (Peretz et al., 2001a; Moore et al., 2005).  The 
incubation time for the first transmission of infectious prions from humans with CJD to mice 
was between 300 to 800 days.  The second passage of these infective agents from mice to mice 
only takes ~120 days while the same incubation time was observed for the third passage from 
mice to mice (Tateishi et al., 1996).  The species barrier is very effective for rabbits which have 
not yet been infected by various prions (Morales et al., 2007a).  Transgenic mouse models were 
used to verify the species barrier which proves that differences in the primary structure of PrP 
between the donor-PrP
Sc
 and the recipient-PrP
C
 help stabilize the transmission barrier (Prusiner 
et al., 1990; Collinge et al., 1991; Palmer et al., 1991).  For example, transgenic mice 
expressing Syrian hamster prions were highly susceptible to the disease when inoculated with 
the infective agent from hamsters (Bruce et al., 1994; Prusiner et al., 1990).  However, the 
prion strain responsible for the efficient transmission of BSE to humans causing vCJD does not 
follow the species barrier rule (Bruce et al., 1994, 1997).  Perhaps the type of prion strain also 
affects the ease of transmission from one species to another (Collinge and Clark, 2007).  The 
biochemical characteristics of strains show different banding pattern in Western blots following 
proteolysis (Figure 1.12B) (Collinge and Clark, 2007; Telling et al., 1996; Collinge et al., 1996; 
Collinge and Rosser, 1996).  Multiple strains generated from scrapie infected prions (Figure 
1.12A) when serially passaged to mice showed that a single strain may retain its original 
biochemical and neuropathological characteristics, even after passaging through different  
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Figure 1.12   Diagram explaining prion strains.  Image (A) shows the propagation of prion 
strains by the template assisted conversion which requires the recruitment of PrP
C
 monomers to 
the different PrP
Sc
 strains to generate more of the specific strain.  Image (B) shows that strains 
can be characterized due to their different neuropathology, incubation period and Western blots.  
Image (C) shows a single strain may retain its characteristics, even after serial passage and re- 
isolation in the original host (Reprinted by permission from Collinge and Clark, 2007.  
Copyright 2007 AAAS). 
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species and finally re-isolating it from the original mice (Figure 1.12C) (Fraser et al., 1973; 
Bruce et al., 1994; Collinge and Clark, 2007). 
 
1.4.4    Interaction of metal ions with prion protein  
                           The unstructured N-terminal region of PrP
C
 contains four repeats of an eight-residue 
sequence PHGGGWGQ known as the octapeptide repeat region (Figure 1.13) which is highly 
conserved among species (Wopfner et al., 1999; Millhauser, 2007).  Interestingly, Cu(II) binds 
to the octapeptide repeat region and  this binding is one of the main functions of PrP
C
 in Cu(II) 
homoestasis.  Though copper is an essential trace metal, it can also be toxic in excess quantity 
(Hornshaw et al., 1995a, b; Brown et al., 1997; StÖckel et al., 1998; Viles et al., 1999; Whittal 
et al., 2000; Millhauser, 2007).  The binding of Cu(II)  assists in the endocytosis of PrP
C
 (Pauly 
and Harris, 1998).  Wild-type nerve cells in culture have shown resistance to oxidative stress 
and ROS generated by Cu(II) as compared to cells lacking PrP
C
, indicating the requirement for 
the octarepeat region (Brown et al., 1998a).  PrP knockout mice are susceptible to tissue 
damage through lipid oxidation as compared to wild-type mice (Klamt et al., 2001).  It has been 
shown that the binding of Cu(II) to PrP
C 
 causes structural changes  and may cause different 
misfolding patterns (Viles et al ., 1999).   
                           A crystal structure of Cu(II) bound to the HGGGW peptide  revealed that Cu(II)  co-
ordinates with three nitrogen atoms (one from histidine) and one oxygen atom as an equatorial 
ligand in addition to an axial water molecule to form a square-pyramidal complex (Burns et al., 
2002).  At physiological pH, the affinity for binding Cu(II) (Kd) in the square-pyramidal 
complex is ~ 1-9 µM (Garnett and Viles, 2003; Walter et al., 2006; Wells et al., 2006 ).  Cu(II) 
binds the octapeptide repeat region at Histidine (His) 60, His 68, His 76, and  His 84 (Viles et 
al., 1999; Jones et al., 2005; Klewpatinond et al., 2008).  Additional binding sites for copper 
outside the octarepeat region have been identified at His 95 and His 110 (Klewpatinond and 
Viles, 2007a, b).  It has also been shown that the binding of Cu(II) to the full length 
recombinant  prion  protein first occurs between the octapeptide repeat region and at His 95 or 
110 with subsequent  loading to the octapeptide repeat region (Klewpatinond et al., 2008).  
Many articles have been published on the  affinity of Cu(II) to PrP
C 
(Jackson et al., 2001; 
Kramer et al., 2001; Thompsett et al., 2005; Walter et al., 2006; Wells et al., 2006).  The 
binding affinity of Cu(II) to the full length prion has an  approximate Kd value of  ~10 nM  
48 
 
 
 
 
 
 
 
 
Figure 1.13 The octapeptide repeat region in PrP
C
.  The octapeptide repeat domain (blue) 
comprises four, eight-residue long PHGGGWGQ sequences.  (Reprinted by permission 
from Millhauser, 2007.  Copyright 2007 Annual Reviews). 
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              (Viles et al., 2008).  In vitro studies on the affinity of copper to denatured PrP
Sc
 showed an 
increase in protease resistivity and infectivity (Pauly and Harris, 1998; Quaglio et al., 2001; 
Sigurdsson et al., 2003; Kuczius et al., 2004; Singh et al., 2010).  The recombinant full length 
cellular prion protein binds several metal ions other thancopper.  The binding of Zn(II), Mn(II), 
Fe(II) and Ni(II) has been confirmed in many prion-metal interaction studies (Pan et al., 1992;  
Hornshaw et al., 1995a, b; Brown et al., 2000; Jackson et al., 2001; Jones et al., 2004, 2005; 
Basu et al., 2007).  Zn(II) has also been associated with  the induction of prion endocytosis and 
PrP
C
 binding (Pauly and Harris, 1998; Perera and Hooper, 2001; Qin et al., 2002).  Zn(II) binds 
the octapeptide repeat region with a dissociation constant of approximately ~ 200 µM, which is 
much lower than that of copper binding (Walter et al., 2007).  The interaction of Fe(II) with 
PrP
C 
depends mostly on the conformation of PrP
C
 and not a specific amino acid sequence 
(Singh et al., 2010).  It has been suggested that PrP
C
 may act as an iron transporter from the 
endosomes to the cytosol (Miura et al., 2005).  Furthermore, using a confocal single-molecule 
detection system, the binding of Mn(II) caused a pro-aggregatory effect at low micromolar 
concentrations (Giese et al., 2004).  Another study which used vibrational raman spectroscopy 
and ultraviolet circular dichroism showed that Mn(II) reinforced the α-helix content to ~ 30%  
as compared to the opposing effect of Cu(II) (Zhu et al., 2008).   
 
1.4.5 Therapeutics and treatment for prion diseases 
                          Cell culture models have been used for the study of various therapeutic agents designed 
to reduce the propagation of PrP
Sc
.  Polyanionic glycans such as pentosan polysulphate (PPS) 
and dextran sulphate (DS) have been reported to decrease PrP
Sc
 levels in scrapie infected cells 
(Caughey and Raymond, 1993; Caughey et al., 1994; Barret et al., 2003).  Heteropolyanionic-
23 (HPA-23) is an antiviral compound that delays the onset of the formation of scrapie in mice 
and hamsters following inoculation of the infective agent.  HPA-23 is strain dependent and has 
less effect if administered after post-infection (Kimberlin and Walker, 1983, 1986).  Heparin 
sulfate also reduced the accumulation of PrP
Sc 
in scrapie infected cell cultures (Caughhey and 
Raymond., 1993; Gabizon et al., 1993).  In an opposing effect, both heparin sulphate and PPS 
stimulate the cell-free conversion of PrP
Sc 
(Wong et al., 2001).  Congo Red (CR) dye is mainly 
used in the staining of histopathological samples.  The administration of CR to hamsters during 
intracerebral and intraperitoneal inoculation delayed the onset of scrapie, but did not have an 
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effect if administered after intracerebral inoculation (Ingrosso et al., 1995; Poli et al., 2004).  
Suramin (polysulphonated naphthyl urea) reduced the level of PrP
Sc
 in scrapie-infected 
neuroblasma (cancer) cells (ScN2a) and also prolonged the incubation time for the disease in 
hamsters when administered during intraperitoneal (injection of a substance into the body 
cavity) inoculation (Ladogana et al., 1992; Nunziante et al., 2005).  Polycationic compounds 
such as dentritic polyamines (polypropyleneimine, polyethyleneimine and polyamidoamide), 
phosphorous-containing dentrimers, and lipopolyamines, all reduced pre-existing PrP
Sc
 in 
ScN2a cells (Supattapone et al., 1999, 2001; Winklhofer and Tatzelt, 2000; Solassol et al., 
2004).  Many other compounds such as amphotericin B, porphyrins, acridine and phenothiazine 
have also been tested for the reduction of PrP
Sc 
(Caughey et al., 1998; Mange et al., 2000; 
Korth et al., 2001).  While amphotericin B delayed the onset of disease in hamsters, porphyrins, 
acridine, and phenothiazine reduced the level of PrP
Sc 
in ScN2a cell cultures (Pocchiari et al., 
1987, 1989; Adjou et al., 1995, 1999, 2000).   
            In the development of therapeutic agents for prion disease, one of the main obstacles 
that has to be overcome is that the drugs have to cross the blood-brain barrier (BBB).  The 
administration of quinacrine, an antimalarial drug, to CJD patients with an initial dose of 1000 
mg, followed by a 300 mg daily dosage thereafter, showed hepatic toxicity (Prusiner et al., 
2004).  The development of anti-PrP antibodies for PrP
C
 has also been useful in reducing the 
propagation of PrP
Sc
 in cell cultures by a mechanism whereby PrP
C
 specific antibodies bind 
PrP
C
 and hence reduce the pool of available PrP
C
 needed for scrapie transformation (Enari et 
al., 2001; Peretz et al., 2001b; Gilch et al., 2003).  Peripherally infected scrapie mice that were 
passively immunized with anti-PrP antibodies showed a significant reduction in PrP
Sc
 levels in 
spleen samples (Heppner et al., 2001; White et al., 2003).  In summary, many other therapeutic 
agents have been discovered in cellular in vitro studies which are too extensive to mention at 
this point.  For example, RNA aptamers (short strands of oligonucleotides), RNA interference 
strands, Statins (drugs used to reduce cholesterol levels), copper, dominant-negative inhibitors 
coupled with protein-X (a putative cofactor for prion conversion) mimetics, curcumin (major 
component in turmeric), dimethyl sulphoxide, and passive immunization with monoclonal 
antibodies have been investigated (Trevitt and Collinge, 2006).   
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1.5 Diagnostic methods for prion diseases 
1.5.1 Bioassays using PrP conformation 
            The BSE crisis in Britain and its link to vCJD has raised the extremely important 
question; can we detect PrP
Sc
 in human blood samples?   At present, there is no pre-mortem 
testing for human or animal prion diseases.  The only positive diagnosis is post-mortem brain 
histology testing.  Clinical symptoms are the main factors that assist in early diagnosis of 
human prion disease.  Rodent models have been used to test the level PrP
Sc
 in blood.  Blood 
samples collected from  rodents  infected with  scrapie prions  revealed a  1 pg/ml [~100 
infectious units (IU) in 1 ml or ~ 3x10
-14 
M] detection limit in the blood buffy coat  at the onset 
of symptomatic  disease (Brown, 2001; Brown et al., 2001).  During incubation, the detection 
limit is estimated at a 10 fold lower value of 10 IU or 0.1 pg/ml (~ 3 x 10
-15 
M).  The number of 
molecules in plasma and red blood cells are estimated to be 5-10 folds lower than that present in 
the buffy coat (Brown et al., 1998b).  Human and cattle blood samples would contain much 
lower numbers of PrP
Sc
 molecules.  At present, there is no direct test for this level of sensitivity, 
but an amplification step, for example the protein misfolding cyclic amplification (PMCA)  
assay can be used to increase the detection limit in blood (Soto, 2004).  PrP
C
 has been detected 
in blood plasma, milk, and urine (Narang et al., 2005; Franscini et al., 2006; Thackray et al., 
2006).  PrP
Sc
 has also been reported in the urine of hamsters, cattle and humans but the elevated 
levels of PrP
C
 (0.3 - 4.7 ng/ml) in naturally infected sheep urine samples cannot be explained 
(Shaked et al., 2001; Andrievskaiai et al., 2008).  Further investigations to establish if the 
increase of urinary PrP
C
 is accompanied by scrapie infectivity in urine, needs to be explored 
(Andrievskaiai et al., 2008). 
            The PrP
Sc 
conformational-dependent immunoassay (Inpro, CDI by Beckman Coulter) is 
an excellent method used to differentiate PrP
C
 and denatured PrP
Sc
.  These antibodies do not 
bind to native PrP
Sc
 (Figure 1.14) (Safar et al., 1998, 2002).  The antibody binds only a 
conformationally-dependent epitope that is always accessible in PrP
C
 but only becomes exposed 
in PrP
Sc
 after denaturation.  For this purpose, all samples are divided into two aliquots (Bellon 
et al., 2003).  One aliquot is denatured using 4 M (final concentration) Gdn-HCl and heating at 
83ºC for 6 minutes, while the other aliquot is left untreated.  The assay includes a sandwich 
immunoassay coupled with fluorescence labeled antibody fragments to detect prions (Bellon et 
al., 2003).  For the sandwich enzyme-linked immunosorbent assay (ELISA), microtitre plates 
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Figure 1.14 InPro conformational-dependent immunoassay (CDI).  First the sample is 
processed to chemically separate PrP
C 
from PrP
Sc
.  Denatured PrP
Sc
 is then transferred to 
capture plates that utilize a fluorescent tagged Fab residue which is released for positive 
samples.  (Reprinted with permission from InPro CDI Robust BSE testing Kit-BR-9918A; 
product licensed under patents from Inpro Biotechnology Inc, South San Francisco, California.  
Founded by Stanley B.  Prusiner.  Copyright 2005 Beckman Coulter, Inc). 
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are coated with 10 µg monoclonal antibodies (mAbs) followed by the loading of denatured and 
native samples.  Following incubation, a labeled detection antibody fragment is added.  The 
presence of the disulphide bond enhances the detection of mAb binding, in contrast to the 
reduced sample which is treated with 3.3 mM dithiothreitol (DTT) for 6 minutes (Bellon et al., 
2003).  These experiments suggest that mAb binding depends on the correctly formed 
disulphide bridge between Cys 179 and Cys 214.  The detection limit for CDI is 0.5 - 5.0 pmol 
and is a highly sensitive test independent of the proteinase K digestion step.   
             With respect to protein conformation, the production of conformational antibodies that 
can specifically bind PrP
Sc
 but not PrP
C
 is a very key advance.  In a study done by Korth and 
co-workers, an IgM monoclonal antibody named 15B3, that immunoprecipitated bovine, 
murine, and human PrP
Sc
 but not PrP
C
 was produced in 1997 (Korth et al., 1997).  However 
further studies using this antibody have not been published as of yet.  In another study, 
immunoprecipitation, plate-capture immunoassay, and flow cytometry assays showed that an 
antibody raised against the epitope, tyrosine-tyrosine-arginine, bound PrP
Sc
 and not PrP
C
 
(Paramithiotis et al., 2003).  Furthermore, these antibodies not only recognize protease 
resisitant PrP but also misfolded protease sensitive prion protein (Paramithiotis et al., 2003).  
The YYR motif is blocked in PrP
C
 but is available in PrP
Sc
.  Another PrP
Sc
 specific antibody 
called V5B2 bound PrP
Sc 
(and not PrP
C
) to brain samples of CJD patients (Curin Serbec et al., 
2004).  RNA aptamers have also been used to specifically interact with the N-terminus of 
recombinant PrP
C 
and native PrP
C
 but not with native PrP 27-30.  This study suggests that PrP
SC
 
specific RNA aptamers may be able to screen infective samples in the future (Weiss et al., 
1997). 
 
1.5.2 Bioassays using PK-resistant PrP 
            Current diagnostics for prion diseases mainly use the proteinase K digestion method to 
validate the presence of PrP
Sc 
(McKinley et al., 1983; Meyer et al., 1986).  This conventional 
method produces PrP 27-30, a ~142 amino acid residue fragment from PrP
Sc
, in the presence of 
proteinase K, where ~ 67 amino acids from the N-terminus are completely digested (McKinley 
et al., 1991).  Commercially available assay kits from Prionics-Check Western test, 
CEA/BioRad test, Enfer test, and Prionics-Check LIA test are being routinely used in 
government laboratories, university laboratories, and other research facilities for post-mortem 
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detection of  PrP
Sc
 (Soto, 2004).  The method used by prionics-check western test is as follows: 
A sample containing the obex region of the brain is first homogenized followed by the addition 
of proteinase K (Soto, 2004).  The samples are then loaded on to a SDS-polyacrylamide gel for 
electrophoresis.  Next, Western blot analysis is carried out using monoclonal antibody 6H4.  
The antibody binds epitope DYEDRYYRE which contains the Helix-1 region of the bovine 
prion protein.  The detection limit of the test is in 5.0 - 20 pmol (Schaller et al., 1999; Oesch et 
al., 2000; Soto, 2004).  The CEA/BioRad test consists of two distinct phases, a concentration 
phase followed by a sandwich immunoassay (Soto, 2004).  In the first phase brain samples are 
homogenized and treated with proteinase K.  The PrP
Sc
 is then concentrated using 
centrifugation, followed by the addition of a denaturant to dissolve the PrP
Sc 
pellet.  In the, 
second phase the denatured sample is added to micro plates containing an immobilized 
monoclonal antibody (capture antibody) which binds PrP
Sc
.  The plates are then washed and a 
second monoclonal antibody coupled to an enzyme (antibody-peroxidase), which binds another 
site of PrP
Sc
, is added.  The binding of the second antibody is proportional to the immobilized 
sample which is detected by enzyme activity (Moynagh and Schimmel 1999; Grassi et al., 
2001; Bennion and Daggett, 2002).  The detection limit in this test is 0.5-2.0 pmol (Soto, 2004).  
The Prionics-Check LIA test developed by Biffiger and co-workers used two different 
monoclonal antibodies for the capture and detection of PrP 27-30 (Biffiger et al., 2002).  In this 
method, brain samples are first homogenized followed by proteinase K digestion.  These 
samples are then pre-treated with assay buffer and incubated for 60 minutes with detection 
antibodies that are conjugated with horseradish peroxidase.  These pre-treated samples are then 
loaded onto micro plates precoated with a capture antibody (6H4) (Biffiger et al., 2002).  A 
chemiluminescence substrate for peroxidase is then added and the emitted light is measured 
using a luminometer (Biffigner et al., 2002).  The detection limit of this assay is between 1.0-
5.0 pmol (Soto, 2004).  The diagnostic Enfer test uses a rapid sample extraction procedure 
coupled to a chemiluminescence’s ELISA method (Soto, 2004).  The procedure includes 
homogenization, extraction, and proteinase K digestion of brain samples followed by simple 
ELISA detection.  The detection limit for this test is 1.0-10 pmol (Moynagh and Schimmel, 
1999; Bennion and Daggett, 2002; Soto, 2004).  Methods such as cell blot and slot blot have 
also been developed for the detection of PrP
Sc
 (Bosque and Prusiner, 2000).  In the cell blot 
method, cells infected with prions are plated on cover slips which are placed on a 24-well plate.  
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After 4 days of incubation in culture medium, the cover plates are removed (Bosque and 
Prusiner, 2000).  The slot blot method utilizes BSE infected brain tissue or cell lysates that are 
filtered using a commercially available slot blot device that include a nitrocellulose or cellulose 
acetate membrane, followed by proteinase K detection (Winklhofer et al., 2001).  Other 
methods that use the proteinase K digestion step include immunohistochemistry, cell culture 
assays, and protein misfolding cyclic amplification (PMCA) based methods (McBride et al.,  
 1988; Klohn et al., 2003; Castilla et al., 2005).   
           PMCA is a technique for accelerated prion replication.  It is based on the observations 
that the transmissible agent for prion diseases is PrP
Sc
 (Saborio et al., 2001).  The PMCA 
method is a two step process (Figure 1.15) (Soto et al., 2002; Castilla et al., 2005; Morales et 
al., 2007b).  First, samples containing extremely small amounts of PrP
Sc
 are incubated with 
excess amounts of PrP
C
 which then converts PrP
C→PrPSc.  In the second step, sonication is 
used to disrupt the aggregates that act as seeds for further conversion and amplification of PrP
C
 
to the infective conformation (Figure 1.15A).  This is achieved by repetitive cycles of serial 
dilution of the newly synthesized PrP
Sc 
with fresh brain homogenate samples (Figure 1.15B).  
The final product is subjected to proteinase K digestion followed by gel electrophoresis (Soto et 
al., 2002; Castilla et al., 2005; Morales et al., 2007b).  PMCA is a very useful tool for prion 
diagnostic assays.  A detection limit of 6-12 pg (0.2 - 0.4x10
-15
 mol) of PrP
Sc 
after a 10000 fold 
dilution and 10 cycles has been successfully described (Telling, 2001). 
 
1.5.3 Bioassays using aggregation of PrP 
            A method to detect PrP
Sc
 aggregates in cerebrospinal fluid (CSF) was first reported by 
Kretzschmar and co-workers (Bieschke et al., 2000).  Prion protein aggregates in CSF samples 
from patients with suspected CJD were labeled with specific antibody probes that were tagged 
with a fluorescent dye.  The intensity of these signals was measured using a confocal-dual color 
fluorescence spectrometer that produced a detection limit of 2 pM concentrations for 
aggregated PrP
Sc
 (Bieschke et al., 2000).  In another study, a novel enzyme-linked 
immunosorbent assay that reacts specifically with dimers or aggregates of PrP was reported by,            
Sy and coworkers (Pan et al., 2005).  Most of the current in vitro diagnostic methods use 
proteinase K resistivity or treatment with Gdn-HCl that denatures the protein which in turn 
assists the binding of mAbs to hidden epitopes.  On the other hand, the mAb, 11G5, reacted  
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Figure 1.15 Protein misfolding cyclic amplification (PMCA).  Image (A) shows incubation of 
large amounts of PrP
C 
with small amounts of PrP
Sc
 followed by sonication which forms new 
seeds that are then incubated at 37 ºC for the conversion of PrP
C→ PrPSc.  Image (B) shows 
newly synthesized PrP
Sc
 is diluted in new aliquots of normal brain homogenates (Reprinted 
with permission from Morales et al., 2007b (Microbial food contamination, second edition).  
Copyright 2010 Taylor and Francis Group, LLC).   
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with both dimers and PrP
Sc
 aggregates.  The epitope region covered by 11G5 is a.a.114-130 
which includes the β-strand (a.a.128-131).  This aggregated ELISA method had a detection 
limit of 0.006 µg to 0.06 µg of PrP.  Furthermore, these authors speculate that dimers 
andaggregates of PrP may share similarities in this conformational region that leads to the 
conversion of PrP
C→PrPSc (Pan et al., 2005). 
            At present there are many methods and protocols available for in vitro conversion of the 
recombinant prion protein to amyloid fibrils (Apetri et al., 2005; Breydo et al., 2005; Ryou and 
Mays, 2008).  Most conversion methods require a source of PrP
Sc
,
 
which is incubated with PrP
C
 
for the scrapie conversion (Raeber et al., 1992; Kocisko et al., 1994; Lucassen et al., 2003; 
Deleault et al., 2005; Atarashi et al., 2007, 2008).  In contrast, a novel in vitro cell- free method 
that does not require a source of PrP
Sc
 for the formation of amyloid fibrils was developed by 
Baskakov and co-workers (Baskakov et al., 2002).  The recombinant Syrian hamster prion 
protein (a.a. 90-231) was refolded into a β-oligomeric isoform at pH 3.7 in the absence of PrPSc 
with 5 M urea and was monitored by circular dichroism (Baskakov et al., 2002).  These β-
oligomers can then be converted into amyloid fibrils using constant shaking at 37 ºC under 
acidic conditions (Baskakov et al., 2002; Baskakov et al., 2004; Bocharova et al., 2005).  
Fibrils formation was monitored by staining the samples with congo red (CR) dye or the 
fluorescent dye thioflavin T (ThT) (Baskakov et al., 2002).  ThT fluoresces only when bound to 
fibrils and does not interfere with fibril formation (Bourhim et al., 2007).  Recently, Prusiner’s 
laboratory developed an in vitro protease-sensitive synthetic prion that was formed using an 
unseeded polymerization method (Colby et al., 2010).  For this purpose, the production of 
amyloid fibrils at 37ºC in 3 M urea and pH 5.0 using recombinant mouse PrP (a.a. 89-230)  was 
monitored using a ThT binding assay (Baskakov et al., 2002; Legname et al., 2004; Colby et 
al., 2010).  These recombinant PrP amyloids transmitted prion disease to transgenic mice that 
overexpressed the N-terminally truncated prion protein.  These amyloid fibers proved to be 
highly infectious but remained protease sensitive (Colby et al., 2010).  Furthermore, prions 
isolated from these sick animals transmitted the disease to healthy animals (Colby et al., 2010).   
    
1.6   Thesis objectives 
            Single-molecule nanopore analysis is an attractive analytical method which can be 
developed to identify specific conformational changes that occur in proteins and peptides.  
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Prion diseases are thought to arise from the misfolding and aggregation of the normal cellular 
prion protein, PrP
C
 to an oligomeric β-sheet rich form known as the scrapie isoform, PrPSc 
(Prusiner, 1982).  The research performed in this thesis presents the initial foundation and proof 
of principle for the development of an electrophoretic prion detector.   
            The preliminary work includes nanopore analysis of peptides protected with an acetyl  
or an Fmoc group and peptides having different secondary structures such as α-helical and β-
sheet hairpin conformations.  These experiments were designed to study the interactions 
between peptides and pores and to gain a more detailed view of the effects of peptide 
conformation on translocation or intercalation. 
     The next sets of experiments were designed in an effort to try and develop an 
electrophoretic prion detector using αHL pores.  First, peptides with different secondary 
structures within the recombinant bovine prion protein were analyzed.  The goal of this set of 
experiments was to investigate if small peptides from α-helical and β-sheet segments in the 
bPrP would give specific blockade current (I) and blockade time (T) signatures with nanopores.  
The next objective of this project was to determine if the full length recombinant bovine prion 
protein, bPrP (a.a.  25-242) interacts with the αHL pore.  For this purpose, different voltages 
were also used with different orientations with respect to the location of the negative potential 
at the cis or trans side of the lipid bilayer.   
            Another objective of this project was to demonstrate that the conformation of the prion 
protein can be modulated by binding divalent metal ions.  The N-terminal region of PrP
C
 is 
involved in the binding of copper, at the four octapeptide repeat regions (PHGGGWGQ) 
located between residues 51 and 91 (Viles et al., 1999).  Furthermore, PrP
C 
also binds several 
other metal ions other than copper (Quaglio et al., 2001; Todorova-Balvay et al., 2001; Burns et 
al., 2003; Morante et al., 2004; Leach et al., 2006).  Based on these findings, nanopore analysis 
of bPrP(25-242) in the presence of  Cu(II), Zn(II), Ni(II), and Mn(II) was carried out. 
            The addition of anti-PrP antibodies to prion proteins and peptides while recording the 
difference in the number of events is a positive approach towards a diagnostic test for BSE.  
The next sets of experiments were designed to identify distinct conformational changes that 
occurred due to complex formation between antibodies and prion peptides and proteins.   
           Recently it has also been demonstrated that proteins can translocate the αHL pore, 
especially in the presence of denaturing agents which aid in protein unfolding (Oukhaled et al., 
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2007; Stefureac et al., 2008).  The next objective was to identify conformational changes that 
occurred in bPrP in the presence of Gdn-HCl.  The conformational changes that occur due to 
complex formation was further investigated by the addition of antibodies to the unfolded 
bPrP(25-242).  Based on these objectives, a non-prion peptide was also analyzed.   
            The N-terminus signal prion peptides have potent antiprion effects.  Peptide PrP (a.a.  1-
30) significantly reduced PrP
Sc 
levels in prion infected mouse neuronal hypothalamic cells but 
had no effect on PrP
C
 levels in noninfected cells (Löfgren et al., 2008).  Based on these 
findings, the next objective of this project was to determine if the conformation of the prion 
protein can be modulated using signal prion peptides.  For this purpose, we used the N- and C-
terminal signal prion peptides.   
            The fundamental event in the formation of PrP
Sc
 is the conversion of -helices in PrPC 
into -sheets (Pan et al., 1993).  The final goal of this project was to demonstrate if fibril 
formation of the full length bPrP was possible at low concentrations of Gdn-HCl so as to 
monitor the folding intermediates using αHL nanopores.   
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2.0   MATERIALS AND METHODS 
 
2.1 Chemical and biological reagents, supplies, and equipment 
            A list containing all the chemical and biological reagents, equipment, and supplies are 
presented in Table 2.1.  The names and addresses of the pharmaceutical companies are listed in 
Table 2.2. 
 
2.2 Nanopore detection of peptides  
 
2.2.1    Acetylated and Fmoc protected peptides 
            Acetylated peptides, Ac-D2A14K2 and Ac-D2A7PA6K2 and Fmoc-protected peptides, 
Fmoc-D2A14K2 and Fmoc-D2A7PA6K2 were analyzed.  The Fmoc-protected peptides were 
greater than 90% pure, while peptide Ac-D2A7PA6K2 was 96% pure.  Stock solutions of 10 
mg/mL for the acetylated peptides and 5 mg/mL for the Fmoc-protected peptides were prepared 
in 10 mM potassium phosphate (KH2PO4/K2HPO4) buffer with 1.0 M KCl at pH 7.8.  The 
electrolyte solution for nanopore experiments was also 1.0 M KCl in 10 mM potassium 
phosphate buffer at pH 7.8.  Once a stable α-hemolysin pore insertion was detected (fewer than 
3 pores), 20-30 µL of the acetylated peptides or 10 µL of the Fmoc-protected peptides were 
added to the 1.5 mL cis chamber proximal to the aperture.  The experiments were carried out 
using an Axopatch 200B amplifier connected to a CV203BU head-stage at 22 ± 1ºC with an 
applied potential of -100 mV  at the cis side and at a bandwidth of 10 KHz.  The blockade 
current populations were obtained by fitting the blockade current distribution with the Gaussian 
function.  The lifetime data were obtained by fitting each blockade duration distribution with a 
single exponential function. 
 
2.2.2 The capped and uncapped β-sheet hairpin peptides 
            The capped (Ac-SESYINPDGTWTVTE-NH2) and uncapped (SESYINPDGTWTVTE) 
β-sheet hairpin peptides with purities of 72% and 79%, respectively, were analyzed.  Mass 
spectrometry was performed on all peptides to confirm molecular weight.  Stock solutions of 10 
mg/mL were prepared in 10 mM potassium phosphate buffer with 1.0 M KCl at pH 7.8 for 
nanopore analysis.  Nanopore experiments were carried out as stated in section 2.2.1 using 2 µL 
of stock peptide solutions. 
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Table  2.1 Chemical and biological reagents, equipment, and supplies 
 
Item        Supplier 
Chemical and biological reagents 
1,2-diphytanoyl-sn-glycero-3-phosphocholine in CHCl3 
Ac-D2A14K2 peptide 
Ac-D2A7PA6K2 pepide 
Argon (gaseous)       
2-[N-cyclohexylamino]ethanesulfonic acid (CHES) 
CuSO4.5H2O    
Decane (anhydrous) 
Ethylenediaminetetraacetic acid (EDTA) 
Fmoc-D2A14K2  peptide 
Fmoc-D2A7PA6K2 peptide 
Fmoc-α helical hairpin peptide 
(FNMQCQRRFYEALHDPNLNEEQRNAKIKSIRDDC) 
with a disulfide link at Cys 5 & 34 
Guanidine Hydrochloride (Gdn-HCl) 
Hydrochloric acid (HCl) 
Manganese Chloride (MnCl2.4H20) 
Nickel Chloride (NiCl2.6H20) 
Nitrogen (gaseous) 
Peptide RG-23    
RYSPTSPSYSPTSPSYSPTSPSG 
Potassium Chloride (KCl) 
PrP(1-24): MVKSHIGSWILVLFVAMWSDVGLC 
PrP(106-126): KTNMKHMAGAAAAGAVVGGLG 
PrP(143-169): SAMSRPLIHFGNDYEDRYYRENMYRYP 
Ac-PrP(145-162): Ace-DSRPLIHFGSDYEDRYYR 
PrP (155-162): DYEDRYYR 
PrP(243-264): VILFSSPPVILLISFLIFLIVG 
 
Avanti Polar Lipids 
Sigma-Genosys 
Sigma-Genosys 
Praxair 
Sigma-Aldrich 
Sigma-Aldrich 
Sigma-Aldrich 
BDH 
Chi Scientific 
Chi Scientific 
Chi Scientific 
 
 
EM SCIENCE 
BDH 
Fisher Scientific 
Sigma-Aldrich 
Praxair 
Chi Scientific 
 
Sigma-Aldrich 
American Peptide 
Anaspec 
Sigma-Genosys 
Sigma-Genosys 
Sigma-Genosys 
American Peptide 
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Sodium phosphate, dibasic (Na2HPO4) 
Sodium phosphate, monobasic (NaH2PO4) 
Trifluoroacetic acid (TFA) 
Tris-[hydroxymethyl] aminomethane (Tris) 
Tris-2-carboxyetyhyl-phosphine hydrochloride (TCEP) 
Zinc Chloride (ZnCl2) 
α-hemolysin (αHL) 
α-helical hairpin 
peptide(FNMQCQRRFYEALHDPNLNEEQRNAKIKSIRDDC)  
with a disulfide link at Cys 5 & 34 
capped  β-sheet hairpin peptide 
(Ac-SESYINPDGTWTVTE-NH2) 
uncapped β-sheet hairpin peptide 
(SESYINPDGTWTVTE) 
 
Equipment and supplies 
Active-air floating table 
Automatic Pipettes and tips 
Axopatch 200B amplifier 
Barnstead Thermolyne Labquake 
Basic pH meter 
Digitat 1322A digitizer 
DynaPro-MS800 DLS instrument 
F-2500 fluorescence spectrophotometer 
Falcon tubes 
Faraday cage 
Headstage model CV203BU 
Microcentrifuge tubes 
Microliter syringes 
ONEAC PC750A power supply 
pClamp 9.0 software 
Sigma-Aldrich 
Sigma-Aldrich 
Sigma-Aldrich 
Sigma 
Fluka Biochemika 
BDH 
Sigma-Aldrich 
Sigma-Genosys 
 
 
Sigma-Genosys 
 
Sigma-Genosys 
 
 
 
Kinetic Systems 
Eppendorf 
Axon Instruments 
Barnstead Thermolyne 
Fisher 
Axon Instruments 
Wyatt Technology 
Hitachi 
VWR 
Warner Instruments 
Axon Instruments 
VWR 
Hamilton 
ONEAC 
Axon Instruments 
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Perfusion bilayer chamber and cup 
Size 000 paintbrushes 
Syringes and needles 
Welch vacuum pump 
Warner Instruments 
Island Blue 
Becton Dickinson 
Thomson Industries 
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Table  2.2  Pharmaceutical companies and addresses 
 
Company                         Address 
American Peptide 
Anaspec 
Avanti Polar Lipids 
Axon Instruments 
Barnstead Thermolyne 
BDH 
Beckton Dickinson 
Chi Scientific 
EM SCIENCE 
Eppendorf 
Fluka Biochemika 
Hamilton 
Hitachi 
Island Blue 
ONEAC 
Praxair  
Sigma 
Sigma-Aldrich 
Sigma-Genosys 
Thomson Industries 
VWR   
Warner Instruments 
Wyatt Technology 
American Peptide Company, Inc., Sunnyvale, CA, USA. 
Anaspec, Fremont, CA, USA. 
Avanti Polar Lipids, Alabaster, AL,USA 
Axon Instruments, Foster City, CA, USA. 
Barnstead Thermolyne, Dubuque, IA, USA. 
British Drug House, Saskatoon, SK, Canada. 
Beckton Dickinson and Co., Franklin Lakes, NJ, USA. 
Chi Scientific, Maynard, MA, USA.   
EM Industries Inc., Gibbstown, NJ, USA. 
Eppendorf AG, Hamburg, Germany. 
Fluka Biochemika, Buchs, Switzerland. 
Hamilton, Reno, NV, USA. 
Hitachi Ltd., Tokyo, Japan. 
Island Blue Art Supplies, Victoria, BC, Canada. 
ONEAC, Libertyville, IL,USA 
Praxair, Inc., Saskatoon, SK, Canada. 
Sigma Chemical Company, St.Louis, MO, USA. 
Sigma-Aldrich Canada Ltd., Oakville, ON, Canada. 
Sigma-Genosys, The Woodlands, TX, USA. 
Thomson Industries Inc., Louisville, KY, USA. 
VWR, Mississauga, ON, Canada. 
Warner Instruments, Hamden, CT, USA. 
Wyatt Technology Corporation, Santa Barbara, CA, USA. 
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2.2.3 The α-helical hairpin peptides 
            The α-helical hairpin peptide (FNMQCQRRFYEALHDPNLNEEQRNAKIKSIRDDC), 
containing a disulfide link at Cys 5 & 34, with and without Fmoc was analyzed (see Figure 3.6 
on page 91) (Du and Gai, 2006).  The Fmoc-α-helical hairpin peptide was 85% pure while the 
peptide without Fmoc had a purity of 79%.  Mass spectrometry was performed on all peptides 
to confirm molecular weight.  Stock solutions of 3.3 mg/mL (Fmoc-α-helical hairpin peptide) 
and 5 mg/mL (α-helical hairpin peptide, without Fmoc) were prepared in 10 mM potassium 
phosphate buffer with 1.0 M KCl at pH 7.8 for nanopore analysis.  The experiments for the α-
helical hairpin peptide that did not contain Fmoc were performed in three separate buffers, 
using 20-40 µL of peptide solution.  The three buffers were: 1.0 M KC1 in 10 mM phosphate 
buffer at pH 7.0, 1.0 M KC1 in 10 mM Tris-HCl buffer at pH 8.5 and 1.0 M KCl in 10 mM 
CHES buffer at pH 9.0.  The reason for the higher pH range was to confer negative charges on 
the unlinked sulfur atoms at Cys 5 and 34.  Tris-2-carboxyethyl-phosphine hydrochloride 
(TCEP) was used as the reducing agent to produce the unlinked or reduced sample of the α-
helical hairpin peptide.  The concentration of TCEP was at least 10 or 20 times greater than that 
of the peptide.   
             For the Fmoc-α-helical hairpin peptide, the electrolyte solution was 1.0 KCl in 10 mM 
potassium phosphate at pH 7.0 and 10 µL peptide solutions were used for nanopore analysis.  
TCEP was also used to produce the reduced form of the peptide.  Nanopore experiments were 
carried out as stated in section 2.2.1. 
  
2.3 Nanopore detection of prion peptides and proteins  
            Prion peptides, PrP(155-165):DYEDRYYRENM, and PrP(168-178):YPNQVYYRPMD 
were generous gifts from  Dr. Olga Andrievskaia, from the Canadian Food Inspection Agency, 
Nepean, Ontario, Canada (Andrievskaia et al ., 2006).  Mass spectrometry was performed on all 
peptides to confirm molecular weight.  Peptides, PrP (155-162): DYEDRYYR, Ac-PrP(145-
162):Ac-DSRPLIHFGSDYEDRYYR and  PrP(143-169):SAMSRPLIHFGNDYEDRYYRENM 
YRYP were also analyzed.  These peptides contain a α-helical region (a.a. 155-162) and a β-
strand sequence  (a.a. 172-175).  PrP(143-169) was 98% pure, while the mass of all the other 
peptides were confirmed with mass spectrometry.  Peptide stock solutions of 5 mg/mL were 
prepared in 10 mM potassium phosphate buffer with 1.0 M KCl at pH 7.8 for nanopore 
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analysis.  Nanopore experiments were carried out using 10 µL stock peptide solutions with a 
working buffer, 1.0 M KCl, 10 mM phosphate buffer at pH 7.8.  The recombinant bovine prion 
protein (bPrP, net charge +8) containing residues 25-242 with a C-terminal His5 tag was also a 
generous gift from Dr. Olga Andrievskaia (Andrievskaia et al., 2006).  A 1 mg/mL prion 
protein stock solution was prepared in 10 mM Tris-HCl buffer with 0.1 mM EDTA at pH 8.0 
for all nanopore experiments.  Nanopore analysis was carried out as stated in section 2.2.1, 
using 20 µL of bPrP in 1.0 M KCl and 10 mM phosphate buffer at pH 7.8.  When the prion 
protein was used in the experimental method stated in section 2.2.1, it was known as “vestibule 
up-stream” (with cis side negative).  The same analysis method was repeated for the prion 
protein but at applied potentials of -50 mV and -150 mV.   
           The prion protein was also analyzed by adding the protein to the trans side of the cup 
which contains the stem of αHL and also the positive electrode.  This orientation is known as 
“stem down-stream” for the positively charged protein. 
 
2.4   Prion protein and metal interactions 
2.4.1    Nanopore detection of prion protein-metal interactions  
            Stock solutions of Cu(II), Zn(II), Ni(II), Mn(II), and EDTA were prepared.  First, 20-70 
µl of the 1 mg/ml stock protein was added to the 1.5 mL cis chamber, proximal to the aperture.  
Then the divalent metal ion solution was added to the cis side of the chamber and mixed very 
gently with a pipette tip.  The concentration of the divalent metal ion was kept at least 10 times 
greater than that of the protein.  For example, when the concentration of bPrP in the cup was  
2.8 µmol/L, the Cu(II) concentration was kept at 28 µmol/L.  This solution was then left to 
incubate for 15-30 minutes.  Nanopore analysis was carried out as stated in section 2.2.1, using 
1.0 M KCl in 10 mM Tris-HCl buffer at pH 7.8.   
 
2.4.2    Dynamic light scattering 
            Dynamic light scattering (DLS) is a technique used to determine particle size 
(Fratantoni et al., 1984).  The basic theory behind DLS is that when a laser light is focused on a 
solution with particles in Brownian motion, the scattered light intensity fluctuates (Maurer-
Spurej et al., 2006).  The interaction of light with a moving particle causes a Doppler shift.  
This in turn changes the wavelength of the incoming light which is related to the size of the 
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particle.  There are two main assumptions for DLS (“Dynamic Light Scattering” by Sartor, M., 
University of California, San Diego).  First, the particles are in Brownian motion and second  
that Stokes-Einstein relation can be easily applied for the diffusion coefficient, D: 
                                                          D=KBT/6πηRH                                                   Equation 2.1 
Where KB, is the Boltzmann constant, T is the temperature in Kelvin degrees (the experiments 
in this thesis were conducted at room temperature), π = 22/7, η, is the viscosity of the solvent 
and RH is the hydrodynamic radius of the particles been analyzed.  Using this equation, the 
radius of molecules can be calculated (Maurer-Spurej et al., 2006; “Dynamic Light Scattering” 
by Sartor, M., University of California, San Diego).   
            DLS measurements were performed using a DynaPro-MS800 DLS instrument located at 
the Saskatchewan Structural Science Centre (SSSC), University of Saskatchewan.  DLS was 
used to analyze the particle size of the full length bovine prion protein and complexes formed in 
the presence of Cu(II) and Mn(II).  The protein (bPrP) having a concentration of 15-20 µg/mL 
was investigated in the presence of divalent metal ions, Cu(II) and Mn(II) where the 
concentration of the divalent metal ion was kept at least 10 times greater than that of the 
protein.  The standard molecular weight (Mw) of the proteins was calculated from the 
hydrodynamic radius of the particles, using the standard curve model that is applied for the 
globular proteins: 
                                                   Mw = [(RH factor) x RH] 
power
                                      Equation 2.2 
Where the R H factor is 1.68 and the power is 2.3398.  The factor and power are derived from the 
molecular dimensions of globular proteins and pullulans (homopolysaccaride consisting of 
maltotriose units) families (Bugs et al., 2004).   
            The result summary obtained from DLS experiments includes the following parameters: 
D (x10
-9
 cm
2
/s), RH (nm), Intensity (%) and Mw (kDa).  The data were then plotted in graphs 
having a y-axis of intensity (%) or mass (%) vs the logarithmic value of the hydrodynamic 
radius, log RH (nm).   
 
2.5   Nanopore detection of antibody-peptide interactions  
               Monoclonal antibody Jel352 which binds the epitope YSPTSPS was prepared and 
purified in Dr. Jeremy Lee’s Laboratory (Moyle, et al., 1989).  The concentration of the stock 
solution of Jel352 was 1.84 mg/mL.  Stock solutions of 5 mg/mL RG23 were prepared in 1 M 
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KCl, 10 mM phosphate buffer at pH 7.8.  Control experiments were carried out with peptide 
PrP(168-178).  2 µL peptide solutions were incubated with varying concentrations of antibody 
for 1 hour, at room temperature.  These solutions were then added to the cis chamber proximal 
to the aperture.  The electrolyte solution used for the nanopore experiments was 1.0 M KCl in 
10 mM potassium phosphate buffer at pH 7.8.  Nanopore analysis was carried out as stated in 
section 2.2.1. 
 
2.6  Prions and antibody 
 
2.6.1    Nanopore detection of prion peptide-antibody interactions  
 
            Monoclonal antibody, M2188, binds epitope, 
146
SRPLIHFG
153
 in the bovine prion was a 
generous gift from Dr. Olga Andrievskaia.  The expression and purification of this antibody is 
presented in Andrievskaia et al., 2006.  The concentration of the M2188 stock solution was 2.44 
mg/mL.  Prion, antibody interactions with the peptides, Ac-PrP(145-162) and PrP(143-169) 
containing the epitope SRPLIHFG were analyzed with M2188 using an αHL pore.  Control 
experiments were carried out with peptide, PrP(168-178).  5 µL from 5 mg/mL stock peptide 
solutions was incubated with varying concentrations of antibody for 1 hour at room 
temperature.  These solutions were added to the cis chamber proximal to the aperture.  The 
electrolyte solution for nanopore analysis was 1.0 M KCl in 10 mM potassium phosphate buffer 
at pH 7.8.  Nanopore experiments were carried out as stated in section 2.2.1. 
          Peptide SN4:GSVYYRPPRYYVPRYYVSGSVYYRPPRYYVPRYYVGSS was a 
generous gift from Dr. Scott Napper (University of Saskatchewan, Department of Biochemistry, 
and VIDO, 120 Veterinary Road, Saskatoon, Saskatchewan).  Polyclonal antibodies, SN4Ab 
and SN6Ab, which bind the epitope 
172
VYYRP
176
, were also kind gifts from Dr. Scott Napper 
(Paramithiotis et al., 2003 and Hedlin et al., 2010).  Antibody SN4Ab had a concentration of 
1.35 mg/mL while antibody SN6Ab had a concentration of 3.6 mg/mL.  5 mg/mL stock 
solutions of the peptide SN4 were prepared in 10 mM potassium phosphate buffer with 1.0 M 
KCl at pH 7.8.  Prion peptide, antibody interactions for peptides, SN4 and PrP(168-178) 
containing the epitope VYYRP  was analyzed as follows: 1 µL from 5 mg/mL stock peptide 
solutions were incubated with varying concentrations of antibody for 1 hour at room 
temperature.  Nanopore analysis was carried out as stated in section 2.2.1. 
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  2.6.2    Nanopore detection of prion protein-antibody interactions  
            Prion protein-antibody interactions were studied using bPrP and antibodies M2188 and 
SN4Ab.  A 1 mg/mL bPrP stock solution was prepared in 10 mM Tris-HCl buffer with 0.1 mM 
EDTA at pH 8.0.  20 µL from the stock protein solution were incubated with varying 
concentrations of antibody for 1 hour at room temperature.  Nanopore analysis was carried out 
as stated in section 2.2.1, using 1.0 M KCl in 10 mM potassium phosphate buffer at pH 7.8.   
 
 2.6.3    Nanopore detection of the unfolded prion protein-antibody interactions  
            20 µL from the prion protein stock solution (1 mg/mL) were denatured using 0.9 M 
Gdn-HCl.  After incubating this premix for 5-10 minutes at room temperature, the interaction of 
antibodies, M2188 and SN6Ab were investigated in separate nanopore experiments.  The 
addition of antibody at a protein: immunoglobulin ratio of 2:1 was then incubated for 15 
minutes.  This solution was then added to the cis chamber proximal to the aperture.  Nanopore 
experiments were carried out as stated in section 2.2.1, using 1.0 M KCl in 10 mM potassium 
phosphate buffer at pH 7.8.  The final concentration of Gdn-HCl in the cis chamber was 0.018 
M. 
 
2.7    Nanopore detection of signal prion peptides and protein interactions  
            Signal prion peptides, PrP(1-24): MVKSHIGSWILVLFVAMWSDVGLC  and  
PrP(243-264):VILFSSPPVILLISFLIFLIVG were analyzed.  Mass spectrometry was performed 
on these peptides to confirm their molecular weights.    PrP(106-126):KTNMKHMAGAAAAG 
AVVGGLG was also analyzed, and had a purity of over 95%.  Control experiments were 
conducted with peptide RG23(RYSPTSPSYSPTSPSYSPTSPSG).  Stock peptide solutions of 1 
mg/mL were prepared in 10 mM potassium phosphate buffer with 1.0 M KCl at pH 7.8 for all 
nanopore experiments.  1 mg/mL bPrP solutions were prepared in 10 mM Tris-HCl buffer with 
0.1 mM EDTA at pH 8.0.  20 µL of protein solution was incubated with peptide PrP(1-24) at a 
peptide-to-protein molar ratio of 1:1 for 1 hour at room temperature.  This solution was then 
added to the cis chamber proximal to the aperture.  The same analysis was repeated with 
peptides, PrP(243-264), PrP(106-126), and RG23.  Nanopore analysis was carried out as stated 
in section 2.2.1, using 1.0 M KCl in 10 mM potassium phosphate buffer at pH 7.8. 
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2.8   Aggregation of the full length prion protein 
2.8.1    Method for prion protein aggregation and nanopore detection  
            Here we attempted to aggregate the full length bovine prion protein, bPrP(25-242),  with 
 a C-terminal His5 tag  at pH 7.5 using the method described by Aperti et al, 2005.  However, 
that group used an N-terminaly truncated human prion protein, PrP(90-231) with 1 M or 2 M 
Gdn-HCl (Aperti et al, 2005).  1 mg/mL prion protein stock solutions were prepared in 10 mM 
Tris-HCl buffer with 0.1 mM EDTA at pH 8.0.  The master mix contained: 125 µL of 40 µM (1 
mg/mL) of bPrP(25-242), 5 µL of 1 M Tris-HCl at pH 7.4, and 20.37 µL of 6.38 M Gdn-HCl.  
The final concentration of Gdn-HCl was 0.86 M in this mixture.  This sample was incubated at 
37ºC and continuously rotated at 8 rotations per minute (rpm) using a Barnstead Thermolyne 
Labquake rotator.  20µL samples were withdrawn at different time intervals of 0, 18, 25, 44, 
and 68 hours followed by nanopore analysis using αHL pores.  The electrolyte solution for 
nanopore experiments was 1.0 M KCl in 10 mM potassium phosphate buffer at pH 7.8.  
Nanopore anlysis was carried out as stated in section 2.2.1. 
 
2.8.2    Thioflavin T fluorometric assay 
            For the formation of fibrils, a fluorometric Thioflavin T (ThT) was measured using an 
F-2500 Fluorescence spectrophotometer.  Samples were withdrawn at 0, 18, 25, 44, and 68 
hours and transferred to a quartz cell containing 10 µM ThT in 50 mM phosphate at pH 6.4.  
After 30 seconds of incubation, the fluorescence of ThT was measured at 482 nm upon 
excitation at 450 nm.  The final prion protein concentration in the ThT buffer was 0.415 µM.  A 
stock solution of 1 mg/mL (3.14 mM) ThT was prepared by dissolving dry powder in deionized 
water in the dark.  Using this stock solution, 10 µM ThT solutions in 50 mM phosphate buffer 
at pH 6.4 were prepared fresh daily for the fluorometric assay.   
 
2.9   The patch-clamp experimental apparatus 
 
2.9.1 The patch-clamp Instrument 
            Single-molecule nanopore analysis was conducted using a patch-clamp apparatus as 
shown in Figure 2.1.  The patch-clamp apparatus is made up of a Faraday cage (Warner 
Instrument) containing the perfusion unit (Warner Instruments), headstage (model CV203BU, 
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Figure 2.1   Images of the patch-clamp instrumental set up.  Photograph (A) is the perfusion cup containing the 150 µm aperture.  
Photograph (B) is the perfusion unit comprising the perfusion chamber and cup.  Photograph (C) shows the headstage, perfusion unit 
and electrodes in the Faraday cage.  Photograph (D) shows the entire patch-clamp instrumental setup comprising the Faraday cage, 
digitizer, amplifier and computer with pClamp 9.0 software. 
 
7
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72 
Axon Instruments), measuring and reference electrodes which are connected to the digitizer 
(Digidata 1322A, Axon Instruments) and amplifier (Axopatch 200B, Axon Instruments).  This 
entire set of instruments as shown in Figure 2.1C, is connected to a computer (Figure 2.1D).  
pClamp 9.0 software, that records data which is also used for data analysis, is installed in this 
computer.  The perfusion unit is made up of a black perfusion chamber and a white perfusion 
cup (Figure 2.1B).  The white perfusion cup contains a 150 µm aperture (Figure 2.1A), on 
which the lipid bilayer is formed followed by the insertion of a biological nanopore of αHL or 
aerolysin.  This perfusion unit separates the cis (outside) and trans (inside) compartments, 
which are filled with electrolyte solution and also contain the Ag/AgCl electrodes.  The volume 
in each of these two compartments is approximately 1.5 mL.  For all experiments stated in this 
thesis, a negative electric potential was applied to the cis compartment using the two Ag/AgCl 
electrodes.  The measuring electrode located on the trans side of the cup was connected to a 
gold pin that was further connected to the headstage.  The reference electrode on the cis side of 
the cup was also connected to the headstage.  The perfusion unit is encased in a solid block of 
copper that was placed on an active-air floating table (Kinetic Systems) located inside the 
Faraday cage.  The signals that are transmitted from the headstage are converted from voltage 
to current by the amplifier, and further converted from analog to digital by the digitizer.  The 
patch-clamp instrumental setup was powered through an ONEAC power supply that helps 
protect the network and also reduce electronic noise.   
 
 2.9.2   The formation of a synthetic lipid bilayer and pore insertion  
            First, 75 μL aliquots of the lipid 1,2-diphytanoyl-sn-glycero-3-phosphocholine in CHCl3 
(Avanti Polar Lipids) were stored in Kimble vials at -20
0
C.  Before each experiment, one 
aliquot was dried under vacuum and then re-dissolved in decane to a final concentration of 30 
mg/mL.  The lipid suspension was then applied on both sides of the 150 µm aperture located on 
the white perfusion cup using a size 000 paintbrush (Island Blue paintbrush).  The excess lipid 
was dried under a jet of nitrogen.  As mentioned in section 2.9.1, the bilayer cup has two 
compartments of about 1.5 mL each, which are termed cis and trans.  Once the lipid bilayer is 
dried, the cis and trans compartments are filled with approximately 1.5 mL of 1.0 M KCl, 10 
mM potassium phosphate (KH2PO4/K2HPO4) buffer at pH 7.8.  If different buffers were used 
they have been stated in each experimental method.  A negative transmembrane potential of  
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100 mV was usually applied using the Ag/AgCl electrodes immersed in electrolyte solution, 
where anions are driven from cis to trans.  To ensure the quality of the newly formed 
membrane, the capacitance was monitored using the pClamp 9.0 software and a value of 7-9 pF 
indicates a stable membrane into which a biological pore can insert with ease.  Furthermore, a 0 
pA ionic currentshould be recorded for a well-sealed membrane between the cis and trans 
compartments.  Following the formation of a lipid bilayer, 5-10 μL of 2.0 µg/mL, -hemolysin 
or aerolysin solutions were injected adjacent to the aperture on the cis side.  At an applied 
voltage of -100 mV, a current jump of 100 pA or 50 pA was recorded for a single pore of HL 
or aerolysin, respectively.  If more than one pore of HL or aerolysin was inserted, an open 
pore current that is multiplied by the number of pores was observed.  Once stable pore insertion 
was detected, a solution of the molecules of interest was added to the cis side, proximal to the 
aperture (Figure 2.2).  The experiments were carried out at 22 ± 1°C.   
  
2.9.3  Data recording and collection 
            The Axopatch 200B patch-clamp amplifier was connected directly to the headstage 
which forms an interface between the sample being analyzed and the main instrument device.  
The amplifier receives data from the sample and also filters the data while holding a constant 
applied voltage (Molleman, 2008).  The data were recorded as “fixed-length events”.  This 
means that the data are continuously digitized and displayed, but only saved for segments of 
specified duration (pClamp 9.0 User’s Guide, 2005).  The Axopatch 200B patch-clamp 
amplifier contains a low pass Bessel filter, which filters out all other frequencies except the 
signal of interest.  The use of filters enhances the signal-to-noise ratio. 
 
2.9.4   Raw data analysis and software 
            Raw Clampex data were analyzed using the Clampfit 9.2 software, part of the pClamp 
9.0 package, from Axon Instruments.  The Clampfit 9.2 software includes three main types of 
windows: analysis, results and layout.  In addition, a system lab book and data file index 
window is also featured.  Recorded Clampex data are first opened using the Clampfit-analysis 
window.  This opened data that are viewed on the analysis window are then auto-scaled using 
the command “auto scale all y axes”.  Following this, the “view and data display” command is 
used to display the data as a series of concatenated episodes.  All the data analysis performed in 
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Figure 2.2   Schematic of an α-hemolysin pore embedded into a lipid bilayer.  The lipid bilayer is painted across the 150 µm aperture 
located on the perfusion cup.  The perfusion unit separates the cis and trans sides.  A negative potential of -100 mV is applied 
through the Ag/AgCl electrodes.  The bumping and translocation events of a molecule are shown.  Intercalation events are not 
shown.
7
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this thesis used the “single-channel analysis” command which is displayed in the “event 
detection” tab.  The recorded data are now displayed on the screen with the y-axis presenting 
the amplitude of current blockade as “I Patch (pA)” and the x-axis as “Time (ms)” which 
represents the blockade time shown.  The amplitude of current blockade is due to the molecule 
interacting with the pore and displacing a volume of electrolyte solution, while the blockade 
time can be stated as the transport time or the time taken for a molecule to interact with the pore 
(Henriquez et al., 2004).   
            The interaction of a molecule with the pore can be stated as an “event” which is 
characterized by two parameters, the current blockade (I), and blockade time (T) (Figure 2.3).  
In general, events are of three types and are designated as bumping, intercalation and 
translocation events (Stefureac et al., 2006; Meng et al., 2010).  The bumping events also called 
type-I events have a small current blockade and are due to molecules that bump into the pore 
and then slowly diffuse away (Sutherland et al., 2004b; Stefureac et al., 2006).  The type-II 
events which could be intercalation or translocation have larger current blockades (Stefureac et 
al., 2006; Meng et al., 2010).  An intercalation event has been described in which molecules 
transiently enter the pore but do not translocate.  These events comprise large current blockades 
in which the blockade duration increases with increasing voltage (Meng et al., 2010).  As these 
molecules do not translocate, they diffuse back into the electrolyte solution using the same route 
they entered the pore.  The translocation events are assigned to molecules that are transported 
through the pore where the blockade time decreases with increasing voltage (Akeson et al., 
1999b; Sutherland et al., 2004b; Stefureac et al., 2006 ).  As both of these type-II events 
comprise large current blockades, they can only be distinguished from one another if voltage 
studies are carried out.   
           Once a set of recorded data has been identified, a continuous segment is selected for 
Clampfit 9.2 analysis.  First, a baseline is set at the open pore current level which is marked as a 
horizontal line depicting level zero.  Then a level two detection threshold was performed for all 
data.  The first base line was placed for the detection of type-I events and is marked as 
horizontal level one.  The same was done to detect the type-II events by placing a baseline 
marked as horizontal level two.  All the data analyzed in this thesis used this level two detection 
threshold which can easily identify type-I and type-II event populations (Figure 2.3).  The  
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Figure 2.3 The types of events recorded with an α-hemolysin pore.  The plot consist of 
blockade current (I) vs. blockade time (T).  The type-I events having smaller blockade currents 
are designated as bumping events and the type-II events comprising larger blockade currents 
could be either intercalation or translocation events. 
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ignore duration for events was set at 0.1 ms and the search region was set at cursor 1 and 2 
which depicts the vertical lines shown as number 1 and number 2.  Vertical cursor lines 3 and 4 
are ignored for this analysis.  Once the “event viewer” window pops up, a nonstop analysis is 
conducted.  After the analysis of a segment of recorded data is complete, the “event viewer” 
window is closed and the analyzed data are listed in the results window in a separate 
spreadsheet, named as “events”.  The data are then transferred to a separate spreadsheet and 
then the cycle begins with the selection at another segment for analysis.   
            The rise time of the instrument (Tr), is the time taken for a signal to change from a 
lower to higher value.  This instrument uses a clampfit digital filter known as a lowpass Bessel 
filter.  Tr can be calculated as 0.33/fc, where fc is the frequency of the filter.  The experiments 
conducted in this thesis used a rise time of 50 µs or more, where below this level events are 
considered too fast to be measured.  Once the raw data analysis was complete, it was transferred 
to Origin 7.0 (OriginLab Corporation, Northampton, MA).  The blockade current populations 
were obtained by fitting the blockade current distribution with the Gaussian function.  The 
lifetime data were obtained by fitting each blockade duration distribution with a single 
exponential function.  The bin increments for the blockade current and blockade time were set 
at 1 pA and 0.05 ms, respectively. 
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3.0       RESULTS 
3.1       Analysis of acetylated and Fmoc protected peptides  
3.1.1 Introduction 
            Nanopore analysis of peptides using αHL pores has been previously reported by Lee and 
co-workers (Sutherland et al., 2004a, b; Stefureac et al., 2006; Stefureac and Lee, 2006; Meng 
et al., 2010).  Fluorenylmethyloxycarbonyl (Fmoc) is a protecting group for amines which is 
added to the amino terminus of an amino acid (Carpino and Han, 1972).  Previous studies using 
Fmoc protected peptides revealed that these peptides translocate through the αHL and aerolysin 
pores more easily compared to the unprotected peptides (Stefureac et al., 2006).  This group 
used a set of negatively charged α-helical peptides for their analysis.  All peptides having a 
general formula of Fmoc-DxAyKz  where x and z  were 1, 2 or 3 and y was 10, 14, 18 or 22 
translocated through the αHL pore with blockade currents ranging between -62 pA and -78 pA 
(Stefureac et al., 2006).  Recently, peptides comprising 12 amino acids that were tethered via a 
terminal cysteine to mono-, di-, tri-, and tetrabromomethyl-substituted benzene to construct 
bundles were analyzed at different applied potentials of -50, -100 and -150 mV.  This analysis 
helped to identify a new set of events called “intercalation events” in addition to the bumping 
and translocation events mentioned in Stefureac et al., 2006 (Meng et al., 2010).  The rationale 
for the experiments presented below was first to study the interactions between peptides and 
pores and to try and gain a more detailed view of the effects of acetylation and Fmoc.  Second, I 
wanted to verify whether the introduction of one proline residue at the center of these peptides, 
which can cause a turn, bend or kink in the peptide conformation, was adequate to block the 
pore.   
 
3.1.2 Nanopore detection of Ac-D2A14K2,  Ac-D2A7PA6K2, and Fmoc-D2A7PA6K2  
            Three peptides, Ac-D2A14K2, Ac-D2A7PA6K2, and Fmoc-D2A7PA6K2 were analyzed 
using αHL pores.  All peptides had a net negative charge of -1 (at pH 7.8) and were 18 amino 
acids in length.  The nanopore experiments and data analysis were performed as described in 
the Materials and Methods section.  The interaction of the peptide with the pore can be stated as 
an event, which is characterized by two parameters, the current blockade iblock, and blockade 
time tblock (Figure 3.1).  In general, events are three types, and have been previously described 
in section 2.9.4.  The analyzed data were arranged in histograms by plotting the intensities of 
current blockade vs. the number of events.  The data analysis, in which the number of events is   
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Figure 3.1     A plot of blockade current, I (pA) vs.  blockade time, T (ms) for a string of ionic current pulses for the capped-β hairpin 
peptide.  The inset shows an expanded view of typical type-I events having smaller blockade currents, designated as bumping events 
and the type-II events comprising larger blockade currents which could be either intercalation or translocation events.   
 
    7
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counted for each 1 pA increment in the iblock, was used to plot the graphs.  Each blockade 
current distribution was fitted with a first order decay function to obtain the blockade time 
histograms.  The bin increment for the blockade duration was set at 0.05 ms.   
            For peptide Ac-D2A14K2, the blockade current and blockade time histograms are shown 
in Figure 3.2 and the parameters are listed in Table 3.1.  The Ac-D2A14K2 peptide has a net 
negative charge and thus will be driven through the αHL pore due to the negative potential 
applied on the cis side of the bilayer cup.  Upon addition of Ac-D2A14K2   to the cis side of the 
chamber, the rate of data acquisition was slow and the peptide displayed two event populations 
with approximately equal number of events under each population peak which were fitted with 
a Gaussian distribution.  Due to the single Gaussian distribution for both type-I and type-II 
events, we can conclude that only monomers are present in the peptide solution, whereas if 
complexes are formed they would give rise to multiple peaks (Sutherland et al., 2004b).  
Alternatively, if complexes are forming, they must be very weak and do not affect the type-II 
events (Stefureac et al., 2006).  The average blockade current values for peptide Ac-D2A14K2,   
for type-I (I1) and type-II (I2) events were -26 pA and -64 pA, respectively, with corresponding 
blockade time values (T1) and (T2) of 0.08 ms and 0.09 ms.  The ratio for the type-I (A1) to 
type-II (A2) events for peptide Ac-D2A14K2 was 0.95:1.  The same peptide protected with Fmoc, 
analyzed by Stefureac et al., 2006 was used to compare the difference with the acetylated 
version.  For comparison, the current blockade and blockade time histograms for Fmoc-
D2A14K2 were also included in Figure 3.2 and the parameters were listed in Table 3.1.  
However, peptide Fmoc-D2A14K2 displayed only a single Gaussian distribution of type-II 
events.  The average current blockade for Fmoc-D2A14K2, for the type-II (I2) events was -65 pA 
with a corresponding blockade time value (T2) of 0.34 ms.  Thus, acetylating a peptide reduces 
the number of type-II events as compared to Fmoc which increases it.  The data also reveal that 
the blockade current for the type-II events is essentially the same for both peptides, but the 
blockade duration is much smaller for peptide Ac-D2A14K2. 
            The Ac-D2A7PA6K2 peptide contains a proline which causes a turn or kink in the α-helix 
(Cheng and Chang, 1999).  For peptides Ac-D2A7PA6K2 and Fmoc-D2A7PA6K2, the blockade 
current and time histograms are shown in Figure 3.3 and the parameters are listed in Table 3.2.  
When peptide Ac-D2A7PA6K2 was added to the cis side of the bilayer cup, the rate of data 
acquisition was as slow as for peptide Ac-D2A14K2.  However the histogram of the blockade  
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Figure 3.2 Current blockade histograms for (a) Ac-D2A14K2 and (b) Fmoc-D2A14K2 tested on 
αHL pores at pH 7.8.  The histogram for Fmoc-D2A14K2 was obtained from Stefureac et al., 
2006.  Single Gaussian functions have been fitted for each population of events and each of the 
two blockade current distributions was fitted with a first order decay function to obtain the 
blockade time shown in panels (c) and (d).  Parameters are presented in Table 3.1.  (Figure 3.2b 
was reprinted by permission from Stefureac et al., 2006.  Copyright 2006 American Chemical 
Society.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
82 
 
 
 
 
Table 3.1.  Interaction parameters of the acetylated and Fmoc protected peptides with αHL 
pores
a
. 
 
Peptide                    I1               I2                  T1             T2            A1               A2          A1/A2       W1            W2                                
                               (pA)      (pA)      (ms)       (ms) 
 
Ac-D2A14K2            -26         -64        0.08       0.09       693      728      0.95       11.4     21.1 
                              
     
Fmoc-D2A14K2         -           -65          -           0.34        -        9505        -             -         8.3 
 
 
a 
I is the current blockade and T is the time of blockade.  The subscripts 1 and 2 refer to Type-I 
and Type-II event populations presented in Figure 3.2.  A1 and A2 are the number of events of 
each population.  W1 and W2 are the peak widths at half-height.  Fmoc-D2A14K2 data was 
obtained from Stefureac et al., 2006.  (The error is estimated to be ±1 pA for I and ±10% for T) 
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Figure 3.3 Current blockade histograms for (a) Ac-D2A7PA6K2 and (b) Fmoc-D2A7PA6K2 
tested on αHL pores at pH 7.8.  Single Gaussian functions have been fitted for each population 
of events and each blockade current distribution was fitted with a first order decay function to 
obtain the blockade time shown in panels (c) and (d).  Parameters are presented in Table 3.2.   
 
 
 
 
 
 
 
 
 
  
84 
 
 
 
 
Table 3.2 Interaction parameters of the acetylated and Fmoc protected peptides which include a 
proline at position 10
a
. 
 
Peptide                      I1               I2                  T1             T2            A1               A2          A1/A2       W1            W2                                
                                 (pA)      (pA)      (ms)       (ms) 
 
Ac-D2A7PA6K2        -24          -          0.03          -           292        -          -          4.7         - 
     
Fmoc-D2A7PA6K2     -         -67            -          0.17         -        5750       -            -        9.5 
                                               
 
 
a 
I is the current blockade and T is the time of blockade.  The subscripts 1 and 2 refer to Type-I 
and Type-II event populations presented in Figure 3.3.  A1 and A2 are the number of events of 
each population.  W1 and W2 are the peak widths at half-height.  (The error is estimated to be 
±1 pA for I and ±10% for T) 
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current for peptide Ac-D2A7PA6K2 (Figure 3.3a) appears different from peptide Ac-D2A14K2, 
with only a single Gaussian distribution for the type-I events and no clear peak for the type-II 
events can be discerned.  The type-II event populations are dispersed with varying blockade 
current values ranging from -40 pA to -100 pA.  Therefore it would appear that many 
conformations of the Ac-D2A7PA6K2 peptide are present in the peptide solution which may 
form multiple complexes that do not readily intercalate or translocate the pore.  The average 
blockade current values for the type-I (I1) events were -24 pA with a corresponding blockade 
time value (T1) of 0.04 ms.  These results show that the addition of a proline in the middle of an 
acetylated peptide further reduces the number of type-II events.  In contrast, the histogram of 
the blockade current for peptide Fmoc-D2A7PA6K2 (Figure 3.2b) gave a single population of 
type-II events having an average blockade current (I2)  of -67 pA with a corresponding 
blockade time (T2) of 0.17 ms.  Thus, acetylation of the N-terminus of peptide D2A7PA6K2 
decreased the number of type-II events as compared to the Fmoc- D2A7PA6K2. 
 
3.2   Analysis of hairpin peptides  
 
3.2.1 Introduction 
 
3.2.1.1   The structure of α-helical and β-sheet hairpin peptides 
 
            In light of the results above, we were encouraged to go a step further and study the 
interactions of peptides that had different secondary structures.  Do different types of secondary 
structures such as α-helical and β-sheet regions in small peptides give specific signatures with 
nanopore analysis?  These data may help to interpret the conformational changes and folding 
patterns that take place during peptide-pore interactions.  For this purpose, a 15-residue β-
hairpin and a 34 residue α-helical hairpin which also contained a disulfide link were analyzed.   
            β-hairpins are the simplest models for the study of  protein folding.  They consist of two 
antiparallel β-strands linked by a turn or a short loop (Wu and Brooks, 2004).  Conformational 
studies of β-hairpins provide insight into the early events of protein folding (Blanco et al., 
1994).  The folding energetics of β-hairpins have been developed using computational models, 
but only a few experimental studies have been reported.  Among them, infra red (IR) and 
temperature-jump (T-jump) studies demonstrate that the folding of a β-hairpin is consistent with 
the hydrophobic collapse model (Pande and Rokhsar, 1999).  The hydrophobic collapse model 
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is mainly applied to the folding pathway of proteins which first fold into native secondary 
structures and then collapse due to the hydrophobic effect that go to form the globular structure 
(Sadqi et al., 2003).  Using a fluorescence T-jump technique, the folding of a 16 residue β-
hairpin fragment from the C-terminal amino acid sequence 41-56, of protein GB1 
(immunoglobulin G binding protein located on the cell wall of group G Streptococci containing 
the immunoglobulin G binding domain B1) at room temperature was 6 μs, which is 30 times 
slower than that of α-helix formation (Kobayashi et al., 1995; Xu et al., 2003).  The folding of a 
β-hairpin follows the basic laws of protein folding, which include hydrogen bonding, 
hydrophobic interactions and a two state behavior (Munoz et al., 1997).  Furthermore, the 
formation of a β-hairpin in the GB1 peptide was studied using multi-probed thermodynamic 
characterization, which is a study of the folding/unfolding equilibrium by measuring 
temperature-dependence on the structural features such as absorption, fluorescence, CD and 
NMR.  It was found that the β-hairpin formation is a first-order phase transition between two 
states without any distinguishable intermediates (Honda et al., 2000). 
            The α-helical hairpin is a helix-turn-helix motif, which consists of two antiparallel 
helices connected by a reverse turn.  The most important aspect in the structure of the α-helical 
hairpin is that it resembles a protein folding intermediate (Fezoui et al., 1994).  IR and T-jump 
studies suggest that the folding of α-helical hairpins is ultra fast with a rate of (~ 4.0 x 105 s-1) 
and the hydrophobic cluster stabilizes the native structure (Du and Gai, 2006).  The helix-turn-
helix is also an important structure for DNA-binding proteins (Huffman and Brennan, 2002).   
          
3.2.2. Nanopore detection of α-helical and β-sheet hairpin peptides 
              
            Three peptides were analyzed; a capped (Ac-SESYINPDGTWTVTE-NH2) and an 
uncapped (SESYINPDGTWTVTE) 15-residue β-hairpin and a 34 residue α-helical hairpin 
(FNMQCQRRFYEALHDPNLNEEQRNAKIKSIRDDC), with a disulfide link between Cys 5 
& 34.  The structure and dimensions of the capped and uncapped β-hairpins are shown in 
Figure 3.4 and both peptides have a net negative charge of -3 and are 15 amino acids in length.  
For the capped and uncapped β-hairpins, the blockade current and blockade time histograms are 
shown in Figure 3.5 and the parameters are listed in Table 3.3.  For both the capped and 
uncapped β-hairpins there was a single Gaussian distribution for each population of events.  
Due to the single Gaussian distribution for both type-I and type-II events, we can conclude that  
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Figure 3.4 Diameter of the loop and the distance between the β-strands of the capped and 
uncapped β-hairpin peptides calculated using Spartan software program (SpartanModel).  The 
dimensions are given in Ångstroms (Å). 
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Figure 3.5 Current blockade histograms for (a) capped β-hairpin and (d) uncapped β-hairpin at pH 7.8.  Single Gaussian functions 
have been fitted for each population of events and each blockade current distribution was fitted with a first order decay function to 
obtain the blockade time shown in panels (b-c) and (e-f).  Parameters are presented in Table 3.3.   
8
8
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Table 3.3   Interaction parameters of the capped and uncapped β-hairpin peptides a. 
 
 
Peptide                               I1             I2                T1           T2          A1             A2        A1/A2     W1           W2                                
                                          (pA)     (pA)    (ms)     (ms) 
β-hairpins  
    
capped                              -30       -72       0.03     0.07    892    2567   0.347    9.6      14.1 
 
 
uncapped                         -30       -67       0.02     0.10   1107    703    1.575    6.3      17.0 
 
 
 
a 
I is the current blockade and T is the time of blockade.  The subscripts 1 and 2 refer to Type-I 
and Type-II event populations presented in Figure 3.5.  A1 and A2 are the number of events of 
each population.  W1 and W2 are the peak widths at half-height.  (The error is estimated to be 
±1 pA for I and ±10% for T). 
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only monomers are present in the peptide solution.  The ratio of type-II (A2) to type-I (A1) 
events for the capped β-hairpin peptide was 2.87:1 which decreased to 0.63:1 for the uncapped 
β-hairpin peptide.  Thus, the uncapped β-hairpin may fold more, causing a reduction in the 
type-II events as compared to the capped β-hairpin. 
            First, the analysis of the α-helical hairpin peptide that did not contain an Fmoc at the N-
terminus was performed at different pH values of 7.0, 8.5, and 9.0 using three separate buffers.  
TCEP was used as the reducing agent to produce the unlinked form of the α-helical hairpin 
peptide.  The concentration of TCEP was kept at least 10 times greater than that of the peptide.  
The reason for an increase in pH was to confer a negative charge on the two Cys derivatives at 
position 5 and 34 in the unlinked peptide (Figure 3.6a).  For the crosslinked α-helical hairpin 
peptide that did not contain Fmoc, there was a single Gaussian distribution for each population 
of events.  However, the number of type-I events for the crosslinked α-helical hairpin peptide 
(without Fmoc) at all the above mentioned pH values was much higher compared to the type-II 
events.  When TCEP was used to form the unlinked peptide, the overall distribution for each 
population did not change significantly.  These results suggest that in the absence of Fmoc, 
crosslinked and unlinked α-helical hairpins give very few type-II events. 
            Due to the results obtained for peptide Fmoc-D2A7PA6K2 which was stated in section 
3.1, where the number of type-II events increased when the acetyl group was substituted by 
Fmoc, it was decided to add an Fmoc to the N-terminus of the 34 residue α-helical hairpin 
(Figure 3.6b).  The results for the Fmoc-crosslinked and Fmoc-unlinked α-helical hairpin 
peptides are shown in Figure 3.7 and the parameters are listed in Table 3.4.  These results are 
different from the α-helical hairpin without Fmoc.  The results for Fmoc-crosslinked α-helical 
hairpin are unusual in that there are three peaks, with two peaks being roughly Gaussian and 
depicting type-I and type-II events at -31 pA and -74 pA respectively (Figure 3.7a).  The peak 
centered between -40 and -50 pA may represent either N- or C-terminal entry into the pore or a 
different conformation.  However, the number of events between -40 to -50 pA decreased for 
the Fmoc-unlinked form (Figure 3.7b).  For the Fmoc-crosslinked α-helical hairpin, the ratio of 
type-II/type-I events was approximately 1:1.  Upon the addition of TCEP this ratio increased to 
approximately 3:1.  These results suggest that Fmoc-crosslinked and Fmoc-unlinked α-helical 
hairpins do interact with αHL pores and cause current blockade events of type-I and type-II.   
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Figure 3.6 α-helical hairpins containing the disulfide link at Cys 5 & 34 shown in dark blue.  
(a) The reaction with TCEP at pH 8.5 and 9.0 gives a negative charge at Cys 5 and 34 in the 
unlinked hairpin.  (b) The N-terminal of the α-helical hairpin is protected with Fmoc and when 
TCEP is added at pH 7.0, no charge is present in the unlinked peptide.  Modified from Du and 
Gai, 2006.  (Reprinted by permission from Du and Gai, 2006.  Copyright 2006 American 
Chemical Society.)    
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Figure 3.7 Current blockade histograms for the (a) Fmoc-crosslinked and (b) Fmoc-unlinked α-
helical hairpin tested on αHL pores at pH 7.0.  Parameters are presented in Table 3.4.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
93 
 
 
 
Table 3.4.  Interaction parameters of the Fmoc-crosslinked and Fmoc-unlinked α-helical 
hairpin peptides at pH 7.0 
a
. 
 
 
Peptide                               I1             I2                T1           T2          A1             A2        A1/A2     W1           W2                                
                                          (pA)     (pA)    (ms)     (ms) 
Fmoc-α-helical hairpin    
 
Fmoc-crosslinked            -31       -74      0.07      0.28    3173   3174   0.99      7.0     24.7  
 
 
Fmoc-unlinked                -31       -77      0.07      0.24    2435   7130   0.34      6.2     20.5 
 
 
 
 
a 
I is the current blockade and T is the time of blockade.  The subscripts 1 and 2 refer to Type-I 
and Type-II event populations presented in Figure 3.7.  A1 and A2 are the number of events of 
each population.  W1 and W2 are the peak widths at half-height.  (The error is estimated to be 
±1 pA for I and ±10% for T). 
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3.3   Nanopore analysis of prion peptides and proteins 
 
3.3.1    Introduction  
           The long term goal of this work was to develop an electrophoretic prion detector using 
αHL pores.  The prion protein has been implicated in a number of neurodegenerative diseases, 
called transmissible spongiform encephalopathies (TSEs) (Prusiner, 2001; Cobb et al., 2009).  
In normal tissue, the prion protein is soluble and protease sensitive and the secondary structure 
is mostly α-helical (PrPC).  In the disease state, the protein aggregates and is insoluble, becomes 
protease resistant, and adopts a mostly -sheet structure (PrPSc) (Morillas et al., 2001; Bennion 
et al., 2004;).  The aggregated PrP
Sc
 eventually leads to neuronal apoptosis similar to other 
protein misfolding diseases such as Alzheimer’s and Parkinson’s disease (Chiti et al., 2006; 
Gaggelli et al., 2006; Lansbury et al., 2006;Uversky et al., 2008).  In contrast to the latter, prion 
diseases are transmissible because PrP
Sc
 can cause the conversion of PrP
C
 to more PrP
Sc
 in an 
autocatalytic reaction (Saborio et al., 2001; Collinge et al., 2007; Castilla et al., 2008; Cobb et 
al., 2009).  Although the incidence of the disease in humans is low, there is evidence that it can 
be transmitted by consuming infected meat from livestock (Prusiner, 2001).  As well, there is 
no reliable pre-mortem test, and so the discovery of a single sick animal has led to the 
mandatory slaughter of the whole herd.  Thus, the development of a simple diagnostic test for 
TSE before the occurrence of neurological symptoms is imperative. 
            First, we wanted to investigate if small peptides having α-helical and β-sheet sequences 
in prions would give specific signatures with nanopore analysis.  Second, we wanted to 
investigate if the full length recombinant bovine prion protein (bPrP) gives type-I or type-II 
events.  For this purpose, bPrP was analyzed at different voltages.  In addition, bPrP was also 
analyzed in the presence of TCEP which reduced the disulfide bond in the protein, as well as 
EDTA a metal chelating agent which sequesters divalent metal ions.  Experiments were also 
conducted using different orientations with respect to the location of the negative potential in 
the cis or trans side of the lipid bi-layer.   
 
3.3.2 α-helical and β-sheet prion peptide analysis with α-hemolysin and aerolysin   
            Three peptides derived from bPrP: PrP(155-162):DYEDRYYR, PrP(145-162):Ac- 
DSRPLIHFGSDYEDRYYR that substituted M with D at position 145, and PrP(168-
178):YPNQVYYRPMD that substituted V with M at position 177, were analyzed (bPrP 
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sequence from NCBI: P10279, gi130910).  Peptides PrP(155-162) and PrP(145-162) contained 
the α-helical region 155-162, while  peptide PrP(168-178) contained the β-strand segment 172-
175.  In addition, PrP(168-178) was also analyzed using an aerolysin pore.   
            Peptide PrP(155-162) has a net negative charge of -1 and the histogram of blockade 
current  and time are shown in Figure 3.8 (a-d) and the parameters are listed in Table 3.5.  
PrP(155-162) is unusual in that it gives three peaks, with each peak being roughly Gaussian.  
The peak 1 in Figure 3.8a centered at -30 pA is due to type-I events, whereas peaks 2 and 3 
which are centered at -50 pA and -60 pA are type-II events.  The simplest explanation is that the 
peaks represent either N- or C-terminal entry to the pore or that the peptide can adopt two 
different conformations.  The blockade current values for PrP(155-162) are not unreasonable as 
the peptide is only 8 amino acids in length and may not be able to form a stable α-helical 
structure as compared to the results obtained for the negatively charged Fmoc-α-helical 
peptides.   
            The acetylated PrP(145-162) is neutral and displayed two event populations that were 
fitted with Gaussian distributions [Figure 3.8 (e-g)].  Surprisingly, even though PrP(145-162) is 
only 18 amino acids in length, it showed a higher blockade current of -87 pA for type-II events.  
Also, for PrP(145-162) the blockade time for the type-II events was 0.23 ms compared to 0.01 
ms recorded for the 18 amino acid long Ac-D2A14K2.   
            The blockade current and time histograms for PrP(168-178) are shown in Figure 3.8 (h-
k) and parameters in Table 3.5.  At an applied voltage of 100 mV, the open current for αHL is 
100 pA, whereas for aerolysin it is 50 pA.  Analysis of PrP(168-178) with αHL displayed a 
single population of type-II events which was fitted with a Gaussian distribution.  Again, 
surprisingly PrP(168-178) which contains only 11 amino acids showed a higher blockade 
current of -74 pA for the type-II events.  However, when PrP(168-178) was analyzed with the 
aerolysin pore (Figure 3.8j), in addition to the type-II event population that was roughly 
Gaussian, a small increase in the number of bumping events were also seen.   
 
3.3.3   Prion protein analysis with α-hemolysin  
3.3.3.1   Nanopore analysis of bPrP at  -50 mV, -100 mV and -150 mV 
           The full length bPrP, having a net charge of +8 at pH 7.8 and containing residues 25-242 
with a C- terminal His5 tag, was analyzed.  The protein was added to the cis side of the 
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Figure 3.8  Current blockade histograms for prion peptides.  (a) PrP(155-162), (e) PrP(145-162) contains the α-helical region and 
PrP(168-178) in (h) and (j)  contains the  β-sheet region in bovine prion protein.  Peptides shown in histograms (a), (e) and (h) were 
tested on αHL pores while histogram (j) was tested on aerolysin.  Histograms of blockade time are shown in (b-d), (f-g), (i) and (j). 
Parameters are presented in Table 3.5.   
9
6
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Table 3.5.  Interaction parameters of the recombinant bovine prion peptides 
a
. 
 
Peptide                             I1               I2                I3                T1            T2           T3         A1              A2            A3             A1/A2        W1            W2         W3                        
                                       (pA)       (pA)     (pA)      (ms)        (ms)      (ms) 
 
(i) Tested with αHL  
  
PrP(155-162)                -33         -51         -59       0.27         0.09      0.05      1709      1571     1571           -            4.9        10.9       2.8 
 
PrP(145-162)                -28           -           -87       0.12           -         0.22       2154         -        1040        2.07          7.2          -        13.1 
 
PrP(168-178)                  -              -          -74          -              -         0.19         -            -         1013           -              -            -         7.64 
 
 
(ii) Tested with aerolysin  
  
 PrP(168-178)                 -              -           -31          -            -           0.13        -             -         3292            -             -           -        9.39 
 
 
 
a 
I is the current blockade and T is the time of blockade.  The subscripts 1 and 2, 3 refer to Type-I and Type-II events, respectively.  
The current blockade histograms are shown in Figure 3.8.  A1, A2 and A3 are the number of events of each population.  W1, W2 and 
W3 are the peak widths at half-height.  (The error is estimated to be ±1 pA for I and ±10% for T). 
 
 
9
7
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chamber, which also contained the vestibule of αHL and the negative electrode.  This type of 
analysis is defined as “vestibule up-stream” for positively charged molecules because any 
interactions with the pore will be diffusion-controlled (Figure 3.9).  After the addition of the 
protein, a complete profile could be accumulated in approximately 3-4 hours (Figure 3.10).  
With a single pore insertion, the rate of data acquisition was slow.  The histograms for the 
blockade current and time are shown in Figure 3.11 and the parameters are listed in Table 3.6.  
For αHL, the open pore current is directly proportional to the applied voltage.  At -50 mV, very 
few translocations were observed (Figure 3.11a); presumably because the potential was not 
sufficiently large to unfold the protein even if it enters the vestibule of the pore.  However at -
100 mV (Figure 3.11b), bPrP displayed two events populations corresponding to type-I (I1= -27 
pA) and type-II (I2= -65 pA) events which were fitted with a Gaussian distribution.  The ratio of 
type-I (A1) to type-II (A2) events was 1.37:1 with approximately 42% being type-II events.  
This ratio decreased to 1.20:1 when EDTA was added (Figure 3.11d).  At -150 mV (Figure 
3.11c), bPrP still displayed two event populations, corresponding to type-I (I1=-39 pA) and 
type-II (I2= -102 pA) events which were fitted with a Gaussian distribution.  The percentage of 
translocation events did not change significantly and only increased to 45%.  Finally, no 
significant change was observed for bPrP in the presence of TCEP.  Although translocation of 
such a large molecule may appear unlikely, further justification and a model for the type-II 
events are presented in section 4.3.1 and Figure 4.1c. 
 
3.3.3.2    Analysis of bPrP, stem down-stream   
            After formation of stable pores in the lipid membrane, the protein was added to the trans 
side of the chamber, which contained the stem of αHL and also the positive electrode.  bPrP has 
a net positive charge and thus will be driven through the pore when added to the trans side.  
This type of analysis is defined as “stem down-stream”.  The histograms of blockade current 
and time are shown in Figure 3.12 and the parameters are listed in Table 3.7.  Again, bPrP 
displayed two events populations corresponding to type-I (I1= -27 pA) and type-II (I2= -71 pA) 
events which were fitted with a Gaussian distribution.  The ratio of type-I (A1) to type-II (A2) 
events reduced to 0.85 as compared to 1.37 when analyzed vestibule up-stream.  Also, the 
blockade time for bPrP when added stem down-stream was approximately twice as large 
compared to vestibule up-stream. 
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Figure 3.9 The α-hemolysin pore depicting vestibule up-stream and stem down-stream 
orientations for bPrP. 
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Figure 3.10 Current traces for bPrP with a single pore of αHL.  Events are recorded for vestibule up-stream experiments.  Typical 
type-I and type-II events are shown. 
 
1
0
0
 
 
  
101 
 
 
 
Figure 3.11 Current blockade histograms for bPrP added vestibule up-stream.  (a) -50 mV, (b) -
100mV, (c) -150mV, and (d) bPrP with EDTA at -100mV tested on αHL pores at pH 7.8.  
Histograms of blockade time are shown in (e), (f-i), (g-j), (i) and (h-kj).  Parameters are 
presented in Table 3.6.   
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Table 3.6.  Interaction parameters of the recombinant bovine prion protein 
a
. 
 
Voltage (mV)                     I1                        I2                       T1                  T2               A1                    A2                     A1/A2            W1                    W2                                 
                                          (pA)              (pA)            (ms)              (ms) 
 
(i) bPrP (vestibule up-stream with cis side negative) 
  
     -50                                -13                  -                 0.03                -               446                -                     -                  5.9                 - 
 
    -100                               -27               -65                0.02              0.13           853              619                1.37             12.2              20.0 
 
    -150                               -39              -102               0.06              0.17           230              193                1.19              9.2               25.0 
 
 
 (ii) bPrP + EDTA (vestibule up-stream with cis side negative) 
 
   -100                               -30               -69                0.02              0.23          2098             1735               1.20              12               18.0 
 
 
 
 a 
I is the current blockade and T is the time of blockade.  The subscripts 1 and 2 refer to Type-I and Type-II event populations 
presented in Figure 3.11.  A1 and A2 are the number of events of each population.  W1 and W2 are the peak widths at half-height.  
(The error is estimated to be ±1 pA for I and ±10% for T). 
1
0
2
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Figure 3.12 Current blockade histograms for bPrP at -100 mV at pH 7.8.  (a) bPrP added stem 
down-stream.  (b) bPrP added vestibule up-stream.  Parameters are presented in Table 3.7. 
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Table 3.7  Interaction parameters of the recombinant bovine prion protein added stem down-stream and vestibule up-stream.   
 
Voltage (mV)                  I1                        I2                         T1                  T2                A1                    A2                     A1/A2             W1                    W2                                 
                                       (pA)             (pA)            (ms)             (ms) 
 
Stem down-stream 
 
    -100                            -27                -71              0.06              0.29           873           1018            0.85              12.1             17.0 
 
 
 
Vestibule up-stream 
 
    -100                            -27                -65              0.02              0.13           853            619            1.37               12.2            20.0 
 
 
 
a 
I is the current blockade and T is the time of blockade.  The subscripts 1 and 2 refer to Type-I and Type-II event populations 
presented in Figure 3.12.  A1 and A2 are the number of events of each population.  W1 and W2 are the peak widths at half-height.  
(The error is estimated to be ±1 pA for I and ±10% for T). 
1
0
4
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3.4   Analysis of the interaction of metal ions with prion protein  
 
3.4.1   Introduction 
            The binding of metal ions to PrP
C
 has received considerable attention because there is 
evidence from multiple lines of research that it can cause changes in conformation (Todorova –
Balvay et al., 2001;Quaglio et al., 2001; Burns et al., 2003; Morante et al., 2004; Leach et al., 
2006).  It has been shown that Cu(II) binding causes structural changes in PrP
C
, suggesting that 
the misfolding and fibrillization of PrP
C
 may be profoundly influenced by the presence of Cu(II).  
The octapeptide repeat (residues 60-91 in human) is highly conserved and contains four tandem 
sequences of PHGGGWGQ.  As many as six Cu(II) molecules can bind to human PrP
C
, whereas 
two bind initially to His95 and His110;  these histidine residues are between the octapeptide repeats 
and the  structured domain (Figure 3.13).  The other four bind to His60, His68, His76, and His84 at 
the four octapeptide repeat sequences (Viles et al., 2008).  Elimination of this region does not 
prevent formation of PrP
Sc
, but addition of further repeats increases the likelihood of the 
development of spontaneous TSE, confirming the region’s importance in disease pathogenesis 
(Goldfarb et al., 1991; Croes et al., 2004). 
             The affinity for other divalent metal ions is reasonably lower (Stockel et al., 1998; 
Millhauser, 2004).  Cu(II) binding to the octapeptide repeat may influence the folding of the C-
terminal domain and cause self-association of the protein (Wells et al., 2006; Thompsett and 
Brown, 2007).  The rationale for the experiments presented below was to demonstrate that the 
conformation of the prion protein can be modulated by binding divalent metal ions.  Therefore, 
nanopore analysis of bPrP in the presence of Cu(II), Zn(II), Ni(II), and Mn(II))was carried out. 
 
3.4.2   Nanopore detection of bPrP(25-242) with metal ions 
            An investigation of the effect of metal ions on bPrP is shown in Figure 3.14 and the 
results are summarized in Table 3.8.  As described earlier, in the absence of metal ions, bPrP 
showed two distinct populations corresponding to type-I and type-II events (Figure 3.14a).  Upon 
addition of Cu(II) (bPrP at 2.8 µmol.L
-1
 and Cu(II) at 28 µmol.L
-1
) the type-II events disappeared 
and the value of  the blockade current for the type-I (I1) events  decreases by about 7 pA.  The 
bumping peak becomes much sharper as was observed previously for Zn(II) binding to a Zn-
finger protein (Stefureac and Lee, 2008).  However, the conformational change induced by Cu(II) 
was readily reversed by the addition of an excess of EDTA (Figure 3.14f).  The addition of  
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Figure 3.13 Human PrP
C
 structure with six Cu(II) binding sites.  Residues 60-90 constitute the 
octarepeat regions and the structured helical region is from 126-231.  (Reprinted by permission 
from Viles et al., 2008.  Copyright 2008 The Biochemical Society) 
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Figure 3.14 Current blockade histograms for metal prion interactions.  (a) bPrP, (b) with Cu(II) 
10 X, (c) with Zn(II) 10 X, (d) with Ni(II) 10 X, (e) with Mn(II) 10 X, and (f) after the addition of 
Cu(II), then EDTA.  Parameters are stated in Table 3.8. 
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Table 3.8 Event parameters for bPrP and metal interactions
a
. 
 
a 
I is the current blockade and T is the time of blockade.  The subscripts 1 and 2 refer to Type-I 
and Type-II event populations presented in
 
Figure 3.1 4.  A1 and A2 are the number of events per 
pore per minute for each population.  W1 and W2 are the peak widths at half-height.  (The error is 
estimated to be ±1 pA for I and ±10% for T).   
 
 
 
 
 
 
 
 
 
 
Compound I1 (pA) I2 (pA) T1 (ms) T2 (ms) A1 A2 A2/A1 W1 W2 
bPrP -31 -66 0.03 0.30 3524 2148 0.6 11.0 18.0 
bPrP : Cu(II) 1:10 -24 - 0.20 - 2608 - - 3.0 - 
bPrP : Zn(II) 1:10 -28 - 0.12 - 3108 - - 10.5 - 
bPrP : Ni(II) 1:10 -31 -71 0.12 0.30 1519 983 0.6 13.9 20.0 
bPrP : Mn(II) 1:10 -30 -75 0.03 0.29 1006 1839 1.8 11.3 10.6 
bPrP:Cu(II):EDTA 
1:10:500 
-31 -74 0.02 0.20 788 527 0.7 11.5 20.0 
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Zn(II) (Figure 3.14c) clearly decreases the proportion of type-II events, but the changes in the 
bumping peak are less pronounced than with Cu(II).  The effect of Ni(II) (Figure 3.14d) was 
tested as a control because of the presence of the His-tag on the bPrP, but there was little change 
compared to Cu(II) or Zn(II).  Surprisingly, the addition of Mn(II) (Figure 3.14e) caused a 
significant increase in the proportion of type-II events with the type-I (A1) to type-II (A2)  ratio 
increasing from 0.6 to 1.8.  Thus, Mn(II)  appears to promotes translocation.   
 
3.4.3    Dynamic light scattering of bPrP(25-242) with metal ions   
            Dynamic light scattering (DLS) experiments of bPrP in the presence of Cu(II) and Mn(II) 
was  performed as stated in the Material and Methods section.  The data were plotted on graphs 
having a y-axis of intensity (%) or mass (%) vs the logarithmic value of the hydrodynamic radius; 
log RH (nm) as shown in Figure 3.15.  The hydrodynamic radius, RH, of bPrP particles at a 
concentration of 100 µg/mL was determined to be 2.55 nm with a molecular weight (Mw) of 
29.09 kDa.  In the presence of Cu(II), aggregation was observed  with a RH value of 
approximately 230.8 nm and a Mw ~ 2.30 X 10
7
.  Yet when Mn(II) was added, the value of RH 
was 3.51 nm while the molecular weight  was approximately 75.94 kDa, which was about twice 
the molecular weight of bPrP.  The concentration of the divalent metal ions in these experiments 
was kept at least 10 times greater than that of the protein.  The measurements observed for DLS 
indicate that the binding of Cu(II) to bPrP caused the hydrodynamic radii of bPrP to increase 
almost 75 fold while the presence of Mn(II) only changed the bPrP radii by 1 nm.  These data 
support the results obtained with nanopore analysis. 
 
3.5   Nanopore detection of antibody peptide interactions 
3.5.1    Introduction 
              The next experiments were designed to identify distinct conformational changes that 
occurred due to complex formation between antibodies and peptides.  For this purpose, the 
evolutionarily conserved C-terminal heptapeptide repeat domain sequence Tyr-Ser-Pro-Thr-Ser-
Pro-Ser, of the largest subunit polypeptide (RPO21) of eukaryotic RNA polymerase II that binds 
to specific monoclonal antibodies developed in Lee’s laboratory was used (Moyle et al., 1989).  
These monoclonal antibodies known as Jel351, Jel352, Jel354 and Jel355 inhibited the initiation 
of transcription from mammalian promoters in vitro. 
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Figure 3.15 Dynamic light scattering measurements of bPrP.  The x-axis and y-axis show the 
logarithmic value of the hydrodynamic radius, RH vs. the percentage of mass.  Graph (A), shows 
bPrP in the absence of metal ions.  Graph (B) shows bPrP in the presence of Cu(II).  Graph (C) 
shows bPrP in the presence of Mn(II). 
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3.5.2   Nanopore analysis of Jel352 and peptide RG23 
            Nanopore analysis is used as a novel method to investigate these interactions.  The 
experiments presented below used a 23 residue peptide, RG23, which has a net charge of +1 at 
pH 7.8.  Peptide RG23:RYSPTSPSYSPTSPSYSPTSPSG contains the sequence YSPTSPS which 
is the epitope for Jel352.  The blockade current histograms for RG23 and a control peptide, 
PrP(168-178),  are shown in Figure 3.16 and the parameters are listed in Table 3.9.  Peptide 
RG23, showed a single Gaussian distribution of type-II events with a peak centered at -75 pA.  
On the addition of Jel352 at a peptide-to-antibody ratio of 2:1, the number of type-II events were 
reduced to approximately half with  the new presence of an additional peak of type-I events 
(Figure 3.16b).  The ratio for the type- I(A1) to type-II (A2) was 0.85.  The antibody by itself 
(Figure 3.16c) also gave rise to a number of events that were subtracted from the event profile of 
the complex (Figure 3.16d).  Alternatively, the apparent events may be due to impurities within 
the antibody preparation.  Intermediate ratios of antibody/peptide were also studied.   
            As a control, the same analysis was repeated with PrP(168-178), which does not contain 
the epitope for Jel352 (Figure 3.16f).  It is clear from the event profile that no significant 
interaction can be detected, although there seemed to be a small increase in the number of type-II 
events, with almost double the peak width at half height (Table 3.9).  In Figure 3.16g, the 
appearance of a negative bumping peak in addition to about a 30% decrease in the type-II events, 
suggested that the complex gave rise to fewer events. 
 
3.6   Analysis of antibody prion interactions  
 
3.6.1 Introduction 
 
             Although the concentration of PrP
Sc
 is highest in the brain, it is also found in lymphoid 
tissue, blood, urine, saliva, and milk (Soto, 2004; Grinkevich et al., 2005; Seeger et al., 2005; 
Sage, 2006).  Thus, a non-invasive diagnostic test is possible but it would have to be extremely 
sensitive since the detection limit would have to be of the order of 100 molecules per ml of blood 
during the presymptomatic phase (Hill et al., 1997).  The test would also have to be extremely 
specific since PrP
C
 is present on the surface of many cell types (Caughey and Baron, 2006).  For 
this reason, several groups have explored the use of antibodies which can distinguish between 
PrP
C
 and PrP
Sc
 based upon the exposure of different epitopes in the two forms (Demart et al., 
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Figure 3.16 Current blockade histograms for peptide and Jel352 interactions.  (a)RG23; (b) RG23 with Jel352, 2:1 ratio; (c) Jel352 
alone; (d) subtraction of Jel352 from panel (b); (e) PrP(168-178); (f) PrP(168-178) with Jel352, 2:1 ratio; (g) subtraction of Jel352 
from panel(f).  Parameters are presented in Table 3.9.
1
1
2
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            Table 3.9 Event parameters for RG23, RG23/Jel352 complex,  PrP(168-178), and PrP(168-178)/Jel352 complex
a 
 
 
 
                  
 
 
 
 
 
 
 
a 
I is the current blockade and T is the time of blockade.  The subscripts 1 and 2 refer to Type-I and Type-II  
event populations presented in
 
Figure 3.16.  A1 and A2 are the number of events per pore per minute for each population. 
 W1 and W2 are the peak widths at half-height.  (The error is estimated to be ±1 pA for I and ±10% for T). 
 
Compound I1 (pA) I2 (pA) T1 (ms) T2 (ms) A1 A2 A1/A2 W1 W2 
          
RG23  - -75  - 0.16  1.6 16.4 0.09 - 14.6 
          
RG23/Jel352 2:1 -30  -67 0.06  0.12  7.2 8.4 0.85 5.9 21.3 
          
PrP(168-178) - -70 - 0.26  - 27.6 - - 6.7 
          
PrP(168-178)/Jel352 2:1 - -72 - 0.22  - 32.1 - - 11.6 
1
1
3
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               1999; Paramithiotis et al., 2003; Andrievskaia et al., 2006; Polymenidou et al., 2008).  One 
promising epitope is VYYRP, residues 171-175 in the bovine sequence, which is buried in PrP
C
 
but is available as part of an exposed -sheet in PrPSC (Paramithiotis et al., 2003).  There is also 
evidence that antibodies can be used therapeutically by blocking conversion or helping to clear 
PrP
SC
 from infected cells (Heppner et al., 2001; Antonyuk et al., 2009).   
            The next set of experiments was designed to identify distinct conformational changes 
that occurred due to complex formation between antibodies and prion peptides and proteins.  
Previous work with peptides showed that the parameters I and T are dependent on many factors 
such as length, charge, hydrophobicity, and even the dipole moment of the peptide (Sutherland 
et al., 2004b; Stefureac et al., 2006; Wolfe et al ., 2007; Movileanu, 2008;).  In addition, 
conformational changes can be detected (Goodrich et al., 2007; Stefureac and Lee, 2008).  For 
example, in the absence of metal ions, Zn-finger peptides can readily translocate, but upon 
binding  Zn(II) the peptide folds into a rigid conformation which is now too large to pass 
through the pore (Stefureac and Lee, 2008).  Similarly, larger molecular complexes have been 
studied using solid state pores.  For example, when an antibody Fab fragment binds to its target, 
the current blockade increases so that the free and bound forms can be distinguished (Siwy et 
al., 2005; Dekker, 2007; Hurt et al., 2009).  Here we provide evidence that PrP
C
 can also give 
type-II events, even though it contains a disulphide bond (see Section 3.3.3).  However, as 
shown in Figure 3.17, the type-II events for the prion peptide or protein are eliminated upon 
binding antibody so that antibody specificity can still be investigated.  It has been shown 
previously that both β-hairpins and disulphide-linked Fmoc-α-helical hairpins can give type-II 
events, suggesting that a single disulphide bond is not sufficient to prevent type-II events 
(Goodrich et al., 2007 and results in section 3.2).   
  
3.6.2    Nanopore detection of PrP(145-162) with antibody M2188  
            A novel detection method for antibody prion interactions that use αHL pores was 
investigated.  Peptide PrP(145-162) containing epitope SRPLIHFG for antibody M2188 (IgG) 
was analyzed.  Nanopore detection of antibody prion interactions were analyzed as described in 
the Materials and Methods section.  At these concentrations, a complete profile could be 
accumulated in approximately 2-3 hours.  The histograms of blockade current for PrP(145-162) 
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Figure 3.17 Antibody binding to a peptide will prevent translocation.  The antibody is not 
drawn to scale. 
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with and without M2188 are shown in Figure 3.18  and parameters are listed in Table 3.10.  In 
an attempt to conserve antibody, lower concentration of peptide was used.  The results for 
PrP(145-162) was previously explained in detail in section 3.3.2 (Figure 3.18a).  On the 
addition of antibody M2188 (Figures 3.18b-e) at a peptide-to-immunoglobulin G (IgG) ratio of 
256:1, 128:1, 64:1 and 32:1, only type-I events were observed.  For PrP(145-162), the total 
number of events per pore per minute was 163.  In the presence of M2188, at a peptide-to-IgG 
ratio of 256:1, 128:1, 64:1, and 32:1 this number changed to 119, 110, 85, and 52, respectively.  
The results obtained for PrP(145-162) are unusual, due to the high drop  in the number of 
events at low concentrations of M2188.  For example, only a 6% reduction in the total number 
of events is expected at a peptide-to-IgG ratio of 32:1, assuming the antibody has two binding 
sites.  However, at this ratio a ~ 68% reduction in the total number of events was observed.  To 
address this problem a different peptide was analyzed. 
 
3.6.3   Nanopore detection of PrP(143-169) and PrP(168-178) with antibody M2188  
           PrP(143-169):SAMSRPLIHFGNDYEDRYYRENMYRYP (the epitope for antibody 
M2188 is underlined) with a net charge of +1 was analyzed.  As a control, the same analysis 
was repeated with PrP(168-178):YPNQVYYRPMD having a net charge of  zero,  which does 
not contain the epitope for antibody M2188.  For PrP(143-169), a complete profile could be 
accumulated in about one hour.  Typical traces for PrP(143-169) with and without antibody are 
shown in Figure 3.19.  The histogram of blockade current for PrP(143-169) is shown in Figure 
3.20A and the event parameters are listed in Table 3.11.  Also, the histograms of blockade 
duration are presented in Figure 3.21.  PrP(143-169) is unusual in that it gives three peaks, with 
each peak being  roughly Gaussian.  As shown previously, the peak centered at – 30 pA is due 
to bumping events whereas those at -50 pA and -80 pA are type-II events.  The simplest 
explanation is that the peaks represent either N- or C-terminal entry to the pore or two different 
conformations.  Currently, these possibilities cannot be distinguished.  On the addition of 
antibody M2188 (Figure 3.20B) at a ratio of 2:1 (peptide: M2188), the number of events is 
reduced and no clear peak for the type-II events can be discerned.  The antibody by itself (see 
Figure 3.23C in section 3.6.4) also gave rise to a significant number of events that were 
subtracted from the event profile of the complex (Figure 3.20C).  In this case, the average 
number of type-II events was reduced even further, although the event profile in the bumping  
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Figure 3.18 Current blockade histograms for PrP(145-162) and M2188 interactions.  (a) 
PrP(145-162); (b) PrP(145-162) with M2188, 256:1 ratio: (c) PrP(145-162) with M2188, 128:1 
ratio; (d) PrP(145-162) with M2188, 64:1 ratio; (e) PrP(145-162) with M2188, 32:1 ratio tested 
on αHL pores at pH 7.8.  Parameters are presented in Table 3.10. 
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Table 3.10  Event parameters for PrP(145-162) and PrP(145-162)/M2188 complex
a
. 
 
     Compound                                               I1                        I2                       T1                  T2               A1                    A2                        W1                    W2                                 
                                                                     (pA)             (pA)          (ms)             (ms) 
 
 
    PrP(145-162)                                          -28               -87             0.12              0.22           106              57                   7.2           13.1 
 
    PrP(145-162)/M2188 256:1                   -25                 -               0.11                -               89                 -                    5.5              - 
              
    PrP(145-162)/M2188 128:1                   -25                 -               0.12                -               75                 -                    5.6              - 
 
    PrP(145-162)/M2188  64:1                    -24                 -               0.11                -               65                 -                    5.1              - 
 
    PrP(145-162)/M2188  32:1                    -25                -                0.11                -               28                 -                    4.9              - 
 
 
 
 
a 
I is the current blockade and T is the time of blockade.  The subscripts 1 and 2 refer to Type-I and Type-II event populations 
presented in
 
Figure 3.18.  A1 and A2 are the number of events per pore per minute for each population.  W1, and W2 are the peak 
widths at half-height.  (The error is estimated to be ±1 pA for I and ±10% for T). 
                                                                                  
1
1
8
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Figure 3.19 Current traces for PrP(143-169) without antibody (A) and with antibody (B).  
Typical bumping and translocation events are indicated.  In the presence of antibody, the event 
frequency is decreased and those events that do occur are mostly bumping.   
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Figure 3.20 Current blockade histograms for prion peptide and M2188 interactions.  (A) PrP(143-169); (B) PrP(143-169) 
with M2188, 2:1 ratio; (C) subtraction of M2188 from panel B; (D) PrP(168-178); (E) PrP(168-178) with M2188,4:1 ratio; 
(F) subtraction of M2188 from panel E.  Parameters are presented in Table 3.11.   
1
2
0
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Table 3.11 Event parameters for PrP(143-169), PrP(143-169)/M2188 complex, PrP(168-178), and PrP(168-178)/M2188 complex
a 
 
 
a 
I is the current blockade and T is the time of blockade.  The subscript 1 and 2, 3 refer to type-I and Type-II events, respectively.  
Event populations are presented in Figure 3.20.  A1, A2 and A3 are the number of events per pore per minute for each population.  W1, 
W2 and W3 are the peak widths at half -height.  (The error is estimated to be ±1 pA for I and ±10% for T).   
 
Compound I1 (pA) I2 (pA) I3 (pA) T1 (ms) T2 (ms) T3 
(ms) 
A1 A2 A3 W1 W2 W3 
             
PrP(143-169)  -29  -49  -84  0.16  0.25  0.41  15.6 9.6 4.3 8.5 9.6 15.0 
             
PrP(143-169)/M2188 2:1 -32  - - 0.02  - - 3.7 - - 11.7 - - 
             
PrP(168-178) - - -74  - - 0.19  - - 12.0 - - 7.6 
             
PrP(168-178)/M2188 4:1 - - -72  - - 0.27  - - 13.5 - - 8.5 
1
2
1
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Figure 3.21 Histograms of blockade times for PrP(143-169).  (a) PrP(143-169) peak 1, (b) 
PrP(143-169) peak 2, (c)PrP(143-169) peak 3, and (d) peak 1 with antibody.  The best fit single 
exponential is shown.  The values are listed in Table 3.10.   
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region appears to be more complex.   
            PrP(168-178), which does not contain the epitope for antibody M2188, was analyzed 
(Figures 3.20D-F).  It is clear from the event profiles that no significant interaction was 
detected, although there appeared to be a small increase in the blockade time for the type-II 
events (Table 3.11).  Intermediate ratios of antibody/peptide were also studied and the results 
are summarized in Figure 3.22.  No significant change in the number of events was detected 
with PrP(168-178), whereas  the total number of events was reduced  to approximately 12% at 
the highest ratio of antibody with PrP(143-169). 
 
3.6.4   Nanopore detection of bPrP(25-242) with antibody M2188 
            Experiments with the full-length bPrP are shown in Figure 3.23A and the event 
parameters are listed in Table 3.12.  The peak centered at −65 pA, which is due to type-II 
events, is much broader than that for the peptide; this may be caused by different orientations of 
the protein as it enters the pore or different modes of unfolding as it passes through the pore.  
The ratio of the type-II (A2) to type-I (A1) events is approximately 1:2.  On the addition of 
antibody, no clear peak for the type-II events can be seen and the ratio of type-II (A2) to type-I 
(A1) events decreases to approximately 1:10.  Compared with the PrP peptides, the total 
number of events per pore per minute is much lower and so subtraction of the control with 
antibody alone (Figure 3.23C) is more important.  The antibody alone shows a sharp bumping 
peak at approximately −24 pA and a few events with blockade currents above −40 pA.  It seems 
very unlikely that the latter represent type-II events of the antibody because it is an order of 
magnitude larger than the pore and contains multiple, very stable β-sheet domains with several 
disulfide bonds.  Alternatively, the apparent type-II events may be due to impurities within the 
antibody preparation.  After subtraction (Figure 3.23D), the average number of events with a 
blockade current above −30 pA is insignificant, but there is now a large negative bumping peak 
between -20 pA and -30 pA. 
 
3.6.5   Nanopore detection of peptides SN4 and PrP(168-178)  with antibody SN4Ab 
           The interaction of peptide SN4 and PrP(168-178)  with antibody SN4Ab  were analyzed.  
Peptide SN4 contained six copies of epitope 
172
VYYRP
176 
compared to a single copy in 
PrP(168-178).  SN4Ab binds residue 
172
VYYRP
176
 which is blocked in PrP
C
 but available in 
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Figure 3.22 Numbers of translocation events as a function of antibody (M2188): peptide ratio 
for the two peptides.  To conserve antibody, only single experiments were performed for each 
ratio.  In the absence of antibody, the reproducibility was estimated to be ± 20%.   
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Figure 3.23 Current blockade histograms for prion protein and M2188 interactions.  (A) bPrP, 
(B) bPrP with M2188 at a 2:1 ratio, (C) M2188 alone, and (D) subtraction of panel C from 
panel B.  The values are listed in Table 3.12.   
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    Table 3.12  Event parameters for bPrP,bPrP/M2188 complex, and M2188
a 
 
a 
I is the current blockade and T is the time of blockade.  The subscripts 1 and 2 refer to Type-I and Type-II event populations 
presented in
  
Figure 3.23.  A1 and A2 are the number of events per pore per minute for each population.  W1 and W2 are the peak 
widths at half-height.  (The error is estimated to be ±1 pA for I and ±10% for T).   
 
 
 
 
 
 
 
 
 
 
 
 
Compound I1 
 (pA) 
I2 
 (pA) 
T1 
 (ms) 
T2  
(ms) 
A1 A2 W1 W2 
         
bPrP  -27  -65  0.02  0.15  3.7 3.4 12.2 20.0 
         
bPrP/M2188 2:1 -26 - 0.19  - 3.5 - 8.0 - 
         
M2188 -23  - 0.12  - 6.6 - 2.1 - 
         
1
2
6
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PrP
Sc
.  The results for peptides SN4 and PrP(168-178) are shown in Figure 3.24 and the 
parameters are present in Table 3.13.  In the absence of antibody, PrP(168-178) displayed a single 
population of type-II events with a peak centered at -74 pA.  On the addition of antibody SN4Ab 
(Figure 3.24b) at a peptide-to-antibody ratio of 2:1, the number of type-II events  were reduced 
by ~ 55%, after the background for antibody was subtracted (Figure 3.24c).  The antibody alone 
shows bumping events, at approximately −30 pA and a few events with blockade currents above 
−40 pA (Figure 3.24c).  Alternatively, the apparent events may be due to impurities within the 
antibody preparation as proposed earlier in section 3.5.2.  Peptide SN4 has a net charge of +6 and 
is 38 amino acids in length.  Peptide SN4 displayed two event populations of type-I and type-II 
events with peaks centered at -28 pA and -71 pA, respectively.  On the addition of antibody 
SN4Ab, (Figure 3.24e) at a peptide-to-antibody ratio of 2:1, the number of events was reduced 
and no clear peak for the type-II events was discerned.  Also, the number of type-I events was 
increased by 36%.  The bumping peak became much sharper as was observed previously for the 
prion and Cu(II) interactions. 
 
3.6.6   Nanopore detection of bPrP(25-242) with antibody SN4Ab 
             Experiments with the full-length bPrP are shown in Figure 3.25 and the parameters are 
listed in Table 3.14.  The results for bPrP as seen previously, displayed two event populations of 
type-I and type-II events with peaks centered at -31 pA and -68 pA, respectively (Figure 3.25a).  
On the addition of antibody SN4Ab (Figure 3.25b) at a protein-to-antibody ratio of 2:1, the 
blockade current for the type-II events increased to -79 pA while the ratio for the type-II (A2) to 
type-I (A1) events did not change.  The number of type-II and type-I events was reduced by 23% 
and 70%, respectively, after subtraction of the control with antibody alone (Figure 3.25c). 
 
3.7   Analysis of antibody interactions with the unfolded prion protein 
 
3.7.1   Introduction  
            Recently it has been demonstrated that proteins can translocate the αHL pore, especially 
in the presence of denaturing agents which aid in protein unfolding (Oukhaled et al., 2007; 
Stefureac et al., 2008).  The rationale for the experiments presented below was to study 
conformational changes that occurred in bPrP(25-242) in the presence of Gdn-HCl.  Furthermore, 
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Figure 3.24 Current blockade histograms for peptide and SN4Ab interactions (a) PrP(168-178); (b) PrP(168-178) with SN4Ab, 
2:1 ratio; (c) subtraction of SN4Ab from panel (b); (d) peptide SN4 ;(e) peptide SN4 with SN4Ab, 2:1 ratio; (f) subtraction of 
SN4Ab from panel (e).  Parameters are presented in Table 3.13. 
1
2
8
 
 
  
129 
                       
                       
                       
                      Table 3.13  Event parameters for PrP(168-178), PrP(168-178)/SN4Ab complex, peptide SN4, and  peptide SN4/SN4Ab 
                      complex
a 
 
 
 
a 
I is the current blockade and T is the time of blockade.  The subscripts 1 and 2 refer to Type-I and Type-II event populations 
presented in
 
Figure 3.24.  A1 and A2 are the number of events per pore per minute for each population.  W1 and W2 are the peak 
widths at half-height.  (The error is estimated to be ±1 pA for I and ±10% for T) 
 
Compound I1 (pA) I2 (pA) T1 (ms) T2 (ms) A1 A2 A1 /A2  W1 W2 
PrP(168-178) - -74  - 0.19  - 12.0 - - 7.6 
PrP(168-178)/SN4Ab  2:1 -32  -71  0.09  0.27  5.5 8.1 0.67 13.2 11.0 
          
Peptide SN4 -28  -71  0.03 0.20  2.7 4.4 0.62 11.2 17.0 
Peptide SN4/SN4Ab  2:1 -30  - 0.02  - 5.3 - - 8.0 - 
1
2
9
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Figure 3.25 Current blockade histograms for prion protein and SN4Ab interactions.  (a) bPrP, 
(b) bPrP with SN4Ab at a 2:1 ratio, (c) SN4Ab alone, and (d) subtraction of panel (c) from 
panel (b).  The values are listed in Table 3.14. 
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             Table 3.14 Event parameters for bPrP, bPrP/SN4Ab complex, and SN4Ab
a 
 
 
 
 
 
 
 
 
 
 
 
 
 
a 
I is the current blockade and T is the time of blockade.  The subscripts 1 and 2 refer to Type-I and Type-II event populations 
presented in
 
Figure 3.25.  A1 and A2 are the number of events per pore per minute for each population.  W1 and W2 are the peak 
widths at half-height.  (The error is estimated to be ±1 pA for I and ±10% for T). 
 
 
Compound I1 
 (pA) 
I2 
 (pA) 
T1 
 (ms) 
T2  
(ms) 
A1 A2 A1 /A2 W1 W2 
          
bPrP  -31  -68  0.01  0.17  2.3 3.0 0.76 8.7 28.2 
          
bPrP/SN4Ab 2:1 -31  -79  0.02  0.12 2.1 2.8 0.75 8.9 28 
          
SN4Ab -30  - 0.03  - 1.8 - - 10.9 - 
          
1
3
1
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the conformational changes that occur due to complex formation were further investigated by 
the binding of antibodies M2188 and SN6Ab.  As mentioned earlier, M2188 binds the epitope 
146
SRPLIHFG
153
 available in PrP
C
 whereas SN6Ab binds residues 
172
VYYRP
176
 which are 
blocked in PrP
C
 but available in PrP
Sc
. 
 
3.7.2 Nanopore detection of the unfolded bPrP(25-242) with antibodies, M2188 and  
SN6Ab 
           First, bPrP was pre-treated with 0.9 M Gdn-HCl.  Experiments with the full-length bPrP 
are shown in Figure 3.26 and the event parameters are listed in Table 3.15.  Analysis of bPrP in 
the presence of Gdn-HCl displayed a single population of type-II events with a peak centered at 
-73 pA (Figure 3.26b).  A three fold increase in the number of type-II events and also an 
increase in the blockade current (I2) by about 5 pA was observed.  The final concentration of 
Gdn-HCl in the cup was 18 mM.  Thus, this treatment suggests full or partial unfolding of bPrP 
resulting in an increase of type-II events.   
          Then, antibodies M2188 and SN6Ab were analyzed.  The results for the interactions of 
the unfolded bPrP in the presence of M2188 or SN6Ab are shown in Figure 3.27(a-d) and 
Figure 3.27(e-h), respectively.  The parameters are listed in Table 3.16.  On the addition of 
M2188 (Figure 3.27b), at a protein-to-antibody ratio of 2:1, the number of events are reduced  
and no clear peak for the type-II events can be discerned.  As previously mentioned, the 
antibody by itself (Figure 3.27c) also gives rise to a significant number of events that were 
subtracted from the event profile for the complex (Figure 3.27d).  In this case, the average 
number of type-II events is reduced even further, although the event profile in the bumping 
region appears to be more complex. 
            However on the addition of SN6Ab (Figure 3.27b), at a protein-to-antibody ratio of 2:1, 
a two fold increase of the type-II events was observed.  In addition, an increase in the blockade 
current (I2) of about 10 pA was apparent.  In the presence of SN6Ab, the blockade duration for 
the type-II events increased from 0.11 to 0.23 ms.  The VYYRP epitope is blocked in bPrP but 
may be accessible in the unfolded bPrP. 
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Figure 3.26 Current blockade histograms for bPrP in the presence of Gdn-HCl.  (a) bPrP and 
(b) bPrP pre-treated  with 0.9 M Gdn-HCl.  The values are listed in Table 3.15. 
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                            Table 3.15  Event parameters for bPrP and bPrP pre-treated with 0.9M Gdn-HCl
a
 
 
 
 
                      
                     
a 
I is the current blockade and T is the time of blockade.   The subscripts 1 and 2 refer to Type-I and Type-II event populations 
presented in
 
Figure 3.26.  A1 and A2 are the number of events per pore per minute for each population.  W1 and W2 are the peak 
widths at half-height.  (The error is estimated to be ±1 pA for I and ±10% for T).   
 
 
 
 
 
 
 
 
 
 
 
Compound I1 (pA) I2 (pA) T1 (ms) T2 (ms) A1 A2 A1 /A2  W1 W2 
          
 bPrP -31  -68  0.01  0.17  2.3 3.0 0.76 8.7 28.2 
          
 bPrP pre-treated 
 with 0.9M Gdn-HCl   
-28 -73 0.02  0.11  2.0 8.8 0.22 14.9 14.9 
          1
3
4
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      Figure 3.27 Current blockade histograms for the unfolded bPrP and antibody interactions.  (a,e) bPrP pre-treated with 0.9M Gdn-HCl, (b) 
           unfolded bPrP with M2188, 2:1 ratio,  (c) M2188 alone,  (d) subtraction of panel (c) from panel ( b),  (f) unfolded bPrP with SN6Ab, 2:1 ratio,  
           (g) SN6Ab alone and (h) subtraction of panel (g) from panel (f).  The y-axis of histogram (a) and (e) are different.  The values are listed in Table 
           3.16. 
1
3
5
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                   Table 3.16  Event parameters for bPrP pre-treated with 0.9M Gdn-HCl, unfolded bPrP/M2188 complex, unfolded  bPrP/SN6Ab complex,  
                   M2188 and SN6Ab
a
 
                      
                           a 
I is the current blockade and T is the time of blockade.  The subscripts 1 and 2 refer to bumping (Type-I) and translocation (Type-
II) event populations presented in
 
Figure 3.27.  A1 and A2 are the number of events per pore per minute for each population.  W1 and 
W2 are the peak widths at half-height.  (The error is estimated to be ±1 pA for I and ±10% for T).
Compound I1 (pA) I2 (pA) T1 (ms) T2 (ms) A1 A2 A1 /A2  W1 W2 
 bPrP pre-treated  
 with 0.9M GdnHCl   
 
-28  -73  0.02  0.11  2.0 8.8 0.22 14.9 14.9 
Unfolded bPrP/ M2188   2:1 
 
 
-29  -75  0.02  0.23  4.4 3.2 1.15 19.2 20.8 
Unfolded bPrPl/ SN6Ab   2:1 
 
 
-27 -83  0.01  0.23  5.4 13.8 0.39 18.65 12.61 
M2188 
 
 
-23  - 0.12  - 6.6 - - 2.1 - 
SN6Ab 
 
- - - - 1.3 - - - - 
1
3
6
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3.8 Analysis of prion protein and signal prion peptide interactions  
 
3.8.1    Introduction 
            After the translocation of PrP into the endoplasmic reticulum (ER) lumen, the 
attachment of  the two N-linked carbohydrate moieties at Asn
181
 and Asn
197
 is initiated along 
with the cleavage of the N-terminal signal peptide (a.a.1-22).  Then, prior to the addition of a 
glycosylphosphatidylinositol (GPI) anchor at Ser 
231
, the C-terminal signal peptide (a.a.  231-
264) is cleaved.  Subsequently a disulphide bond is formed between Cys
179
 and Cys 
214
 (see 
Introduction, Figure 1.11a).  The N-terminus signal prion peptides have potent antiprion effects.  
bPrP(1-30) significantly reduced PrP
Sc 
levels in prion infected mouse neuronal hypothalamic 
cells but had no effect on PrP
C
  levels in noninfected cells (Löfgren et al., 2008).  PrP(106-126) 
binds the plasma membrane and initiates aggregation of PrP
C
, which then is weakly proteinase 
K resistant (Gu et al., 2002).  Studies on the C-terminal signal peptide including any amino acid 
sequence within the PrP(231-264) region have not been published as yet.  The N- and C-
terminal cleavages may be important in the generation of soluble and membrane-bound forms 
of the protein that are biologically active (Harris et al., 1993).  Here we investigated the 
interactions between PrP(1-24) or PrP(243-264) with bPrP.  We also investigated the interaction 
of PrP(106-126), which is known to cause aggregation to the prion protein. 
 
3.8.2    Nanopore detection of  bPrP(25-242) with signal prion peptides 
            Interaction of bPrP with PrP(1-24):MVKSHIGSWILVLFVAMWSDVGLC or 
PrP(243-264):VILFSSPPVILLISFLIFLIVG was analyzed.  Control experiments were also 
conducted with peptide RG23 in presence of bPrP.  The analysis of peptides PrP(1-24), 
PrP(243-264) or RG23 with bPrP was done as stated in the Material and Methods section.  
PrP(1-24)  has an overall net charge of +1 and is highly hydrophobic with  limited solubility in 
phosphate buffer.  As a result, PrP(1-24) does not give  consistent nanopore results.  The results 
for PrP(1-24) and bPrP are shown in Figure 3.28(a-d) and the parameters are listed in Table 
3.17.  PrP(1-24) displayed two peaks with each peak being roughly Gaussian (Figure 3.28b).  
The peaks centered at -29 pA and -69 pA was due to type-I and type-II events, respectively.  
The ratio for the type-I (A1) to type-II (A2) was 0.26 to 1.  On the addition of PrP(1-24) to bPrP 
(Figure 3.28c)  at a peptide-to-protein molar ratio of  1:1, the number of events is reduced, 
when compared to the theoretical sum of the histograms for PrP(1-24) and bPrP (Figure 3.28d).  
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Figure 3.28  Current blockade histograms for signal prion peptides and bPrP interactions.  (a,e,i) bPrP; (b) PrP(1-24); (c) PrP(1-24) 
with bPrP,1:1 ratio; (d) sum of panel(a) and panel(b); (f) PrP(243-264); (g) PrP(243-264) with bPrP,1:1 ratio; (h) sum of panel(e) and 
panel (f); (j) control peptide RG23; (k) RG23 with bPrP,1:1 ratio; (l) sum of panel(i) and panel(j).  Parameters are presented in Table 
3.17.
1
3
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 Table 3.17 Event parameters for bPrP, PrP(1-24), PrP(1-24)/bPrP complex, PrP(243-264), PrP(243-264)/bPrP complex, RG23,  and 
 RG23/bPrP complex
a 
                                
 
 
a 
I is the current blockade and T is the time of blockade.   The subscripts 1 and 2 refer to bumping (Type-I) and translocation (Type-
II) event populations presented in
 
Figure 3.28.  A1 and A2 are the number of events per pore per minute for each population.  W1 and 
W2 are the peak widths at half-height.  (The error is estimated to be ±1 pA for I and ±10% for T). 
 
compound I1 (pA) I2 (pA) T1 (ms) T2 (ms) A1 A2 A1 /A2  W1 W2 
          
bPrP -31  -68  0.01  0.17  2.3 3.0 0.76 8.7 28.2 
          
PrP(1-24) -29  -69 0.04 0.18  3.0 11.3 0.26 16.2 18.2 
          
bPrP:PrP(1-24)  1:1 -29  -78  0.02  0.13  3.8 2.7 1.40 10.8 21.1 
          
Theoretical sum of bPrP & PrP(1-24) histograms -30  -69  - - 5.3 14.1 0.37 12.3 19.5 
          
PrP(243-264) -29  - 0.02 - 2.1 - - 12.3 - 
          
bPrP:PrP(243-264)  1:1 -30  -84  0.02  0.03 1.6 2.3 0.69 8.7 20.5 
          
Theoretical sum of bPrP & PrP(243-264)  histograms -31 - - - 4.9 - - 12.5 - 
          
RG23 -32 -75  0.02  0.11  2.0 4.5 0.44 10.0 17.9 
          
bPrP:RG23  1:1 -29  -79.   0.03  0.16  2.6 4.5 0.57 10.0 14.3 
          
Theoretical sum of bPrP & RG23 histograms -31 -73  - - 4.8 7.5 0.64 11.4 21.5 
          
1
3
9
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Other groups have also shown using Western blots, that bovine PrP(1-30) significantly reduced 
PrP
Sc
 levels in chronically infected prion cell lines (Löfgren et al., 2008). 
           The analysis of PrP(243-264) and bPrP is also shown in Figure 3.28(e-h) and  the 
parameters are listed in Table 3.17.  PrP(243-264) with a net charge of zero and displayed two 
peaks with each peak being roughly Gaussian.  The peaks centered at -29 pA and -60 pA were 
due to type-I and type-II events, respectively.  In addition, events between -80 pA and -100 pA 
were also observed.  These events do not follow a Gaussian distribution.  Therefore, PrP(243-
264) may have more than one conformation.  Alternatinely, the peaks may represent N- or C- 
terminal entry into the pore.  Upon the addition of PrP(243-264) to bPrP (Figure 3.28g)  at a 
peptide-to-protein ratio of  1:1, there was an increase in the blockade current  for the type-II 
events and a subsequent reduction in the number of type-I events when compared to the 
theoretical sum of PrP(243-264) and bPrP (Figure 3.28h).  These novel results suggest that the 
N-terminal and C-terminal prion peptides interact with the prion protein and cause 
conformational changes in bPrP
C
. 
            A similar analysis was performed with a control peptide RG23, shown in Figure 3.28 (i-
l) and the parameters listed in Table 3.17.  RG23 has an overall net charge of +1 and displayed 
two peaks with each peak being roughly Gaussian.  The peaks centered at -32 pA and -75 pA 
were due to type-I and type-II events, respectively (Figure 3.26j).  On the addition of RG23 to 
bPrP (Figure 3.28k), at a peptide-to-protein ratio of 1:1, the number of type-II events remained 
the same.  When this event profile was compared to the theoretical sum of RG23 and bPrP 
(Figure 3.28l), only a -6 pA reduction in the type-II events was seen for the sum of graphs.  The 
ratio for the type-I (A1) to type-II (A2) for the premix of RG23 and bPrP was 0.57 to 1.  
However, for the theoretical sum of RG23 and bPrP this ratio only changed to 0.64:1. 
 
3.8.3    Nanopore detection of bPrP(25-242) with  PrP(106-126)  
            A similar analysis was performed using  
PrP(106-126):KTNMKHMAGAAAAGAVVGGLG which has an overall net charge of +3 at 
pH 7.8.  The results are shown in Figure 3.29 and the parameters are listed in Table 3.18.  
PrP(106-126) displayed two event populations with each peak being roughly Gaussian (Figure 
3.29b and e).  The peaks centered at -29 pA and -72 pA were due to type-I and type-II events, 
respectively.  Upon the addition of PrP(106-126) to bPrP (Figure 3.29c),  at a peptide-to-protein 
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Figure 3.29 Current blockade histograms for PrP(106-126) and bPrP interactions.  (a) bPrP; (b,e) PrP(106-126); (c) bPrP with 
PrP(106-126), 1:1 ratio; (d) sum of panel (a) and panel (b); (f) bPrP with PrP(106-126), 1:3 ratio; (g) sum of panel (a) and panel (e).  
Parameters are presented in Table 3.18. 
 
1
4
1
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                Table 3.18 Event parameters for bPrP, PrP(106-126), bPrP/PrP(106-126) complex and the sum of  bPrP with  PrP(106-126)
a
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a 
I is the current blockade and T is the time of blockade.  The subscripts 1 and 2 refer to Type-I and Type-II event populations 
presented in
 
Figure 3.29.  A1 and A2 are the number of events per pore per minute for each population.  W1 and W2 are the peak 
widths at half-height.  (The error is estimated to be ±1 pA for I and ±10% for T). 
 
compound I1 (pA) I2 (pA) T1 (ms) T2 (ms) A1 A2 A1 /A2  W1 W2 
          
bPrP -31 -68  0.01 0.17 2.3 3.0 0.76 8.7 28.2 
          
PrP(106-126) - 0.0016 mg/mL in 
the cup 
-29 -72 0.02 0.19 0.9 1.3 0.91 12.3 32.3 
          
bPrP:PrP(106-126)  1:1 
 
-31 -79 0.02 0.19 2.3 3.3 0.69 13.6 25.0 
Sum of bPrP & PrP(106-126)  
histograms for 1:1 molar ratio 
-31 -69 - - 3.2 4.2 0.76 9.5 29.7 
          
PrP(106-126) – 0.005 mg/mL in 
the cup 
-29 -72 0.02 0.19 2.9 3.9 0.74 12.3 32.3 
          
bPrP:PrP(106-126 ) 1:3 -31 - 0.02 - 3.3 - - 7.4 - 
          
Sum of bPrP & PrP(106-126)  
histograms for 1:3 molar ratio 
-30 -70 - - 5.2 6.8 0.76 10.6 30.7 
          
1
4
2
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molar ratio of  1:1,an increase in the number of events  was observed.  However, when 
PrP(106-126)  and  bPrP were added at a peptide-to-protein molar ratio of  3:1, the number of 
events was reduced and no clear peak  for the type-II events  could be discerned (Figure 3.29f).   
 
3.9 Analysis of prion protein aggregation 
3.9.1 Introduction 
            Prion diseases are thought to arise from the misfolding and aggregation of the normal 
cellular prion protein, PrP
C
 into an oligomeric β-sheet-rich form known as the scrapie isoform, 
PrP
SC
 (Prusiner, 1982).  A study on the rates of hydrogen/deuterium exchange demonstrated 
that the most likely route for the conversion of PrP
C
 to PrP
Sc 
is through a highly unfolded state 
rather than through a highly organized folding intermediate (Hosszu et al., 1999).  In vitro 
conversion of full length recombinant prion protein is possible under neutral or slightly acidic 
pH (between 5.0 to 7.5) with Gdn-HCl (up to 2 M) or Urea (up to 4 M) (Breydo et al., 2008).  
Also, the N-terminal truncated recombinant human PrP(90-231) can be converted to a variety of 
oligomeric β-sheet rich structures (Apetri et al., 2005).  The formation of amyloid fibrils can be 
monitored using a thioflavin T (ThT) fluorescence assay.  ThT is known to bind to proteins 
containing β-sheets and to fluoresce only in the bound configuration (Bourhim et al., 2007).  
ThT fluorescence of fibrils can vary due to different PrP variants, and the exact values depend 
on several factors, including purity of the protein and conditions of fibril formation (Breydo et 
al., 2008).  The rationale for the experiments presented below was to demonstrate if fibril 
formation of the full length bPrP was possible at low concentrations of Gdn-HCl so as to 
monitor the folding intermediates (Apetri et al., 2005). 
 
3.9.2 Nanopore detection of bPrP(25-242) aggregation 
            For this purpose we used the protocol stated in Apetri et al., 2005 but pre-mixed 
bPrP(25-242) with 0.86 M Gdn-HCl at pH 7.5.  Following continuous rotation at 8 rpm and at 
37ºC, samples were withdrawn at different time intervals of 0, 18, 25, 44, and 68 hours.  These 
samples were analyzed using nanopores at pH 7.8, followed by a fluorometric ThT assay.  
Results for the nanopore analysis are shown in Figure 3.30 and the parameters are listed in 
Table 3.19.  On the addition of 0.86 M Gdn-HCl, at 0 hours (Figure 3.30b) bPrP displayed a 
single population of type-II events with a peak centered at -73 pA (Figure 3.30b).  A three fold  
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Figure 3.30 Current blockade histograms for the unfolded bPrP.  (a) bPrP, (b) unfolded bPrP 
with Gdn-HCl at 0 hours, (c) unfolded bPrP with Gdn-HCl at 18 hours, (d) unfolded bPrP with 
Gdn-HCl at 25 hours,  (e) unfolded bPrP with Gdn-HCl at 44 hours, and (f) unfolded bPrP with 
Gdn-HCl at 68 hours.  Parameters are presented in Table 3.19. 
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                                   Table 3.19 Event parameters for bPrP and the unfolded bPrP with Gdn-HCl: samples analyzed at 0, 18, 25, 44, 
                                   and 68 hours
a 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 a 
I is the current blockade and T is the time of blockade.  The subscripts 1 and 2 refer to Type-I and Type-II event 
populations presented in
 
Figure 3.30.  A1 and A2 are the number of events per pore per minute for each population.  
W1 and W2 are the peak widths at half-height.  (The error is estimated to be ±1 pA for I and ±10% for T). 
compound I1 
(pA) 
I2 (pA) T1 (ms) T2 (ms) A1 A2 A1 /A2  W1 W2 
          
bPrP -31 -68  0.01 0.17 2.3 3.0 0.76 8.7 28.2 
          
unfolded bPrP with 
Gdn-HCl  at 0 hours 
-28 -73 0.02 0.11 2.0 8.8 0.22 14.9 14.9 
          
unfolded bPrP with 
Gdn-HCl  at 18 hours 
-22 -77 0.03 0.23 6.9 5.4 1.27 10.5 14.3 
          
unfolded bPrP with  
Gdn-HCl at 25 hours 
-28 -79 0.03 0.24 1.7 2.3 0.73 12.4 12.2 
          
unfolded bPrP with 
Gdn-HCl at 44 hours 
-29 -80 0.02 0.25 3.4 5.9 0.57 16.5 16.8 
          
Unfolded bPrP with 
Gdn-HCl  at 68 hours 
-29 -71 0.02 0.07 2.8 3.6 0.77 11.4 33.0
1 
1
4
5
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increase in the number of type-II events and also an increase in the blockade current (I2) by 
about 5 pA was observed.  The following nanopore results were observed after 18, 25, 44, and 
68 hours.  When compared to the 0 hour experiment, at 18 hours (Figure 3.30c), a decrease in 
type-II and an increase in type-I events was observed.  The ratio for the type-I (A1) to type-II 
(A2) at 18 hours was 1.27:1.  When compared to the 18 hour experiment, at 25 hours (Figure 
3.30d), a further decrease in both type-I and type-II events was observed.  The ratio for the 
type-I (A1) to type-II (A2) events reduced to 0.73:1.  When compared to the 25 hour experiment, 
at 44 hours (Figure 3.30e), a two fold increase in both the type-II and type-I events was 
observed.  The ratio for the type-I (A1) to type-II (A2) events further reduced to 0.57:1.  When 
compared to the 44 hour experiment, at 68 hours (Figure 3.30f) a decrease in both type-I and 
type-II events was observed.  However the ratio for the type-I (A1) to type-II (A2) events 
increased to 0.77:1.  So these results do not show any trend except that a decrease in the number 
of type-II events is observed in Figures 3.30(c-f), when compared with the unfolded protein at 
zero hours. 
            The ThT assay (Figure 3.31) only showed a threefold increase in fluorescence after 68 
hours, whereas other groups have observed a 20-30 fold increase in ThT fluorescence.  
However these groups used the N-terminal truncated human PrP(90-231) with 1 M or 2 M Gdn-
HCl (Apetri et al., 2005). 
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 Figure 3.31 Effect of thioflavin T fluorescence on bPrP(25-242) with 0.86 M Gdn-HCl 
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4.0   DISCUSSION 
 
4.1  Acetylated vs.  Fmoc protected peptides  
            The experiments were designed to gain insight into the effect of Fmoc, acetylation or 
proline substitution on negatively charged α-helical peptides.  For simple α-helical peptides that 
are negatively charged, it seems reasonable to assume that the type-II events are translocations.  
In support of this, the blockade current and time increased with the length of the helix 
(Stefureac et al., 2006).   
            As shown in the results (Figures 3.2 and 3.3), Fmoc peptides gave more translocations 
than acetylated peptides.  For example, Ac-D2A14K2 and Fmoc-D2A14K2 are identical except for 
the protecting group; yet Ac-D2A14K2 displayed approximately equal numbers of bumping and 
translocation events, whereas Fmoc-D2A14K2 showed only translocations.  The addition of 
Fmoc increased the overall hydrophobicity of the peptide which may decrease the interaction 
with the outside of the pore and favors translocation.  Furthermore, as the aromatic ring of 
Fmoc is highly polarizable, this may help to steer the peptide into the pore, again increasing the 
number of translocations.  A similar effect has also been observed for a group of negatively 
charged α-helical peptides.  These peptides did not translocate in the absence of Fmoc 
(Stefureac et al., 2006).  In another study, the addition of a toluene molecule to a peptide made 
a large difference in the number of type-II events.  For example, a 12 amino acid long peptide, 
tethered via a terminal cysteine to monobromomethyl-substituted benzene, gave more type-II 
events than the untethered peptide (Meng et al., 2010).   
            Another important observation was the effect of proline on α-helical peptides.  For 
example, Ac-D2A14K2 and Ac-D2A7PA6K2 are identical except for a proline residue at the tenth 
position.  The proline may cause a bend or kink in the peptide conformation.  Peptide Ac-
D2A14K2 displayed two event populations with approximately equal number of events for each 
population whereas Ac-D2A7PA6K2 had only bumping events.  Thus, the addition of a proline in 
the middle of an acetylated peptide appears to further reduce the number of translocation 
events.   
            One the other hand, peptides Fmoc-D2A14K2 and Fmoc-D2A7PA6K2 showed similar 
histograms of blockade current with single peaks, comprising translocation events.  For Fmoc-
D2A7PA6K2, a decrease in the blockade time was the only change in the event parameters.  This 
observation suggests that when a proline is added to the middle of an Fmoc peptide, it will 
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unfold easier into a linear conformation and thus can enter the pore and thread faster than an α-
helix.  These experiments show that nanopore analysis can be a useful tool to identify small 
changes in event parameters.   
 
4.2 β-sheet and α-helical hairpin peptides 
            These experiments were initiated to study the effects of β-sheet and α-helical hairpin 
conformations on translocation or intercalation.  As shown in section 3.2, the capped and 
uncapped β-sheet hairpins have different event parameters.  The uncapped β-hairpin forms a 
more stable “U” shaped conformation due to the electrostatic interactions between the 
positively charged N-terminus and the negatively charged C-terminus, thus reducing the 
number of translocations (see Figures 3.4 and 3.5).  This result also suggests that the uncapped 
β-hairpin has a higher proportion of the folded “U” shaped hairpin population in solution.  This 
observation also agrees with the unpublished data stated in Xu et al., 2003.  However, these 
interactions are diminished in the capped peptide.  Presumably, the capped β-hairpin may 
unfold more easily to form a linear conformation that helps to orient molecules to enter the 
pore, causing a greater number of type-II events.   
            The next question that arises is; are these type-II events in the capped β-hairpin 
intercalations or translocations?   The answer to this question can only be confirmed with 
voltage studies (Meng et al., 2010), but there are several factors that indicate these type-II 
events are translocations.  First, folded molecules give larger blockade durations as compared to 
linear conformations (Goodrich et al., 2007).  The blockade time for the type-II events in the 
capped peptide is smaller when compared with the uncapped.  Second, the diameter of the -
hemolysin pore is 15 Å, whereas the diameter of the folded loop of the “U” shaped β-hairpin is 
about 20 Å (see Figure 3.4).  Thus, for the unfolded peptide, the diameter can be estimated to be 
less than the diameter of -hemolysin.  This estimate is not unreasonable, as the average 
diameter calculated for the Fmoc protected α-helical peptides was about 8.8 Å, suggesting that 
these peptides may interact with the interior walls of the pore (Stefureac, R.I. thesis, page 117, 
Copyright 2006 Radu Ioan Stefureac).  Third, because the peptide has an overall net charge of -
3, molecules will be driven through the pore electrophoretically.  However, the lower 
proportion of type-II events for the uncapped β-hairpin could be translocations or intercalations 
and cannot be differentiated without voltage studies (Meng et al., 2010).   
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            As described earlier, the addition of Fmoc increases the number of type-II events.  
Similarly, the Fmoc-α-helical hairpin displayed equal numbers of both type-I and type-II 
events, whereas in the absence of Fmoc, the peptide gives very few type-II events (see Figures 
3.6 and 3.7).  When TCEP was added, the disulfide bond was reduced, creating an unlinked 
peptide.  The crosslinked and unlinked α-helical hairpin without Fmoc showed no change in the 
histogram for blockade current in the presence of TCEP.  However, for the Fmoc-unlinked-α-
helical hairpin a significant increase in the proportion of type-II events was observed.  Thus, the 
type-II events observed in the crosslinked and unlinked Fmoc-α-helical hairpin could be 
translocations, presuming that the two parallel helixes collapse on each other.  On the other 
hand, the disulphide bond by itself is not expected to prevent translocation, since it is known 
that folded peptides can translocate (Goodrich et al., 2007).  In addition, the increase in the 
proportion of type-II events in the unlinked hairpin is not unreasonable because the collapse of 
the two parallel helixes is less restricted in this conformation.  From the event parameters, this 
collapsed model is favored as compared to the unfolded peptide adopting a linear conformation, 
because only a small change in blockade current was observed.   
 
4.3 Prion peptide and protein analysis 
            The next group of experiments was initiated in an attempt to develop an electrophoretic 
prion detector.  However, first small peptides from α-helical and β-sheet regions in prions were 
investigated.  For example, PrP(155-162) and Ac-PrP(145-162) both contain an α-helical region 
155-162; yet, PrP(155-162) has three peaks in the histogram of blockade current, whereas Ac-
PrP(145-162) has only two with a larger number of bumping events.  For PrP(155-162), the 
blockade current values for the type-II events were represented by peaks 2 and 3 (see Figure 
3.8a), which are slightly lower compared to the negatively charged Fmoc-α-helical peptides 
(Stefuraec et al., 2006).  Yet these values are not unreasonable as the peptide is only 8 amino 
acids in length and may not be able to form a stable α-helical structure.  Presumably, these 
peaks represent either N- or C-terminal entry to the pore or two different conformations.  On the 
other hand, the blockade current and time for the type-II events for Ac-PrP(145-162) are 
significantly greater as compared to PrP(155-162).  However Ac-PrP(145-162) contains both an 
α-helical (a.a. 155-162)  and a non-structured region (a.a. 145-154).  Presumably, if the non-
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structured region folds parallel to the -helical segment, large blockade currents for these type-
II events would be possible. 
           It remains unclear as to whether the type-II events observed for PrP(155-162) and Ac-
PrP(145-162) represent translocations or intercalations.  Again, the answer to this question can 
only be confirmed with voltage studies (Meng et al., 2010).  However, for PrP(155-162) there 
are two factors that indicate peak 3 to be translocations.  First, peak 3 has the highest blockade 
current of -59 pA that can represent translocations for a peptide with a linear conformation.  
This is reasonable when compared to a peptide with 14 amino acids that displayed a blockade 
current of -62 pA (Stefureac et al., 2006).  Second, as the molecule has an overall negative 
charge this would help steer linear conformations into the pore.  Similarly, the type-II events for 
Ac-PrP(145-162) could be translocations  due to the large blockade current of -87 pA. 
            PrP(168-178) containing a β-sheet segment (a.a.172-175) was analyzed using α-
hemolysin and aerolysin.  With aerolysin, PrP(168-178) has two peaks in the histogram of 
blockade current whereas with  α-hemolysin, only a single peak of type-II events can be 
discerned.  Thus, the interactions between peptide and pore are dependent on the type and the 
structure of the pore.  For example, even though both pores have similar diameters (Stefureac et 
al., 2006), the percentage block for the type-II events with aerolysin is 62% compared to 74% 
with α-hemolysin.  Another observation was the increase in bumping events with aerolysin.  
Presumably, the lack of a vestibule in aerolysin may increase peptide collisions with the pore.  
Why do the type-II events with α-hemolysin have a large blockade current of -74 pA for a 11 
amino acid peptide?  One suggestion is that if two peptides enter the pore as a double stranded 
β-sheet, this would displace a greater volume of electrolyte solution, causing a higher blockade 
current (Henriquez et al., 2004).   
             
4.3.1 Intercalation vs.  translocation for the prion protein 
            The interaction of bPrP with αHL showed both type-I and type-II events with about 37% 
being type-II.  There are several lines of evidence that indicate events with blockade currents 
(I2) approximately equal to –65 pA for bPrP represent translocations.  First, the proportion of 
translocations is dependent on the applied potential.  At 50 mV, very few translocations are 
observed, presumably because the potential is not sufficiently large to unfold the protein even if 
it enters the vestibule of the pore.  Second, theoretical studies have estimated that once a strand 
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has entered the pore, the free energy for translocation of the remainder of the protein can be 
small (Makarov, 2009).  For example, the helix α1 region (DYEDRYYR) of bPrP contains 
three negative charges (underlined) which can enter the vestibule and eventually drag the rest of 
the protein through the pore.  Another set of three negative charges located on the loop between 
helix α2 and α3 can facilitate translocation if this region is correctly oriented towards the 
vestibule.  Finally, others have shown that the maltose binding protein of 370 residues can 
translocate especially in the presence of denaturing agents such as guanidinium hydrochloride 
(Oukhaled et al., 2007).  Others in our laboratory have performed similar experiments with 
RNase A (124 residues) for which a majority of events appear to be translocations and the 
proportion increases upon addition of either guanidinium hydrochloride or reducing agents that 
break the disulphide bonds (B. Krasniqi, unpublished results).  A model for the interaction of 
bPrP with the αHL pore is shown in Figure 4.1.  The folded protein can approach the pore 
(Figure 4.1a) or enter the vestibule (Figure 4.1b) in orientations that do not allow it to 
translocate.  These would be recorded as bumping events.  Alternatively, a loop of protein may 
diffuse into the vestibule (Figure 4.1c).  As mentioned earlier, once the negatively-charged 
residues at D(155), E(157), and  D(158) at the N-terminus of helix α1 enter the vestibule, they 
will be pulled into the pore, due to the applied negative potential, eventually dragging the rest 
of the protein through as well.  The disulphide bond by itself is not expected to prevent 
translocation, since it is known that folded peptides can translocate (Goodrich et al., 2007).  
When the voltage was increased to -150 mV the value of the blockade times for both types of 
events increased slightly.   
           On the other hand, when bPrP was added stem down-stream at +100 mV, an increase in 
the number of translocations was detected, as expected.  This is because positively charged 
molecules will be driven through the pore.  An increase in both the translocation blockade 
current and time suggests that the protein takes time to unfold and enter the pore due to the lack 
of a vestibule that may assist in capturing molecules.   
 
4.4      Interaction of metal ions with prion proteins 
             The objective of these experiments was to demonstrate that the conformation of the 
prion protein can be modulated by binding divalent metal ions.  As described in section 3.4, 
analysis of bPrP showed that about 37% were translocation events, but upon addition of Cu(II)  
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Figure 4.1 Model for the interaction of bPrP with the -hemolysin pore.  (a) and (b) represent 
bumping events whereas in (c) the initial orientation will allow the whole protein to translocate.  
(Reprinted by permission from Stefureac et al, 2010.  Copyright 2010 NRC Research Press 
Journals.) 
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or Zn(II) these disappeared and only bumping events were recorded. 
        Although it may prove very difficult to provide direct evidence for translocation, it is clear 
that bPrP forms complexes with Zn(II), and especially with Cu(II), which cannot translocate.  
The bPrP–Cu(II) complex gives a very sharp bumping peak indicative of a single, well-ordered 
conformation.  However, complex formation is readily reversed by the addition of EDTA, so 
there is no evidence that the Cu(II) complex can be identified with PrP
Sc
, a result consistent 
with the work of others (Quaglio et al., 2001; Burns et al., 2003; Morante et al., 2004; 
Thompsett and Brown 2007).  If the model mentioned earlier in Figure 4.1c is correct, it is not 
clear how complex formation could prevent translocation.  One possibility is that the N-
terminal loop now folds back onto helix α1, blocking entry to the vestibule.  In support of this 
model, a recent Raman and circular dichroism study suggests that  the addition of Cu(II) causes 
the loss of helix (α1) (Zhu et al., 2008).  The effect of Mn(II) on bPrP (i.e., increasing the 
proportion of translocations) was most surprising, since there was no evidence that it bound to 
any of the prion peptides in the octarepeat region (Stefureac et al., 2010).  It has been reported 
that Mn(II) can bind to another site centered at residue His95 (Brazier et al., 2008).  Mn(II) can 
also cause structural changes, such as increasing the α-helical content from 25% to 30%, which 
may represent reinforcement or extension of the α1 helix (Zhu et al., 2008).  In turn, an 
extended α- helix at this site may promote translocation.  Ni(II) did not cause any significant 
changes.  The effects of Cu(II) and Mn(II) on bPrP were also confirmed using DLS 
experiments. 
            In conclusion, we have demonstrated that nanopore analysis can be useful for 
interpreting conformational changes caused by the binding of metal ions.  Since these 
experiments can be performed at very low protein concentrations, aggregation or precipitation 
of the protein is much less likely to occur and does not interfere.   
 
4.5 Analysis of Jel352 and peptide interactions  
             These experiments were used to demonstrate complex formation that occurred due to 
antibody peptide interactions.  Peptide RG23 can readily translocate through the pore, but on 
the addition of antibody Jel352, which binds the peptide, the number of translocations is 
decreased to about 50% before the subtraction of the control antibody.  Presumably, this would 
be the case, if a single peptide molecule bound two antibody molecules (Figure 4.2a) using   
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Figure 4.2 Schematic of Jel352 binding a single peptide RG23 at epitopes 1 and 3.  RG23 
contains a triple tandem heptarepeat unit of YSPTSPS numbered as 1, 2 and 3.   YSPTSPS is 
the epitope for Jel352.  (a) Schematic diagram of two Jel352 molecules binding a single peptide 
RG23.  (b) Schematic of a single molecule of Jel352 binding a single peptide of RG23.  
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different epitopes or a single antibody binds to two epitopes on a single peptide (Figure 4.2b).  
The event profile of a control peptide, PrP(168-178), which does not bind the antibody showed 
no decrease in the number of events.  But after the subtraction of antibody the total number of 
events is reduced to approximately 95% and 30% for RG23 and PrP(168-178), respectively.  In 
conclusion, we have demonstrated that because the antibody-peptide complex is too large to 
translocate it diffuses much more slowly to the pore. 
 
4.6   Analysis of antibody prion interactions 
             These studies were intended to demonstrate that complex formation can be monitored 
with nanopores.  A prion peptide, PrP(143–169), can readily translocate through the pore, but 
on the addition of monoclonal antibody M2188, which binds the peptide, the number of 
translocations is reduced because the complex is too large to translocate.  At a peptide-to-
immunoglobulin G (IgG) ratio of 2:1, only bumping events were observed.  The appearance of 
a negative peak (see Figure 3.20C) after the subtraction of the antibody suggests that the 
complex gives rise to fewer bumping events than does the sum of the peptide and antibody 
alone.  This is not unreasonable given that complex formation reduces the number of molecular 
species.  In addition, the complex may diffuse to the pore more slowly than the antibody alone, 
again giving rise to fewer bumping events.  Alternatively, the individual molecules may 
interfere with each others access to the pore even in the absence of significant binding.  The 
event profile of a control peptide PrP(168-178) that does not bind the antibody remained 
unchanged (see Figure 3.20E).   
            Similarly, the presence of M2188 prevents translocation of the full-length prion protein, 
bPrP (see Figure 3.23).  The translocation peak centered at -65 pA is much broader than that for 
the peptide; this may be caused by different orientations of the protein as it enters the pore or 
different modes of unfolding as it passes through the pore.  It is perhaps surprising that the 
translocation time (T2) for bPrP is less than that for PrP(143-169).  However, T2 for maltose 
binding protein of 370 residues is also in the range of 0.2 ms, so the larger value for the peptide 
may be due to a strong interaction with the pore (Oukhaled et al., 2007).  In addition, there are 
other values of blockade time that are difficult to understand, e.g. for example, the bumping 
events of PrP(143-169) and bPrP with and without antibody (see Tables 3.11 and 3.12).  
However, all four events are due to different structures or complexes, and currently the 
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relationship between blockade time and structure is not well understood; thus, predicting T 
values is not possible.   
            Though the work in this thesis represents experiments on complex formation between 
antibodies and peptides and proteins using a biological nanopore, α-hemolysin, there have been 
many previous publications with solid-state pores (Siwy et al., 2005; Sexton et al., 2007; Han et 
al., 2008).  The protein-antibody complexes for protein G/immunoglobulin and ricin/ricin 
antibody were analyzed using gold-plated conical solid-state pores (Siwy et al., 2005).  Protein-
G and ricin were attached to Au using the biotinylated protein.  When the protein bound the 
corresponding analyte, a complete blockade of the ionic current was observed (Siwy et al., 
2005).  Another report on the analysis of BSA and BSA/Fab complex were investigated using a 
PEG-thiol attached to a gold-plated conical nanotube, which displayed different current pulse 
signatures for BSA and the BSA/Fab complex (Sexton et al., 2007).  A 28 nm diameter Si3N4 
pore was used to distinguish between β-human chroionic gonadotropin (β-hCG) and β-hCG-
antibody complex.  The experiments with the antibody gave large blockade currents for 
translocation events, whereas on complex formation with β-hCG the translocations reduced.  
The authors speculated that the reduction in translocation events could be due to the change in 
the electrophoretic mobility of the antibody when bound to β-hCG (Han et al., 2008).   
            Similarly, the antibody SN4Ab, which binds PrP(168-178) and peptide SN4, reduced 
the number of translocation events (see Figure 3.24).  PrP(168-178) has one epitope of VYYRP 
and the antibody, SN4Ab reduced the number of translocations by 55%.  Alternatively, as 
explained earlier, PrP(168-178) may be translocating as a double stranded β-sheet which might 
block the access to the epitope.  On the other hand, peptide SN4 has six epitopes and showed no 
clear translocation peak in the presence of antibody. 
            The event profile of bPrP that does not bind antibody SN4Ab showed an increase in the 
translocation blockade current (see Figure 3.25).  However, after the subtraction of the 
antibody, a reduction in the number of bumping events suggests that a weak complex gives rise 
to fewer bumping events than does the sum of the peptide and antibody alone.  Furthermore, 
these weak interactions are not sufficient to prevent translocations. 
           A three fold increase in the number of translocations with a decrease in bumping events 
was observed when bPrP was pre-treated with 0.9 M Gdn-HCl (see Figure 3.26).  However, 
even though bPrP may be fully unfolded at first, the addition of 1 M KCl may cause it to 
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partially refold, as only a -5 pA increase in blockade current was observed.  One possibility is 
that although the single disulfide link is still intact, the unfolding of helix α1 at the N-terminus, 
which is comprised of negatively charged amino acids, D(155), E(157), and  D(158) may 
enhance entry into the vestibule and thread through the pore.  Even though the unfolded bPrP 
can readily translocate the pore, the addition of antibody M2188 which binds the protein 
reduced the number of events with no clear translocations peak (see Figure 3.27d).  In this case, 
as the location of the epitope for M2188 is at the unstructured N-terminus, it is not affected by 
unfolding and would still be accessible for binding.   
          On the other hand, the addition of antibody SN6Ab, which does not bind bPrP, increased 
the translocation events by 46% (see Figure 3.27h).  This effect of SN6Ab could be due to weak 
interactions between antibody and the epitope sequence VYYRP, which is buried in bPrP 
(without Gdn-HCl) but may be available due to partial unfolding.  The unfolded protein may 
then interact with the antibody which serves as a chaperone that brings molecules to the pore, 
and then break away (Figure 4.3).  We have seen elsewhere that the binding of Fab to 
poly(dT)45 increased the frequency of translocation events which suggests that the rigid form of 
the complex  enhances translocation (Ying et al., 2010).   
          In conclusion, we have demonstrated that complex formation between antibodies and 
prion peptides and proteins can be detected by nanopore analysis.  In principle, a nanopore can 
detect a single molecule; thus, this work represents the first step towards the development of a 
prion detector.  The nanopore will provide the sensitivity and antibodies will provide the 
specificity to distinguish between PrP
C
 and PrP
Sc
. 
 
4.7   Analysis of signal prion peptide and protein interactions  
            These experiments were designed to study signal prion peptides binding to bPrP that 
may cause conformational changes, leading to changes in events parameters.  The addition of 
signal prion peptides, PrP(1-24) and PrP(243-264) to bPrP  changed the event parameters of the 
complex as compared to the sum of the peptide and protein alone.  PrP(1-24) reduced the 
number of type-II events, suggesting that complex formation reduces the number of molecular 
species.  The N-terminus signal prion peptides have potent antiprion effects.  bPrP(1-30) 
significantly reduced PrP
Sc 
levels in prion infected mouse neuronal hypothalamic cells but had  
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Figure 4.3 Schematic of the partially unfolded bPrP in the presence of antibodies, M2188 and 
SN6Ab tested on α-hemolysin. 
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no effect on PrP
C
  levels in noninfected cells (Lofgren et al., 2008).  Surprisingly, this may be a 
new mechanism by which the hydrophobic sequence in PrP(1-24) interacts with PrP
C
.  
Similarly, the addition of PrP(243-264) changed the translocation blockade current and reduced 
the number of bumping events, as compared to the sum of the peptide and protein alone.  This 
is a new finding as no group has reported work on the C-terminal signal peptide.  These signal 
peptides may be very important for the correct folding of native PrP
C
.  Furthermore, the two 
proteolytic cleavages may be important in the generation of soluble and membrane bound 
proteins (Harris et al., 1993; Heller et al., 2003; Orsi and Sitia, 2007).  The interaction of 
PrP(106-126), which is known to cause in vitro fibrillogenicity and toxicity to neurons,  
reduced the number of translocation events (Jeong et al., 2010).  PrP(106-126) binds the plasma 
membrane and initiates aggregation of PrP
C 
(Gu et al., 2002).  The event profile of a control 
peptide changed very little when compared to the above mentioned peptide profiles.   
            These results suggest that the N-and C-terminal signal prion peptides interact with prion 
proteins and change the conformation of the complex which is readily detected by the change in 
event parameters.  Therefore these findings relate to a new mechanism by which these signal 
peptides interact with prion protein (Figure 4.4).  These observations also suggest that the N- 
and C-terminal signal peptides may be useful as therapeutic tools to reduce the pool of available 
PrP
C
 which serves as a template for the conversion of PrP
C → PrPSc (Aguzzi and Calella, 2009). 
 
4.8    Analysis of prion protein aggregation 
 
             The final set of experiments was designed to study the possibility of fibril formation of 
the full length bovine prion protein at low concentrations of Gdn-HCl, so as to monitor the 
folding intermediates.  When bPrP(25-242) was pre-treated with 0.86 M Gdn-HCl at pH 7.5, 
after 68 hours, aggregation was not possible.  This may be due to the low concentration of Gdn-
HCl.  In vitro conversion of the full length recombinant prion protein is possible under neutral 
or slightly acidic pH (between 5.0 to 7.5) with Gdn-HCl (up to 2 M) or urea (up to 4 M) 
(Breydo et al., 2008).  However, it has been reported that in vitro conversion of the N-terminal 
truncated human PrP(90-231) was possible using 1 M or 2 M Gdn-HCl (Aperti et al., 2005).  
Recently, 3 M urea was used in an unseeded method to convert mouse PrP(89-230) into a 
protease-sensitive synthetic prion (Colby et al., 2010).   
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Figure 4.4 Schematic of the interactions between PrP(1-24) and bPrP tested on α-hemolysin.  
When PrP(1-24) interacts with bPrP a change in conformation occurs, which reduces the 
number of events.   
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           These results suggests that the protein unfolds between the first 0-3 hours of the cycle 
and then starts to convert into a different conformation which gives similar event parameters as 
that of bPrP (Figure 4.5).  The conformational conversion of PrP
C → PrPSc is an important 
biochemical pathway that is not well understood as yet.  A study on the rates of 
hydrogen/deuterium exchange demonstrates that the most likely route for the conversion of 
PrP
C → PrPSc is through a highly unfolded state rather than through a highly organized folding 
intermediate (Hosszu et al., 1999).  These findings suggest that nanopores can be used to 
monitor conformational changes that occur in proteins in the presence of a denaturant.  These 
results further suggest that higher concentrations of Gdn-HCl should be used for the 
aggregation of the full length protein.  However, these concentrations may affect the stability of 
the α-hemolysin pore.  Finally, if aggregation is successful, a nanopore should detect no events 
because the aggregated complex will be too large to cause type-I or type-II events. 
 
4.9 Future directions 
                            Using nanopore analysis, the experiments presented in this thesis show that Cu(II) 
induces a conformational change in full-length bPrP(25-242) (see Figure3.14b).  Briefly, native 
PrP
C
 can unfold and translocate through an α-hemolysin nanopore (see Figure 3.14a) but in the 
presence of Cu(II) a conformational change occurs which prevents translocation.  Similarly, the 
addition of the N-terminal signal prion peptide PrP(1-24) also prevents translocation 
presumably because the complex cannot unfold (see Figure 3.28c).  The ability of this 
technique to detect minor conformational differences within the protein and to assign distinctive 
signature spectra may offer a more sensitive and high-throughput methodology for describing 
conformational isomers of PrP.   
         The experiments presented in this thesis extended this technique with the use of prion-
specific antibodies; the PrP/antibody complex is too large to translocate whereas unbound 
molecules are uneffected (Madampage et al., 2010).  Additionally, the development of 
antibodies to different epitopes of PrP that enable conformational discrimination of PrP
Sc
 and 
PrP
C
 would be useful.  These experiments provide proof of principle that conformational 
changes and PrP
C
/antibody interactions are easily detected by nanopore analysis.  The technique 
has the following advantages: speed - the results are available in 2-3 hours or less: specificity -
provided by PrP
C
 or PrP
Sc 
specific antibodies; and sensitivity - the pore can theoretically detect 
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             Figure 4.5 Schematic of the unfolding of bPrP pre-treated with 0.86 M Gdn-HCl.   
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a single molecule or complex.  This type of test would be extremely beneficial for the meat 
industry as well as in the diagnosis of human prion diseases.  Although the incidence of prion 
disease in humans is low, early detection would help patients seek medical advice.  At present, 
PMCA, a technique for accelerated prion replication, is a useful tool for prion diagnostic assays 
(Saborio et al., 2001).  A detection limit of 6-12 pg (0.2-0.4x10
-15
 mol) of PrP
Sc 
after a 10000 
fold dilution and 10 cycles has been successfully described (Telling, 2001).   
            Future work will include the development of a panel of prion proteins from different 
species which will “naturally” (have a preference to) misfold into different conformations based 
on the concept of the species barrier.  Different conformations will expose different epitopes 
which can then be detected by specific antibodies (e.g VYYR is buried in PrP
Sc
).  Furthermore, 
PrP
C
 can be induced to convert to PrP
Sc
 and because of low concentrations; the altered 
conformation can be detected by nanopore analysis before PrP
Sc
 aggregates. 
            As mentioned earlier, an important finding of this work was the interactions between 
signal prion peptides and proteins.  Further studies on the N- and C-terminal signal peptides 
may be useful as a therapeutic tool to reduce the pool of available PrP
C
 which serves as a 
template for the conversion of PrP
C → PrPSc (Aguzzi and Calella, 2009).  Furthermore, 
nanopore analysis of drugs or peptides that bind to PrP which may cause conformational 
changes, leading to the prevention of conversion to PrP
Sc
 is very important. 
              Finally, the analytical method used for nanopore analysis in this thesis can be applied 
to the detection of other protein misfolding diseases such as Alzheimer’s and Parkinsons.  
Similarly, if the protein is bound to an antibody, then translocation will be inhibited so that 
antibody discrimination of the native and misfolded conformations can be analyzed.  In the long 
term, it is envisaged that these experiments will lead to the construction of a rapid and sensitive 
prion detector to detect PrP
Sc
 while also providing information on specific strains.  The major 
additional requirement will be the production of solid-state nanopores with specific antibodies 
lining the pore. 
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